molecule_chembl_id,target_chembl_id,target_pref_name,standard_type,standard_relation,standard_value,standard_units,assay_chembl_id,assay_type,assay_description,document_chembl_id,readout,smiles
CHEMBL11425,CHEMBL2056,Dopamine D1 receptor,IC50,=,3311.31,nM,CHEMBL668641,B,"Binding affinity towards Dopamine receptor D1 by displacement of [3H]SCH-23,390",CHEMBL1129704,IC50,O=C1CC2(CCCC2)CC(=O)N1CCCCNCC1COc2ccccc2C1
CHEMBL417608,CHEMBL2056,Dopamine D1 receptor,IC50,=,13803.84,nM,CHEMBL668641,B,"Binding affinity towards Dopamine receptor D1 by displacement of [3H]SCH-23,390",CHEMBL1129704,IC50,CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)CC1COc2cccc(OC)c2C1
CHEMBL416523,CHEMBL2056,Dopamine D1 receptor,IC50,=,831.76,nM,CHEMBL668641,B,"Binding affinity towards Dopamine receptor D1 by displacement of [3H]SCH-23,390",CHEMBL1129704,IC50,COc1cccc2c1CC(CNCCCCN1C(=O)CC3(CCCC3)CC1=O)CO2
CHEMBL11262,CHEMBL2056,Dopamine D1 receptor,IC50,=,34673.69,nM,CHEMBL668640,B,Compound was evaluated for the binding affinity towards Dopamine receptor D1 by displacement of [3H]raclopride.,CHEMBL1129704,IC50,CCCN(CCC)CC1COc2cccc(OC)c2C1
CHEMBL11592,CHEMBL2056,Dopamine D1 receptor,IC50,=,39810.72,nM,CHEMBL857157,B,Compound was evaluated for the Dopamine receptor D1 by displacement of [3H]SCH-23390.,CHEMBL1129704,IC50,CCCN(CCCCN1C(=O)CC2(CCCC2)CC1=O)C1COc2cccc(OC)c2C1
CHEMBL116463,CHEMBL2056,Dopamine D1 receptor,IC50,=,376.0,nM,CHEMBL674242,B,Inhibition of human dopamine receptor D1,CHEMBL1134625,IC50,N#Cc1ccc(CCOC(=O)NC2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1
CHEMBL326263,CHEMBL2056,Dopamine D1 receptor,IC50,=,1120.0,nM,CHEMBL674242,B,Inhibition of human dopamine receptor D1,CHEMBL1134625,IC50,N#Cc1ccc(CCOC(=O)N2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1
CHEMBL113956,CHEMBL2056,Dopamine D1 receptor,IC50,=,967.0,nM,CHEMBL674242,B,Inhibition of human dopamine receptor D1,CHEMBL1134625,IC50,CCOc1ccc(CCNC(=O)N2CCN(CCCC(c3ccc(F)cc3)c3ccc(F)cc3)CC2)cc1
CHEMBL117537,CHEMBL2056,Dopamine D1 receptor,IC50,=,2750.0,nM,CHEMBL674242,B,Inhibition of human dopamine receptor D1,CHEMBL1134625,IC50,O=C(CCCc1ccccc1)N1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL114280,CHEMBL2056,Dopamine D1 receptor,IC50,=,2500.0,nM,CHEMBL674242,B,Inhibition of human dopamine receptor D1,CHEMBL1134625,IC50,Oc1nc2ccccc2n1CCCNCc1cc2c(cc1Cl)OCO2
CHEMBL114484,CHEMBL2056,Dopamine D1 receptor,IC50,=,2740.0,nM,CHEMBL674242,B,Inhibition of human dopamine receptor D1,CHEMBL1134625,IC50,Cc1ccc(CN2CCC(n3c(O)nc4ccccc43)CC2)c(Cl)c1
CHEMBL115444,CHEMBL2056,Dopamine D1 receptor,IC50,=,7580.0,nM,CHEMBL674242,B,Inhibition of human dopamine receptor D1,CHEMBL1134625,IC50,O=C(OCc1cc2c(cc1Cl)OCO2)N1CCC(n2c(O)nc3ccccc32)CC1
CHEMBL194837,CHEMBL2056,Dopamine D1 receptor,IC50,=,7.5,nM,CHEMBL881881,B,Inhibitory concentration against dopamine receptor D1,CHEMBL1140405,IC50,Cc1cc(OCCN(C)C)nc2ccc(NC(=O)COc3ccc(Cl)cc3Cl)cc12
CHEMBL189118,CHEMBL2056,Dopamine D1 receptor,IC50,=,900.0,nM,CHEMBL881881,B,Inhibitory concentration against dopamine receptor D1,CHEMBL1140405,IC50,Cc1cc(N(C)CCN(C)C)nc2ccc(NC(=O)/C=C/c3ccc(OC(F)(F)F)cc3)cc12
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,IC50,=,0.66,nM,CHEMBL881983,B,Percent inhibition against Dopamine receptor D1 at 1 uM,CHEMBL1140374,IC50,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL1729,CHEMBL2056,Dopamine D1 receptor,IC50,=,1700.0,nM,CHEMBL858802,B,Binding affinity to dopamine receptor D1,CHEMBL1149398,IC50,COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC
CHEMBL250699,CHEMBL2056,Dopamine D1 receptor,IC50,=,7000.0,nM,CHEMBL928139,B,Displacement of [3H]SCH-23390 from dopamine D1 receptor,CHEMBL1142222,IC50,COc1cc(NC(=O)c2ccc(-c3ccc(Cl)cc3)o2)cc(OC)c1
CHEMBL461571,CHEMBL2056,Dopamine D1 receptor,IC50,=,1530.0,nM,CHEMBL980769,B,Displacement of radioligand from dopamine D1 receptor,CHEMBL1139415,IC50,Cc1c(C(=O)c2ccc(Cl)cc2)c2ccc(OC(F)(F)F)cc2n1Cc1cccc(O[C@H](C)C(=O)O)c1
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,IC50,=,0.96,nM,CHEMBL953136,B,Displacement of radiolabeled SCH 23390 from human dopamine D1 receptor,CHEMBL1140203,IC50,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,IC50,=,0.74,nM,CHEMBL982013,B,Inhibition of human dopamine D1 receptor,CHEMBL1155111,IC50,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL584554,CHEMBL2056,Dopamine D1 receptor,IC50,=,4900.0,nM,CHEMBL1046707,B,Inhibition of dopamine D1 receptor,CHEMBL1154177,IC50,CCN(CC)C(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C(=O)Nc2ccccc2)C1
CHEMBL1275709,CHEMBL2056,Dopamine D1 receptor,IC50,=,7200.0,nM,CHEMBL1285526,B,Binding affinity to dopamine D1,CHEMBL1275372,IC50,CN(C)[C@@H]1CC[C@H](c2c[nH]c3ccc(C#N)cc23)C1
CHEMBL1275791,CHEMBL2056,Dopamine D1 receptor,IC50,=,25000.0,nM,CHEMBL1285526,B,Binding affinity to dopamine D1,CHEMBL1275372,IC50,CN(C)[C@H]1CC[C@@H](c2c[nH]c3ccc(F)cc23)C1
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,IC50,=,0.82,nM,CHEMBL1663582,B,Inhibition of human dopamine D1 receptor,CHEMBL1649335,IC50,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL270299,CHEMBL2056,Dopamine D1 receptor,IC50,=,4412.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1
CHEMBL493,CHEMBL2056,Dopamine D1 receptor,IC50,=,2889.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL508112,CHEMBL2056,Dopamine D1 receptor,IC50,=,1189.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,c1ccc2sc(SSc3nc4ccccc4s3)nc2c1
CHEMBL296419,CHEMBL2056,Dopamine D1 receptor,IC50,=,4010.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
CHEMBL1113,CHEMBL2056,Dopamine D1 receptor,IC50,=,392.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
CHEMBL1381098,CHEMBL2056,Dopamine D1 receptor,IC50,=,27576.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,S=C=Nc1cccc2ccccc12
CHEMBL3215298,CHEMBL2056,Dopamine D1 receptor,IC50,=,6119.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O
CHEMBL633,CHEMBL2056,Dopamine D1 receptor,IC50,=,9142.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1
CHEMBL1403281,CHEMBL2056,Dopamine D1 receptor,IC50,=,403.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL629,CHEMBL2056,Dopamine D1 receptor,IC50,=,355.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN(C)CCC=C1c2ccccc2CCc2ccccc21
CHEMBL1289,CHEMBL2056,Dopamine D1 receptor,IC50,=,563.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,Clc1cc(Cl)c(OCC#CI)cc1Cl
CHEMBL305660,CHEMBL2056,Dopamine D1 receptor,IC50,=,1192.9,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1
CHEMBL64894,CHEMBL2056,Dopamine D1 receptor,IC50,=,3102.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]
CHEMBL808,CHEMBL2056,Dopamine D1 receptor,IC50,=,9225.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
CHEMBL1385840,CHEMBL2056,Dopamine D1 receptor,IC50,=,294.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL30008,CHEMBL2056,Dopamine D1 receptor,IC50,=,3874.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1
CHEMBL119443,CHEMBL2056,Dopamine D1 receptor,IC50,=,5901.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL726,CHEMBL2056,Dopamine D1 receptor,IC50,=,23.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
CHEMBL442,CHEMBL2056,Dopamine D1 receptor,IC50,=,1728.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL1108,CHEMBL2056,Dopamine D1 receptor,IC50,=,1092.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL2056,Dopamine D1 receptor,IC50,=,110.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1626,CHEMBL2056,Dopamine D1 receptor,IC50,=,1535.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
CHEMBL7002,CHEMBL2056,Dopamine D1 receptor,IC50,=,19785.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1
CHEMBL1628227,CHEMBL2056,Dopamine D1 receptor,IC50,=,688.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN(C)CCC=C1c2ccccc2COc2ccccc21
CHEMBL1255837,CHEMBL2056,Dopamine D1 receptor,IC50,=,1179.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O
CHEMBL118,CHEMBL2056,Dopamine D1 receptor,IC50,=,27994.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1
CHEMBL964,CHEMBL2056,Dopamine D1 receptor,IC50,=,2158.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CCN(CC)C(=S)SSC(=S)N(CC)CC
CHEMBL104,CHEMBL2056,Dopamine D1 receptor,IC50,=,9017.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1
CHEMBL1732,CHEMBL2056,Dopamine D1 receptor,IC50,=,2395.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL411,CHEMBL2056,Dopamine D1 receptor,IC50,=,7763.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,IC50,=,107.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL71,CHEMBL2056,Dopamine D1 receptor,IC50,=,225.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL415,CHEMBL2056,Dopamine D1 receptor,IC50,=,1113.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
CHEMBL516,CHEMBL2056,Dopamine D1 receptor,IC50,=,158.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
CHEMBL1479,CHEMBL2056,Dopamine D1 receptor,IC50,=,20449.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
CHEMBL723,CHEMBL2056,Dopamine D1 receptor,IC50,=,1498.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
CHEMBL564,CHEMBL2056,Dopamine D1 receptor,IC50,=,2464.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN(C)CCCN1c2ccccc2Sc2ccccc21
CHEMBL643,CHEMBL2056,Dopamine D1 receptor,IC50,=,2744.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC(CN1c2ccccc2Sc2ccccc21)N(C)C
CHEMBL531,CHEMBL2056,Dopamine D1 receptor,IC50,=,679.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL1909072,CHEMBL2056,Dopamine D1 receptor,IC50,=,32.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL715,CHEMBL2056,Dopamine D1 receptor,IC50,=,72.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL1262,CHEMBL2056,Dopamine D1 receptor,IC50,=,4136.1,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL445,CHEMBL2056,Dopamine D1 receptor,IC50,=,539.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CNCCC=C1c2ccccc2CCc2ccccc21
CHEMBL716,CHEMBL2056,Dopamine D1 receptor,IC50,=,429.3,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL584,CHEMBL2056,Dopamine D1 receptor,IC50,=,12935.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C
CHEMBL728,CHEMBL2056,Dopamine D1 receptor,IC50,=,155.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL1065,CHEMBL2056,Dopamine D1 receptor,IC50,=,943.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1
CHEMBL534,CHEMBL2056,Dopamine D1 receptor,IC50,=,872.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1
CHEMBL21731,CHEMBL2056,Dopamine D1 receptor,IC50,=,373.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CNCCCC12CCC(c3ccccc31)c1ccccc12
CHEMBL6437,CHEMBL2056,Dopamine D1 receptor,IC50,=,543.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN1CCN2c3ccccc3Cc3ccccc3C2C1
CHEMBL91,CHEMBL2056,Dopamine D1 receptor,IC50,=,6247.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL19215,CHEMBL2056,Dopamine D1 receptor,IC50,=,74.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
CHEMBL1200633,CHEMBL2056,Dopamine D1 receptor,IC50,=,4514.8,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O
CHEMBL157138,CHEMBL2056,Dopamine D1 receptor,IC50,=,173.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL1909065,CHEMBL2056,Dopamine D1 receptor,IC50,=,2908.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C
CHEMBL1201356,CHEMBL2056,Dopamine D1 receptor,IC50,=,1077.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL479,CHEMBL2056,Dopamine D1 receptor,IC50,=,194.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
CHEMBL83,CHEMBL2056,Dopamine D1 receptor,IC50,=,8502.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
CHEMBL18797,CHEMBL2056,Dopamine D1 receptor,IC50,=,27822.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1
CHEMBL85,CHEMBL2056,Dopamine D1 receptor,IC50,=,479.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL1306,CHEMBL2056,Dopamine D1 receptor,IC50,=,25480.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
CHEMBL17157,CHEMBL2056,Dopamine D1 receptor,IC50,=,2673.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1
CHEMBL81,CHEMBL2056,Dopamine D1 receptor,IC50,=,3864.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,IC50,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12
CHEMBL2047561,CHEMBL2056,Dopamine D1 receptor,IC50,=,9650.0,nM,CHEMBL2050797,B,Displacement of [3H]SCH23390 from dopamine D1 receptor,CHEMBL2046296,IC50,OC(CCN1CC=C(Cc2ccccc2)CC1)c1cc2ccccc2s1
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,IC50,=,2.52,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL487387,CHEMBL2056,Dopamine D1 receptor,IC50,=,12.29,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL2057457,CHEMBL2056,Dopamine D1 receptor,IC50,=,56.37,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2057456,CHEMBL2056,Dopamine D1 receptor,IC50,=,30.7,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(cc1O)[C@@H]1Cc3c(CO)c(OC)cc(OC)c3CN1CC2
CHEMBL2057455,CHEMBL2056,Dopamine D1 receptor,IC50,=,4.86,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL2057454,CHEMBL2056,Dopamine D1 receptor,IC50,=,98.13,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(O)c(OC)c3[C@@H]1C2
CHEMBL2057453,CHEMBL2056,Dopamine D1 receptor,IC50,=,68.89,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1ccc2c(c1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL2057452,CHEMBL2056,Dopamine D1 receptor,IC50,=,2917.2,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(cc1OC)C1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2057451,CHEMBL2056,Dopamine D1 receptor,IC50,=,684.0,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2057446,CHEMBL2056,Dopamine D1 receptor,IC50,=,45.45,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(OC)c(OC)c3[C@@H]1C2
CHEMBL2057445,CHEMBL2056,Dopamine D1 receptor,IC50,=,14.29,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)cc(OC)c3[C@@H]1C2
CHEMBL2057443,CHEMBL2056,Dopamine D1 receptor,IC50,=,141.58,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(c(OC)c1)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL2057442,CHEMBL2056,Dopamine D1 receptor,IC50,=,113.81,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(cc1OC)[C@@H]1Cc3c(CO)c(OC)cc(OC)c3CN1CC2
CHEMBL2057441,CHEMBL2056,Dopamine D1 receptor,IC50,=,188.96,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(OC)cc3[C@@H]1C2
CHEMBL2057438,CHEMBL2056,Dopamine D1 receptor,IC50,=,323.79,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,IC50,COc1cc(OC)c2c(c1CO)C[C@H]1c3cc4c(cc3CCN1C2)OCO4
CHEMBL1814790,CHEMBL2056,Dopamine D1 receptor,IC50,=,0.22,nM,CHEMBL2395589,B,Binding affinity to human dopamine D1 receptor by radioligand displacement assay,CHEMBL2390917,IC50,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1.O=C(O)/C=C\C(=O)O
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,IC50,=,1.4,nM,CHEMBL2395275,B,Displacement of [3H]SCH23390 from human recombinant dopamine D1 receptor expressed in CHO cells after 2 hrs,CHEMBL2390918,IC50,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL1814790,CHEMBL2056,Dopamine D1 receptor,IC50,=,0.27,nM,CHEMBL2395700,B,Binding affinity to human dopamine D1 receptor by radioligand displacement assay,CHEMBL2390830,IC50,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1.O=C(O)/C=C\C(=O)O
CHEMBL3408841,CHEMBL2056,Dopamine D1 receptor,IC50,=,6000.0,nM,CHEMBL3412829,B,Inhibition of dopamine D1 receptor (unknown origin),CHEMBL3407472,IC50,CCOc1nc(NC(=O)C(C)(C)NC(=O)c2ccc3c(C4CCCC4)c(-c4ccc(F)cn4)n(C)c3c2)ccc1/C=C/C(=O)O
CHEMBL13668,CHEMBL2056,Dopamine D1 receptor,IC50,=,0.31,nM,CHEMBL3779712,B,Displacement of [3H]SCH23390 from human recombinant Dopamine D1 receptor expressed in CHO cells,CHEMBL3774372,IC50,CN1CCc2cc(Cl)c(O)cc2C(c2ccccc2)C1
CHEMBL13668,CHEMBL2056,Dopamine D1 receptor,IC50,=,0.31,nM,CHEMBL3876353,B,Displacement of [3H]SCH 23390 from human recombinant dopamine D1 receptor expressed in CHO cells measured after 60 mins by scintillation counting method,CHEMBL3875185,IC50,CN1CCc2cc(Cl)c(O)cc2C(c2ccccc2)C1
CHEMBL3927835,CHEMBL2056,Dopamine D1 receptor,IC50,=,370.3,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1OC)C1Cc3c(OC)ccc(OC)c3CN1CC2
CHEMBL3955446,CHEMBL2056,Dopamine D1 receptor,IC50,=,648.23,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1OC)[C@@H]1Cc3cc(OC)c(OC)c(OC)c3CN1CC2
CHEMBL3896617,CHEMBL2056,Dopamine D1 receptor,IC50,=,2032.5,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1ccc2c(c1)CCN1Cc3c(cc(OC)c(OC)c3OC)CC21
CHEMBL3982119,CHEMBL2056,Dopamine D1 receptor,IC50,=,101.39,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1OC)[C@@H]1Cc3c(OC)ccc(OC)c3CN1CC2
CHEMBL3903297,CHEMBL2056,Dopamine D1 receptor,IC50,=,299.52,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL3897805,CHEMBL2056,Dopamine D1 receptor,IC50,=,47.9,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4
CHEMBL3921127,CHEMBL2056,Dopamine D1 receptor,IC50,=,763.07,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(c(OC)c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL2057451,CHEMBL2056,Dopamine D1 receptor,IC50,=,684.01,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2057452,CHEMBL2056,Dopamine D1 receptor,IC50,=,2917.2,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1OC)C1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL3912178,CHEMBL2056,Dopamine D1 receptor,IC50,=,1008.16,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1OC)C1Cc3cc(O)c(O)cc3CN1CC2
CHEMBL3906676,CHEMBL2056,Dopamine D1 receptor,IC50,=,1499.85,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1OC)CN1CCc3cc(O)c(O)cc3C1C2
CHEMBL3912606,CHEMBL2056,Dopamine D1 receptor,IC50,=,1057.1,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(c(OC)c1OC)CN1CCc3cc(O)c(O)cc3C1C2
CHEMBL2334893,CHEMBL2056,Dopamine D1 receptor,IC50,=,8.19,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1O)[C@@H]1Cc3cc4c(cc3CN1CC2)OCO4
CHEMBL3913343,CHEMBL2056,Dopamine D1 receptor,IC50,=,7.22,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1O)[C@@H]1Cc3c(OC)ccc(OC)c3CN1CC2
CHEMBL2057457,CHEMBL2056,Dopamine D1 receptor,IC50,=,56.37,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL3986624,CHEMBL2056,Dopamine D1 receptor,IC50,=,49.23,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCCO4
CHEMBL3896731,CHEMBL2056,Dopamine D1 receptor,IC50,=,416.4,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,Cc1ccc(C)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4
CHEMBL3897805,CHEMBL2056,Dopamine D1 receptor,IC50,=,483.67,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4
CHEMBL3917753,CHEMBL2056,Dopamine D1 receptor,IC50,=,13.27,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1ccc(OC)c2c1C[C@H]1c3cc(O)c(O)cc3CCN1C2
CHEMBL2334881,CHEMBL2056,Dopamine D1 receptor,IC50,=,14.65,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCCO4
CHEMBL2057441,CHEMBL2056,Dopamine D1 receptor,IC50,=,113.81,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(OC)cc3[C@@H]1C2
CHEMBL2057438,CHEMBL2056,Dopamine D1 receptor,IC50,=,323.79,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc(OC)c2c(c1CO)C[C@H]1c3cc4c(cc3CCN1C2)OCO4
CHEMBL2057443,CHEMBL2056,Dopamine D1 receptor,IC50,=,141.58,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(c(OC)c1)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL2057455,CHEMBL2056,Dopamine D1 receptor,IC50,=,9.85,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL13668,CHEMBL2056,Dopamine D1 receptor,IC50,=,2.52,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,IC50,CN1CCc2cc(Cl)c(O)cc2C(c2ccccc2)C1
CHEMBL3913343,CHEMBL2056,Dopamine D1 receptor,IC50,=,1900.0,nM,CHEMBL3888604,B,"[35S]GTPγS Binding Assay: For detecting the agonism action of the compounds, the [35S]GTPγS binding assay was performed at 30° C. for 40 mins in reaction buffer containing 50 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EDTA, 100 mM NaCl and 1 mM (DL)-dithiothreitol (DTT). The assay mixture (200 μL) contained 30 μg of membraneprotein, 0.1 nM [35S]GTPγS, and 40 μM guanosine triphosphate (GDP) with various concentration of the compound. The D1 receptor agonist SKF38393 and sntagonist SCH23390 were used for reference. Non specific binding was measured in the presence of 100 μM 50-guanylimidodiphosphate (Gpp(NH)p). The reaction was terminated by adding 3 mL of ice-cold washing buffer (50 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EDTA, and 100 mM NaCl) and was rapidly filtered with GF/C glass fiber filters (Whatman) and rinsed for three times.",CHEMBL3886775,IC50,COc1cc2c(cc1O)[C@@H]1Cc3c(OC)ccc(OC)c3CN1CC2
CHEMBL2057455,CHEMBL2056,Dopamine D1 receptor,IC50,=,1400.0,nM,CHEMBL3888604,B,"[35S]GTPγS Binding Assay: For detecting the agonism action of the compounds, the [35S]GTPγS binding assay was performed at 30° C. for 40 mins in reaction buffer containing 50 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EDTA, 100 mM NaCl and 1 mM (DL)-dithiothreitol (DTT). The assay mixture (200 μL) contained 30 μg of membraneprotein, 0.1 nM [35S]GTPγS, and 40 μM guanosine triphosphate (GDP) with various concentration of the compound. The D1 receptor agonist SKF38393 and sntagonist SCH23390 were used for reference. Non specific binding was measured in the presence of 100 μM 50-guanylimidodiphosphate (Gpp(NH)p). The reaction was terminated by adding 3 mL of ice-cold washing buffer (50 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EDTA, and 100 mM NaCl) and was rapidly filtered with GF/C glass fiber filters (Whatman) and rinsed for three times.",CHEMBL3886775,IC50,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL13668,CHEMBL2056,Dopamine D1 receptor,IC50,=,740.0,nM,CHEMBL3888604,B,"[35S]GTPγS Binding Assay: For detecting the agonism action of the compounds, the [35S]GTPγS binding assay was performed at 30° C. for 40 mins in reaction buffer containing 50 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EDTA, 100 mM NaCl and 1 mM (DL)-dithiothreitol (DTT). The assay mixture (200 μL) contained 30 μg of membraneprotein, 0.1 nM [35S]GTPγS, and 40 μM guanosine triphosphate (GDP) with various concentration of the compound. The D1 receptor agonist SKF38393 and sntagonist SCH23390 were used for reference. Non specific binding was measured in the presence of 100 μM 50-guanylimidodiphosphate (Gpp(NH)p). The reaction was terminated by adding 3 mL of ice-cold washing buffer (50 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EDTA, and 100 mM NaCl) and was rapidly filtered with GF/C glass fiber filters (Whatman) and rinsed for three times.",CHEMBL3886775,IC50,CN1CCc2cc(Cl)c(O)cc2C(c2ccccc2)C1
CHEMBL4128926,CHEMBL2056,Dopamine D1 receptor,IC50,=,0.21,nM,CHEMBL4121475,B,Displacement of [3H]-SCH 23390 from human recombinant dopamine D1 receptor after 60 mins by scintillation counting analysis,CHEMBL4118122,IC50,CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12
CHEMBL4171368,CHEMBL2056,Dopamine D1 receptor,IC50,=,5750.0,nM,CHEMBL4137529,B,Inhibition of dopamine D1 receptor (unknown origin),CHEMBL4130635,IC50,CCC[C@@H](CCO)Nc1nc(N)nc2cc(OC)ccc12
CHEMBL4467483,CHEMBL2056,Dopamine D1 receptor,IC50,=,4073.8,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3
CHEMBL4564103,CHEMBL2056,Dopamine D1 receptor,IC50,=,100.0,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3
CHEMBL4579687,CHEMBL2056,Dopamine D1 receptor,IC50,=,1479.11,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3
CHEMBL4513262,CHEMBL2056,Dopamine D1 receptor,IC50,=,251.19,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3
CHEMBL4439029,CHEMBL2056,Dopamine D1 receptor,IC50,=,1584.89,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,CCc1ccc2c3c1CCN(C)[C@@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL4442011,CHEMBL2056,Dopamine D1 receptor,IC50,=,1513.56,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,CCc1ccc2c3c1CCN(C)[C@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL4589737,CHEMBL2056,Dopamine D1 receptor,IC50,=,1412.54,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1ccc(C)c3c1[C@@H](C2)N(C)CC3
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,IC50,=,4.365,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL4467483,CHEMBL2056,Dopamine D1 receptor,IC50,=,4080.0,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@@H](C2)N(C)CC3
CHEMBL4564103,CHEMBL2056,Dopamine D1 receptor,IC50,=,110.7,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1c(Br)ccc3c1[C@H](C2)N(C)CC3
CHEMBL4579687,CHEMBL2056,Dopamine D1 receptor,IC50,=,815.7,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@@H](C2)N(C)CC3
CHEMBL4513262,CHEMBL2056,Dopamine D1 receptor,IC50,=,232.4,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1ccc(Br)c3c1[C@H](C2)N(C)CC3
CHEMBL4439029,CHEMBL2056,Dopamine D1 receptor,IC50,=,1603.0,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,CCc1ccc2c3c1CCN(C)[C@@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL4442011,CHEMBL2056,Dopamine D1 receptor,IC50,=,1522.0,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,CCc1ccc2c3c1CCN(C)[C@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL4589737,CHEMBL2056,Dopamine D1 receptor,IC50,=,1427.0,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,COc1ccc2c(c1OC)-c1ccc(C)c3c1[C@@H](C2)N(C)CC3
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,IC50,=,4.34,nM,CHEMBL4345336,B,Antagonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,IC50,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL304535,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.4,nM,CHEMBL668635,B,Binding affinity to displace [3H]- SCH 23390 against Dopamine receptor D1,CHEMBL1125095,KI,Cc1cccc([C@H]2CN(C)CCc3cc(Cl)c(O)cc32)c1
CHEMBL58422,CHEMBL2056,Dopamine D1 receptor,Ki,=,513.0,nM,CHEMBL668636,B,Binding affinity to displace [3H]-SCH- 23390 against Dopamine receptor D1,CHEMBL1125095,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H]2c3ccccc3CC[C@H]21
CHEMBL303012,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.6,nM,CHEMBL668635,B,Binding affinity to displace [3H]- SCH 23390 against Dopamine receptor D1,CHEMBL1125095,KI,Cc1ccc([C@H]2CN(C)CCc3cc(Cl)c(O)cc32)cc1
CHEMBL307790,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.0,nM,CHEMBL668635,B,Binding affinity to displace [3H]- SCH 23390 against Dopamine receptor D1,CHEMBL1125095,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3C[C@@H]21
CHEMBL56666,CHEMBL2056,Dopamine D1 receptor,Ki,=,531.0,nM,CHEMBL668636,B,Binding affinity to displace [3H]-SCH- 23390 against Dopamine receptor D1,CHEMBL1125095,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H]2c3ccccc3CC[C@@H]21
CHEMBL294012,CHEMBL2056,Dopamine D1 receptor,Ki,=,898.0,nM,CHEMBL668636,B,Binding affinity to displace [3H]-SCH- 23390 against Dopamine receptor D1,CHEMBL1125095,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@H]21
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.3,nM,CHEMBL668635,B,Binding affinity to displace [3H]- SCH 23390 against Dopamine receptor D1,CHEMBL1125095,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL444321,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.8,nM,CHEMBL668635,B,Binding affinity to displace [3H]- SCH 23390 against Dopamine receptor D1,CHEMBL1125095,KI,Cc1ccccc1[C@H]1CN(C)CCc2cc(Cl)c(O)cc21
CHEMBL298406,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.9,nM,CHEMBL668636,B,Binding affinity to displace [3H]-SCH- 23390 against Dopamine receptor D1,CHEMBL1125095,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21
CHEMBL59,CHEMBL2056,Dopamine D1 receptor,Ki,=,192.0,nM,CHEMBL668635,B,Binding affinity to displace [3H]- SCH 23390 against Dopamine receptor D1,CHEMBL1125095,KI,NCCc1ccc(O)c(O)c1
CHEMBL24077,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.1,nM,CHEMBL668633,B,Binding affinity against Dopamine receptor D1 in rat radioligand,CHEMBL1125095,KI,Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2
CHEMBL71600,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.0,nM,CHEMBL668636,B,Binding affinity to displace [3H]-SCH- 23390 against Dopamine receptor D1,CHEMBL1125095,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2cccc3ccoc23)C1
CHEMBL100454,CHEMBL2056,Dopamine D1 receptor,Ki,=,66.0,nM,CHEMBL674255,B,In vitro binding affinity of compound against dopamine neuronal Dopamine receptor D1,CHEMBL1150510,KI,CN1CCN(C2=Nc3ccccc3Nc3sc(CO)cc32)CC1
CHEMBL300647,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.3,nM,CHEMBL668634,B,Binding affinity determined in radioreceptor binding assay by using [3H]SCH-23390 radioligand against dopamine receptor D1,CHEMBL1125700,KI,CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Ki,=,24.0,nM,CHEMBL672089,B,Ability to inhibit [3H]-SCH- 23390 binding to Dopamine receptor D1 of canine striatal membranes,CHEMBL1125039,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL715,CHEMBL2056,Dopamine D1 receptor,Ki,=,119.0,nM,CHEMBL674255,B,In vitro binding affinity of compound against dopamine neuronal Dopamine receptor D1,CHEMBL1150510,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL300647,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.1,nM,CHEMBL668639,B,The compound was tested for binding affinity against Dopamine receptor D1 using SCH-23390 as radioligand,CHEMBL1125700,KI,CN(C)C1C=CC2(CC1)c1ccccc1C=Cc1ccc(Cl)cc12
CHEMBL1125,CHEMBL2056,Dopamine D1 receptor,Ki,=,203.0,nM,CHEMBL674255,B,In vitro binding affinity of compound against dopamine neuronal Dopamine receptor D1,CHEMBL1150510,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCNCC1
CHEMBL356597,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.0,nM,CHEMBL672089,B,Ability to inhibit [3H]-SCH- 23390 binding to Dopamine receptor D1 of canine striatal membranes,CHEMBL1125039,KI,CN1CCc2cc(I)c(O)cc2[C@@H](c2ccc(N=[N+]=[N-])cc2)C1
CHEMBL440512,CHEMBL2056,Dopamine D1 receptor,Ki,=,395.0,nM,CHEMBL674255,B,In vitro binding affinity of compound against dopamine neuronal Dopamine receptor D1,CHEMBL1150510,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CC[N+](C)([O-])CC1
CHEMBL45491,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.33,nM,CHEMBL668634,B,Binding affinity determined in radioreceptor binding assay by using [3H]SCH-23390 radioligand against dopamine receptor D1,CHEMBL1125700,KI,CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12
CHEMBL45491,CHEMBL2056,Dopamine D1 receptor,Ki,=,68.0,nM,CHEMBL668634,B,Binding affinity determined in radioreceptor binding assay by using [3H]SCH-23390 radioligand against dopamine receptor D1,CHEMBL1125700,KI,CN(C)C1C=CC2(CC1)c1ccccc1CCc1ccc(Cl)cc12
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.15,nM,CHEMBL672089,B,Ability to inhibit [3H]-SCH- 23390 binding to Dopamine receptor D1 of canine striatal membranes,CHEMBL1125039,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL293828,CHEMBL2056,Dopamine D1 receptor,Ki,=,177.83,nM,CHEMBL668642,B,Binding potency of compound for Dopamine receptor D1 by displacing [3H]SCH-23390 radioligand,CHEMBL1124647,KI,CCCN1CCc2cc(Cl)c(O)cc2[C@@H]1c1ccccc1
CHEMBL303993,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.607,nM,CHEMBL668642,B,Binding potency of compound for Dopamine receptor D1 by displacing [3H]SCH-23390 radioligand,CHEMBL1124647,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H]1c1ccccc1
CHEMBL65397,CHEMBL2056,Dopamine D1 receptor,Ki,=,141.25,nM,CHEMBL668642,B,Binding potency of compound for Dopamine receptor D1 by displacing [3H]SCH-23390 radioligand,CHEMBL1124647,KI,Oc1cc2c(cc1Cl)CCN[C@H]2c1ccccc1
CHEMBL293158,CHEMBL2056,Dopamine D1 receptor,Ki,=,446.68,nM,CHEMBL668642,B,Binding potency of compound for Dopamine receptor D1 by displacing [3H]SCH-23390 radioligand,CHEMBL1124647,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]1c1ccccc1
CHEMBL59603,CHEMBL2056,Dopamine D1 receptor,Ki,=,281.84,nM,CHEMBL668642,B,Binding potency of compound for Dopamine receptor D1 by displacing [3H]SCH-23390 radioligand,CHEMBL1124647,KI,Oc1cc2c(cc1Cl)CNC[C@H]2c1ccccc1
CHEMBL302393,CHEMBL2056,Dopamine D1 receptor,Ki,=,87.1,nM,CHEMBL668642,B,Binding potency of compound for Dopamine receptor D1 by displacing [3H]SCH-23390 radioligand,CHEMBL1124647,KI,CN1Cc2cc(Cl)c(O)cc2[C@H](c2ccccc2)C1
CHEMBL64117,CHEMBL2056,Dopamine D1 receptor,Ki,=,26.92,nM,CHEMBL668642,B,Binding potency of compound for Dopamine receptor D1 by displacing [3H]SCH-23390 radioligand,CHEMBL1124647,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H]1Cc1ccccc1
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.4266,nM,CHEMBL668642,B,Binding potency of compound for Dopamine receptor D1 by displacing [3H]SCH-23390 radioligand,CHEMBL1124647,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL708,CHEMBL2056,Dopamine D1 receptor,Ki,=,330.0,nM,CHEMBL674250,B,Binding affinity towards human Dopamine receptor D1,CHEMBL1149193,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL611801,CHEMBL2056,Dopamine D1 receptor,Ki,=,5400.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,CN(C)C1CCc2cc(O)c(O)cc2C1
CHEMBL34095,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,C=CCN1CCc2c(cc(O)c(O)c2Br)[C@@H](c2ccccc2)C1
CHEMBL715,CHEMBL2056,Dopamine D1 receptor,Ki,=,250.0,nM,CHEMBL674250,B,Binding affinity towards human Dopamine receptor D1,CHEMBL1149193,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL612083,CHEMBL2056,Dopamine D1 receptor,Ki,=,1200.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,CCCN(CCc1ccccc1)[C@H]1CCc2c(O)cccc2C1
CHEMBL716,CHEMBL2056,Dopamine D1 receptor,Ki,=,4240.0,nM,CHEMBL674250,B,Binding affinity towards human Dopamine receptor D1,CHEMBL1149193,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL25856,CHEMBL2056,Dopamine D1 receptor,Ki,=,1200.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2
CHEMBL531,CHEMBL2056,Dopamine D1 receptor,Ki,=,2020.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL59,CHEMBL2056,Dopamine D1 receptor,Ki,=,18200.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,NCCc1ccc(O)c(O)c1
CHEMBL225230,CHEMBL2056,Dopamine D1 receptor,Ki,=,1510.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL609151,CHEMBL2056,Dopamine D1 receptor,Ki,=,1350.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,CN1C[C@H](C(N)=O)C=C2c3cccc4[nH]c(Br)c(c34)C[C@H]21
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,540.0,nM,CHEMBL674250,B,Binding affinity towards human Dopamine receptor D1,CHEMBL1149193,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL85,CHEMBL2056,Dopamine D1 receptor,Ki,=,620.0,nM,CHEMBL674250,B,Binding affinity towards human Dopamine receptor D1,CHEMBL1149193,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL24077,CHEMBL2056,Dopamine D1 receptor,Ki,=,320.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2
CHEMBL145584,CHEMBL2056,Dopamine D1 receptor,Ki,=,48000.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,NCCc1cccc(O)c1
CHEMBL54,CHEMBL2056,Dopamine D1 receptor,Ki,=,270.0,nM,CHEMBL674250,B,Binding affinity towards human Dopamine receptor D1,CHEMBL1149193,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL285802,CHEMBL2056,Dopamine D1 receptor,Ki,=,84.0,nM,CHEMBL674250,B,Binding affinity towards human Dopamine receptor D1,CHEMBL1149193,KI,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21
CHEMBL317741,CHEMBL2056,Dopamine D1 receptor,Ki,=,20.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,C=CCN1CCc2c(cc(O)c(O)c2Cl)[C@@H](c2ccccc2)C1
CHEMBL11608,CHEMBL2056,Dopamine D1 receptor,Ki,=,390000.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,NCCc1ccc(O)cc1
CHEMBL1160787,CHEMBL2056,Dopamine D1 receptor,Ki,=,30.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,Oc1cc2c(c(Cl)c1O)CCNC[C@@H]2c1ccccc1
CHEMBL240773,CHEMBL2056,Dopamine D1 receptor,Ki,=,524810.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL12713,CHEMBL2056,Dopamine D1 receptor,Ki,=,210.0,nM,CHEMBL674250,B,Binding affinity towards human Dopamine receptor D1,CHEMBL1149193,KI,O=C1NCCN1CCN1CCC(c2cn(-c3ccc(F)cc3)c3ccc(Cl)cc23)CC1
CHEMBL157138,CHEMBL2056,Dopamine D1 receptor,Ki,=,77.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL588,CHEMBL2056,Dopamine D1 receptor,Ki,=,40.0,nM,CHEMBL674898,B,Affinity towards Dopamine receptor D1,CHEMBL1131163,KI,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1
CHEMBL321042,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.3,nM,CHEMBL674897,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CN1CCc2cc(Br)c(O)cc2C(c2ccc(N)cc2)C1
CHEMBL322760,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.3,nM,CHEMBL674897,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CN1CCc2cc(Br)c(O)cc2C(c2ccc(Nc3ccc([N+](=O)[O-])c4nonc34)cc2)C1
CHEMBL113196,CHEMBL2056,Dopamine D1 receptor,Ki,=,130.0,nM,CHEMBL674897,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(Nc2ccc([N+](=O)[O-])c3nonc23)cc1)[C@H]1CCc2c(O)cccc2C1
CHEMBL113527,CHEMBL2056,Dopamine D1 receptor,Ki,=,3700.0,nM,CHEMBL674897,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(Nc2ccc([N+](=O)[O-])c3nonc23)cc1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL320779,CHEMBL2056,Dopamine D1 receptor,Ki,=,24000.0,nM,CHEMBL674897,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(N/C(S)=N/c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)cc1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL1159663,CHEMBL2056,Dopamine D1 receptor,Ki,=,4900.0,nM,CHEMBL872877,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(C)cc1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL24077,CHEMBL2056,Dopamine D1 receptor,Ki,=,130.0,nM,CHEMBL872877,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2
CHEMBL2092940,CHEMBL2056,Dopamine D1 receptor,Ki,=,270.0,nM,CHEMBL872877,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(C)cc1)[C@H]1CCc2c(O)cccc2C1
CHEMBL321223,CHEMBL2056,Dopamine D1 receptor,Ki,=,16.0,nM,CHEMBL674897,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CN1CCc2cc(Br)c(O)cc2C(c2ccc(N/C(S)=N/c3ccc4c(c3)C(=O)OC43c4ccc(O)cc4Oc4cc(O)ccc43)cc2)C1
CHEMBL606939,CHEMBL2056,Dopamine D1 receptor,Ki,=,6500.0,nM,CHEMBL872877,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccccc1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL612083,CHEMBL2056,Dopamine D1 receptor,Ki,=,230.0,nM,CHEMBL872877,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccccc1)[C@H]1CCc2c(O)cccc2C1
CHEMBL267930,CHEMBL2056,Dopamine D1 receptor,Ki,=,323.0,nM,CHEMBL872877,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,O=C(CCCN1CCC2(CC1)C(=O)NCN2c1ccccc1)c1ccc(F)cc1
CHEMBL324017,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.3,nM,CHEMBL872877,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CN1CCc2cc(Br)c(O)cc2C(c2ccccc2)C1
CHEMBL111532,CHEMBL2056,Dopamine D1 receptor,Ki,=,710.0,nM,CHEMBL872877,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(N)cc1)C1CCc2c(O)cccc2C1
CHEMBL109897,CHEMBL2056,Dopamine D1 receptor,Ki,=,260.0,nM,CHEMBL674897,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(N/C(S)=N/c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)cc1)[C@H]1CCc2c(O)cccc2C1
CHEMBL109684,CHEMBL2056,Dopamine D1 receptor,Ki,=,804.0,nM,CHEMBL872877,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccccc1)C1CCc2c(O)cccc2C1
CHEMBL538023,CHEMBL2056,Dopamine D1 receptor,Ki,=,10000.0,nM,CHEMBL872877,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,Cl.O=C1OC2(c3ccc(O)cc3Oc3cc(O)ccc32)c2ccc(N/C(S)=N\c3ccc(C4CNCCc5cc(O)c(O)cc54)cc3)cc21
CHEMBL109787,CHEMBL2056,Dopamine D1 receptor,Ki,=,170.0,nM,CHEMBL674897,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(Nc2ccc([N+](=O)[O-])c3nonc23)cc1)C1CCc2c(O)cccc2C1
CHEMBL92649,CHEMBL2056,Dopamine D1 receptor,Ki,=,99.0,nM,CHEMBL674897,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,O=C(CCCN1CCC2(CC1)C(=O)N(CCc1ccc(Nc3ccc([N+](=O)[O-])c4nonc34)cc1)CN2c1ccccc1)c1ccc(F)cc1
CHEMBL320526,CHEMBL2056,Dopamine D1 receptor,Ki,=,340.0,nM,CHEMBL674897,B,Binding affinity against dopamine receptor D1 by using [3H]-SCH- 23390 as radioligand in caudate-putamen of monkey,CHEMBL1125791,KI,CCCN(CCc1ccc(N/C(S)=N/c2ccc3c(c2)C(=O)OC32c3ccc(O)cc3Oc3cc(O)ccc32)cc1)C1CCc2c(O)cccc2C1
CHEMBL139600,CHEMBL2056,Dopamine D1 receptor,Ki,=,1100.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL59725,CHEMBL2056,Dopamine D1 receptor,Ki,=,8800.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL25236,CHEMBL2056,Dopamine D1 receptor,Ki,=,760.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL143352,CHEMBL2056,Dopamine D1 receptor,Ki,=,2300.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccn3nccc23)CC1
CHEMBL139926,CHEMBL2056,Dopamine D1 receptor,Ki,=,2900.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL140968,CHEMBL2056,Dopamine D1 receptor,Ki,=,1400.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL141419,CHEMBL2056,Dopamine D1 receptor,Ki,=,380.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3[te]2)CC1
CHEMBL342060,CHEMBL2056,Dopamine D1 receptor,Ki,=,1500.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccn3nccc3c2)CC1
CHEMBL337531,CHEMBL2056,Dopamine D1 receptor,Ki,=,1400.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[te]1
CHEMBL357684,CHEMBL2056,Dopamine D1 receptor,Ki,=,1200.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL336930,CHEMBL2056,Dopamine D1 receptor,Ki,=,2000.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccnn3c2)CC1
CHEMBL140612,CHEMBL2056,Dopamine D1 receptor,Ki,=,2200.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL423735,CHEMBL2056,Dopamine D1 receptor,Ki,=,1500.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cnn3ccccc23)CC1
CHEMBL424294,CHEMBL2056,Dopamine D1 receptor,Ki,=,670.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL344677,CHEMBL2056,Dopamine D1 receptor,Ki,=,1200.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cccc3ccnn23)CC1
CHEMBL139722,CHEMBL2056,Dopamine D1 receptor,Ki,=,1200.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL141845,CHEMBL2056,Dopamine D1 receptor,Ki,=,1200.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCNC(=O)c2cnn3ccccc23)CC1
CHEMBL142020,CHEMBL2056,Dopamine D1 receptor,Ki,=,1500.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL124444,CHEMBL2056,Dopamine D1 receptor,Ki,=,1100.0,nM,CHEMBL673336,B,Binding affinity for porcine Dopamine receptor D1 by [3H]-SCH- 23390 displacement.,CHEMBL1135974,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1
CHEMBL25856,CHEMBL2056,Dopamine D1 receptor,Ki,=,33.0,nM,CHEMBL674247,B,Binding affinity against cloned human Dopamine receptor D1 using [125I]-SCH 23982 as radioligand transfected in HEK cells,CHEMBL1128531,KI,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2
CHEMBL291143,CHEMBL2056,Dopamine D1 receptor,Ki,=,21.0,nM,CHEMBL674247,B,Binding affinity against cloned human Dopamine receptor D1 using [125I]-SCH 23982 as radioligand transfected in HEK cells,CHEMBL1128531,KI,NC[C@@H]1O[C@H](C23CC4CC(CC(C4)C2)C3)Cc2c1ccc(O)c2O
CHEMBL24077,CHEMBL2056,Dopamine D1 receptor,Ki,=,56.0,nM,CHEMBL674247,B,Binding affinity against cloned human Dopamine receptor D1 using [125I]-SCH 23982 as radioligand transfected in HEK cells,CHEMBL1128531,KI,Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2
CHEMBL28338,CHEMBL2056,Dopamine D1 receptor,Ki,=,49.0,nM,CHEMBL674247,B,Binding affinity against cloned human Dopamine receptor D1 using [125I]-SCH 23982 as radioligand transfected in HEK cells,CHEMBL1128531,KI,CCCc1cc2c(s1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL544814,CHEMBL2056,Dopamine D1 receptor,Ki,=,3050.0,nM,CHEMBL674247,B,Binding affinity against cloned human Dopamine receptor D1 using [125I]-SCH 23982 as radioligand transfected in HEK cells,CHEMBL1128531,KI,CCCc1cc2c(s1)CN[C@H]1CCc3cc(O)c(O)cc3[C@H]21.Cl
CHEMBL59,CHEMBL2056,Dopamine D1 receptor,Ki,=,130.0,nM,CHEMBL674247,B,Binding affinity against cloned human Dopamine receptor D1 using [125I]-SCH 23982 as radioligand transfected in HEK cells,CHEMBL1128531,KI,NCCc1ccc(O)c(O)c1
CHEMBL716,CHEMBL2056,Dopamine D1 receptor,Ki,=,390.0,nM,CHEMBL674248,B,Binding affinity against dopamine receptor D1,CHEMBL1134342,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL543473,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.9,nM,CHEMBL672090,B,Inhibition of [3H]-SCH- 23390 binding to Dopamine receptor D1 from canine striatum,CHEMBL1126025,KI,C=CCN1CCc2cc(Br)c(O)cc2C(c2ccccc2)C1.Cl
CHEMBL534678,CHEMBL2056,Dopamine D1 receptor,Ki,=,48.0,nM,CHEMBL672090,B,Inhibition of [3H]-SCH- 23390 binding to Dopamine receptor D1 from canine striatum,CHEMBL1126025,KI,C=CCN1CCc2ccc(O)cc2C(c2ccccc2)C1.Cl
CHEMBL1744078,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.0,nM,CHEMBL672090,B,Inhibition of [3H]-SCH- 23390 binding to Dopamine receptor D1 from canine striatum,CHEMBL1126025,KI,CN1CCc2ccc(O)cc2[C@@H](c2ccccc2)C1.Cl
CHEMBL85,CHEMBL2056,Dopamine D1 receptor,Ki,=,21.0,nM,CHEMBL674248,B,Binding affinity against dopamine receptor D1,CHEMBL1134342,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL285802,CHEMBL2056,Dopamine D1 receptor,Ki,=,29.0,nM,CHEMBL674248,B,Binding affinity against dopamine receptor D1,CHEMBL1134342,KI,CN(C)CCOC1=Cc2ccccc2Sc2ccc(Cl)cc21
CHEMBL715,CHEMBL2056,Dopamine D1 receptor,Ki,=,10.0,nM,CHEMBL674248,B,Binding affinity against dopamine receptor D1,CHEMBL1134342,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL543704,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.2,nM,CHEMBL672090,B,Inhibition of [3H]-SCH- 23390 binding to Dopamine receptor D1 from canine striatum,CHEMBL1126025,KI,C=CCN1CCc2cc(Cl)c(O)cc2C(c2ccccc2)C1.Cl
CHEMBL1744079,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.58,nM,CHEMBL672090,B,Inhibition of [3H]-SCH- 23390 binding to Dopamine receptor D1 from canine striatum,CHEMBL1126025,KI,CN1CCc2cc(Br)c(O)cc2[C@@H](c2ccccc2)C1.Cl
CHEMBL708,CHEMBL2056,Dopamine D1 receptor,Ki,=,9.5,nM,CHEMBL674248,B,Binding affinity against dopamine receptor D1,CHEMBL1134342,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL543472,CHEMBL2056,Dopamine D1 receptor,Ki,=,702.0,nM,CHEMBL672090,B,Inhibition of [3H]-SCH- 23390 binding to Dopamine receptor D1 from canine striatum,CHEMBL1126025,KI,Cl.Oc1ccc2c(c1)C(c1ccccc1)CNCC2
CHEMBL540857,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.9,nM,CHEMBL672090,B,Inhibition of [3H]-SCH- 23390 binding to Dopamine receptor D1 from canine striatum,CHEMBL1126025,KI,Br.Oc1cc2c(cc1Cl)CCNCC2c1ccccc1
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,53.0,nM,CHEMBL674248,B,Binding affinity against dopamine receptor D1,CHEMBL1134342,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL557799,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.1,nM,CHEMBL672090,B,Inhibition of [3H]-SCH- 23390 binding to Dopamine receptor D1 from canine striatum,CHEMBL1126025,KI,Br.Oc1cc2c(cc1Br)CCNCC2c1ccccc1
CHEMBL1256645,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.17,nM,CHEMBL672090,B,Inhibition of [3H]-SCH- 23390 binding to Dopamine receptor D1 from canine striatum,CHEMBL1126025,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1.Cl
CHEMBL541559,CHEMBL2056,Dopamine D1 receptor,Ki,=,12.0,nM,CHEMBL672091,B,The compound was evaluated for the dissociation constant for inhibiting the binding of [3H]-SCH- 23390 at Dopamine receptor D1,CHEMBL1125221,KI,Br.Oc1cc2c(c(Br)c1O)CCNCC2c1ccccc1
CHEMBL544118,CHEMBL2056,Dopamine D1 receptor,Ki,=,2100.0,nM,CHEMBL672091,B,The compound was evaluated for the dissociation constant for inhibiting the binding of [3H]-SCH- 23390 at Dopamine receptor D1,CHEMBL1125221,KI,CN1CCc2c(Cl)c(O)c(O)c(Cl)c2C(c2ccccc2)C1.Cl
CHEMBL545000,CHEMBL2056,Dopamine D1 receptor,Ki,=,8.8,nM,CHEMBL672092,B,The compound was evaluated for the dissociation constant for inhibiting the binding of [3H]-SCH- 23390 at dopamine receptor D1,CHEMBL1125221,KI,CN1CCc2cc(O)c(O)cc2C(c2ccccc2)C1.Cl
CHEMBL553503,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.0,nM,CHEMBL672092,B,The compound was evaluated for the dissociation constant for inhibiting the binding of [3H]-SCH- 23390 at dopamine receptor D1,CHEMBL1125221,KI,Br.Oc1cc2c(c(Cl)c1O)CCNCC2c1ccccc1
CHEMBL554009,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.2,nM,CHEMBL672092,B,The compound was evaluated for the dissociation constant for inhibiting the binding of [3H]-SCH- 23390 at dopamine receptor D1,CHEMBL1125221,KI,Br.CN1CCc2c(cc(O)c(O)c2Br)C(c2ccccc2)C1
CHEMBL544114,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.0,nM,CHEMBL672092,B,The compound was evaluated for the dissociation constant for inhibiting the binding of [3H]-SCH- 23390 at dopamine receptor D1,CHEMBL1125221,KI,Br.C=CCN1CCc2c(cc(O)c(O)c2Br)C(c2ccccc2)C1
CHEMBL552611,CHEMBL2056,Dopamine D1 receptor,Ki,=,12.0,nM,CHEMBL672091,B,The compound was evaluated for the dissociation constant for inhibiting the binding of [3H]-SCH- 23390 at Dopamine receptor D1,CHEMBL1125221,KI,C=CCN1CCc2cc(O)c(O)cc2C(c2ccccc2)C1.Cl
CHEMBL544115,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.5,nM,CHEMBL672091,B,The compound was evaluated for the dissociation constant for inhibiting the binding of [3H]-SCH- 23390 at Dopamine receptor D1,CHEMBL1125221,KI,Br.C=CCN1CCc2c(cc(O)c(O)c2Cl)C(c2ccccc2)C1
CHEMBL542700,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.1,nM,CHEMBL672091,B,The compound was evaluated for the dissociation constant for inhibiting the binding of [3H]-SCH- 23390 at Dopamine receptor D1,CHEMBL1125221,KI,Cl.Oc1cc2c(cc1O)C(c1ccccc1)CNCC2
CHEMBL542700,CHEMBL2056,Dopamine D1 receptor,Ki,=,25.0,nM,CHEMBL672091,B,The compound was evaluated for the dissociation constant for inhibiting the binding of [3H]-SCH- 23390 at Dopamine receptor D1,CHEMBL1125221,KI,Cl.Oc1cc2c(cc1O)C(c1ccccc1)CNCC2
CHEMBL543398,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.9,nM,CHEMBL672092,B,The compound was evaluated for the dissociation constant for inhibiting the binding of [3H]-SCH- 23390 at dopamine receptor D1,CHEMBL1125221,KI,Br.CN1CCc2c(cc(O)c(O)c2Cl)C(c2ccccc2)C1
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,180.0,nM,CHEMBL674253,B,Compound was tested for the Binding affinity against Human cloned Dopamine receptor D1 by Radio ligand ([3H]SCH-23390) binding assay,CHEMBL1129789,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL54,CHEMBL2056,Dopamine D1 receptor,Ki,=,49.0,nM,CHEMBL674254,B,Compound was tested for the binding affinity against human cloned Dopamine receptor D1 by radioligand ([3H]SCH-23390) binding assay,CHEMBL1129789,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL283247,CHEMBL2056,Dopamine D1 receptor,Ki,=,890.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,CCCCc1cnc2c(c1)[C@@H]1c3cc(O)c(O)cc3CC[C@H]1NC2
CHEMBL287513,CHEMBL2056,Dopamine D1 receptor,Ki,=,560.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3cc4c(nc3CN[C@@H]1CC2)CCCC4
CHEMBL28054,CHEMBL2056,Dopamine D1 receptor,Ki,=,1100.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3cnccc3CN[C@@H]1CC2
CHEMBL26365,CHEMBL2056,Dopamine D1 receptor,Ki,=,390.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3cncc(F)c3CN[C@@H]1CC2
CHEMBL281932,CHEMBL2056,Dopamine D1 receptor,Ki,=,65.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3cccnc3CN[C@@H]1CC2
CHEMBL26965,CHEMBL2056,Dopamine D1 receptor,Ki,=,45.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,CCCc1ccc2c(n1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL25856,CHEMBL2056,Dopamine D1 receptor,Ki,=,33.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2
CHEMBL28338,CHEMBL2056,Dopamine D1 receptor,Ki,=,49.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,CCCc1cc2c(s1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL27117,CHEMBL2056,Dopamine D1 receptor,Ki,=,140.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,Cc1ccc2c(n1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL282136,CHEMBL2056,Dopamine D1 receptor,Ki,=,1100.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,Cc1cncc2c1CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL27101,CHEMBL2056,Dopamine D1 receptor,Ki,=,180.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3ccc(F)nc3CN[C@@H]1CC2
CHEMBL285924,CHEMBL2056,Dopamine D1 receptor,Ki,=,49.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,COc1ccc2c(n1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL275379,CHEMBL2056,Dopamine D1 receptor,Ki,=,240.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,Cc1cnc2c(c1)[C@@H]1c3cc(O)c(O)cc3CC[C@H]1NC2
CHEMBL284644,CHEMBL2056,Dopamine D1 receptor,Ki,=,140.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,Oc1cc2c(cc1O)[C@H]1c3ccncc3CN[C@@H]1CC2
CHEMBL284959,CHEMBL2056,Dopamine D1 receptor,Ki,=,280.0,nM,CHEMBL674251,B,Binding affinity to Dopamine receptor D1 by using radioligand [125I]SCH-23982 in HEK cells,CHEMBL1131704,KI,Cc1cc2c(nc1C)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL307790,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.0,nM,CHEMBL668638,B,Compound was tested for the displacement of [3H]-SCH- 23390 from dopamine receptor D1,CHEMBL1126151,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3C[C@@H]21
CHEMBL63321,CHEMBL2056,Dopamine D1 receptor,Ki,=,192.0,nM,CHEMBL668638,B,Compound was tested for the displacement of [3H]-SCH- 23390 from dopamine receptor D1,CHEMBL1126151,KI,CN1CCc2cc(Cl)c(O)cc2[C@H](c2ccccc2)C1
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.3,nM,CHEMBL668638,B,Compound was tested for the displacement of [3H]-SCH- 23390 from dopamine receptor D1,CHEMBL1126151,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL298406,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.9,nM,CHEMBL668638,B,Compound was tested for the displacement of [3H]-SCH- 23390 from dopamine receptor D1,CHEMBL1126151,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21
CHEMBL611207,CHEMBL2056,Dopamine D1 receptor,Ki,=,317.0,nM,CHEMBL840058,B,Binding affinity towards human D1 dopamine receptor was determined by using [3H]-SCH- 23390 as radioligand,CHEMBL1137093,KI,CN1CCCC[C@@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL182721,CHEMBL2056,Dopamine D1 receptor,Ki,=,3630.78,nM,CHEMBL838637,B,Binding affinity against Dopamine receptor D1,CHEMBL1137161,KI,c1ccc2c(N3CCN(CCc4ccc5c(c4)NCN5)CC3)cccc2c1
CHEMBL184770,CHEMBL2056,Dopamine D1 receptor,Ki,=,4677.35,nM,CHEMBL838637,B,Binding affinity against Dopamine receptor D1,CHEMBL1137161,KI,Cc1cccc(N2CCN(CCc3ccc4[nH]nnc4c3)CC2)c1C
CHEMBL363124,CHEMBL2056,Dopamine D1 receptor,Ki,=,5754.4,nM,CHEMBL838637,B,Binding affinity against Dopamine receptor D1,CHEMBL1137161,KI,c1ccc2c(N3CCN(CCc4ccc5[nH]nnc5c4)CC3)cccc2c1
CHEMBL611207,CHEMBL2056,Dopamine D1 receptor,Ki,=,103.0,nM,CHEMBL840058,B,Binding affinity towards human D1 dopamine receptor was determined by using [3H]-SCH- 23390 as radioligand,CHEMBL1137093,KI,CN1CCCC[C@@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL183776,CHEMBL2056,Dopamine D1 receptor,Ki,=,812.83,nM,CHEMBL838637,B,Binding affinity against Dopamine receptor D1,CHEMBL1137161,KI,COc1ccccc1N1CCN(CCc2ccc3[nH]nnc3c2)CC1
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,31.62,nM,CHEMBL838636,B,Binding affinity against Dopamine D1 receptor,CHEMBL1137161,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL608530,CHEMBL2056,Dopamine D1 receptor,Ki,=,1963.0,nM,CHEMBL840058,B,Binding affinity towards human D1 dopamine receptor was determined by using [3H]-SCH- 23390 as radioligand,CHEMBL1137093,KI,CN1CCCC[C@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL608530,CHEMBL2056,Dopamine D1 receptor,Ki,=,620.0,nM,CHEMBL840058,B,Binding affinity towards human D1 dopamine receptor was determined by using [3H]-SCH- 23390 as radioligand,CHEMBL1137093,KI,CN1CCCC[C@H]1CCN1c2ccccc2Sc2ccc([S+](C)[O-])cc21
CHEMBL184049,CHEMBL2056,Dopamine D1 receptor,Ki,=,35.5,nM,CHEMBL839544,B,Binding affinity for human recombinant dopamine receptor D1,CHEMBL1138672,KI,COc1ccc2c(c1)OCCN(C)CCc1ccccc1C2
CHEMBL184050,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.2,nM,CHEMBL839544,B,Binding affinity for human recombinant dopamine receptor D1,CHEMBL1138672,KI,CN1CCOc2cc(O)ccc2Cc2ccccc2CC1
CHEMBL364586,CHEMBL2056,Dopamine D1 receptor,Ki,=,1651.0,nM,CHEMBL839544,B,Binding affinity for human recombinant dopamine receptor D1,CHEMBL1138672,KI,O=C(c1ccccc1)c1ccccc1OCCN1CCCC1
CHEMBL185875,CHEMBL2056,Dopamine D1 receptor,Ki,=,2621.0,nM,CHEMBL839544,B,Binding affinity for human recombinant dopamine receptor D1,CHEMBL1138672,KI,OC(c1ccccc1)c1ccccc1OCCN1CCCC1
CHEMBL186720,CHEMBL2056,Dopamine D1 receptor,Ki,=,343.0,nM,CHEMBL839544,B,Binding affinity for human recombinant dopamine receptor D1,CHEMBL1138672,KI,CN(C)CCOc1ccccc1Cc1ccccc1
CHEMBL366265,CHEMBL2056,Dopamine D1 receptor,Ki,=,1959.0,nM,CHEMBL839544,B,Binding affinity for human recombinant dopamine receptor D1,CHEMBL1138672,KI,CCN(CC)CCOc1ccccc1Cc1ccccc1
CHEMBL435505,CHEMBL2056,Dopamine D1 receptor,Ki,=,379.0,nM,CHEMBL839544,B,Binding affinity for human recombinant dopamine receptor D1,CHEMBL1138672,KI,c1ccc(Cc2ccccc2OCCN2CCCC2)cc1
CHEMBL364565,CHEMBL2056,Dopamine D1 receptor,Ki,=,33.7,nM,CHEMBL839544,B,Binding affinity for human recombinant dopamine receptor D1,CHEMBL1138672,KI,c1ccc(Cc2ccccc2OCCN2CCCCC2)cc1
CHEMBL365697,CHEMBL2056,Dopamine D1 receptor,Ki,=,201.0,nM,CHEMBL839544,B,Binding affinity for human recombinant dopamine receptor D1,CHEMBL1138672,KI,c1ccc(Cc2ccccc2OCCN2CCOCC2)cc1
CHEMBL184724,CHEMBL2056,Dopamine D1 receptor,Ki,=,1676.0,nM,CHEMBL839544,B,Binding affinity for human recombinant dopamine receptor D1,CHEMBL1138672,KI,CC1CN(CCOc2ccccc2Cc2ccccc2)CCO1
CHEMBL184073,CHEMBL2056,Dopamine D1 receptor,Ki,=,1480.0,nM,CHEMBL839544,B,Binding affinity for human recombinant dopamine receptor D1,CHEMBL1138672,KI,c1ccc(Cc2ccccc2OCCN2CCN(c3ccccc3)CC2)cc1
CHEMBL187367,CHEMBL2056,Dopamine D1 receptor,Ki,=,113.0,nM,CHEMBL839544,B,Binding affinity for human recombinant dopamine receptor D1,CHEMBL1138672,KI,c1ccc(Cc2ccccc2OCCCN2CCCC2)cc1
CHEMBL54,CHEMBL2056,Dopamine D1 receptor,Ki,=,82.0,nM,CHEMBL839544,B,Binding affinity for human recombinant dopamine receptor D1,CHEMBL1138672,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL366164,CHEMBL2056,Dopamine D1 receptor,Ki,=,22.0,nM,CHEMBL829632,B,Inhibition of [3H]SCH-23390 binding to human Dopamine receptor D1,CHEMBL1142715,KI,CN(C)C[C@H]1C[C@@H]2c3ccccc3Sc3ccc(F)cc3[C@H]2O1
CHEMBL329566,CHEMBL2056,Dopamine D1 receptor,Ki,=,63.0,nM,CHEMBL829632,B,Inhibition of [3H]SCH-23390 binding to human Dopamine receptor D1,CHEMBL1142715,KI,CN(C)C[C@H]1C[C@@H]2c3ccccc3Cc3ccccc3[C@H]2O1
CHEMBL364270,CHEMBL2056,Dopamine D1 receptor,Ki,=,250.0,nM,CHEMBL829632,B,Inhibition of [3H]SCH-23390 binding to human Dopamine receptor D1,CHEMBL1142715,KI,CN(C)C[C@@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1
CHEMBL435301,CHEMBL2056,Dopamine D1 receptor,Ki,=,83.0,nM,CHEMBL829632,B,Inhibition of [3H]SCH-23390 binding to human Dopamine receptor D1,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Cl)cc3[C@H]2O1
CHEMBL193435,CHEMBL2056,Dopamine D1 receptor,Ki,=,154.0,nM,CHEMBL829632,B,Inhibition of [3H]SCH-23390 binding to human Dopamine receptor D1,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Oc3ccc(Br)cc3[C@H]2O1
CHEMBL363581,CHEMBL2056,Dopamine D1 receptor,Ki,=,19.0,nM,CHEMBL829632,B,Inhibition of [3H]SCH-23390 binding to human Dopamine receptor D1,CHEMBL1142715,KI,CN(C)C[C@@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1
CHEMBL193639,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.2,nM,CHEMBL829632,B,Inhibition of [3H]SCH-23390 binding to human Dopamine receptor D1,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1
CHEMBL193639,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.0,nM,CHEMBL829632,B,Inhibition of [3H]SCH-23390 binding to human Dopamine receptor D1,CHEMBL1142715,KI,CN(C)C[C@H]1CC2c3ccccc3Sc3ccc(F)cc3[C@H]2O1
CHEMBL240773,CHEMBL2056,Dopamine D1 receptor,Ki,=,63.0,nM,CHEMBL885376,B,"Binding affinity (high) towards human dopamine receptor 2 long against radioligand [3H]spiperone, expressed in Chinese hamster ovary cells",CHEMBL1141074,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL199824,CHEMBL2056,Dopamine D1 receptor,Ki,=,7396.0,nM,CHEMBL868786,B,Binding affinity to dopamine D1 receptor,CHEMBL1148600,KI,Cn1c(=O)cnn(CCCCN2CCN(c3cccc4ccc(O[11CH3])cc34)CC2)c1=O
CHEMBL199876,CHEMBL2056,Dopamine D1 receptor,Ki,=,544.4,nM,CHEMBL864518,B,Binding affinity to dopamine D1 receptor,CHEMBL1148546,KI,O=c1[nH]c2[nH]c(-c3ccc(Cl)cc3)cc2c(=O)n1CCN1CCN(c2ccccc2Cl)CC1
CHEMBL370136,CHEMBL2056,Dopamine D1 receptor,Ki,=,271.6,nM,CHEMBL864518,B,Binding affinity to dopamine D1 receptor,CHEMBL1148546,KI,COc1ccc(-c2cc3c(=O)n(CCN4CCN(c5ccccc5Cl)CC4)c(=O)[nH]c3[nH]2)cc1
CHEMBL370364,CHEMBL2056,Dopamine D1 receptor,Ki,=,388.7,nM,CHEMBL864518,B,Binding affinity to dopamine D1 receptor,CHEMBL1148546,KI,Cc1ccc(-c2cc3c(=O)n(CCN4CCN(c5ccccc5Cl)CC4)c(=O)[nH]c3[nH]2)cc1
CHEMBL443567,CHEMBL2056,Dopamine D1 receptor,Ki,=,566.8,nM,CHEMBL864518,B,Binding affinity to dopamine D1 receptor,CHEMBL1148546,KI,O=c1[nH]c2[nH]c(-c3ccccc3Cl)cc2c(=O)n1CCN1CCN(c2ccccc2Cl)CC1
CHEMBL197656,CHEMBL2056,Dopamine D1 receptor,Ki,=,8550.0,nM,CHEMBL864518,B,Binding affinity to dopamine D1 receptor,CHEMBL1148546,KI,COc1ccccc1-c1cc2c(=O)n(CCN3CCN(c4ccccc4Cl)CC3)c(=O)[nH]c2[nH]1
CHEMBL200802,CHEMBL2056,Dopamine D1 receptor,Ki,=,1040.0,nM,CHEMBL864518,B,Binding affinity to dopamine D1 receptor,CHEMBL1148546,KI,Cc1ccccc1-c1cc2c(=O)n(CCN3CCN(c4ccccc4Cl)CC3)c(=O)[nH]c2[nH]1
CHEMBL203362,CHEMBL2056,Dopamine D1 receptor,Ki,=,516.0,nM,CHEMBL864518,B,Binding affinity to dopamine D1 receptor,CHEMBL1148546,KI,O=c1[nH]c2[nH]c(-c3ccccc3)cc2c(=O)n1CCN1CCN(c2ccccc2Cl)CC1
CHEMBL382850,CHEMBL2056,Dopamine D1 receptor,Ki,=,16.4,nM,CHEMBL859834,B,Inhibition of binding to human D1 receptor expressed in HEK 293 cells by radioligand binding assay,CHEMBL1147728,KI,CCN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL201432,CHEMBL2056,Dopamine D1 receptor,Ki,=,767.0,nM,CHEMBL859834,B,Inhibition of binding to human D1 receptor expressed in HEK 293 cells by radioligand binding assay,CHEMBL1147728,KI,c1ccc2c(c1)CCN(CC1CC1)CCc1c([nH]c3ccccc13)C2
CHEMBL202924,CHEMBL2056,Dopamine D1 receptor,Ki,=,509.0,nM,CHEMBL859834,B,Inhibition of binding to human D1 receptor expressed in HEK 293 cells by radioligand binding assay,CHEMBL1147728,KI,COc1cc2c(cc1OC)Cc1ccccc1CCN(C)CC2
CHEMBL1204122,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.39,nM,CHEMBL859834,B,Inhibition of binding to human D1 receptor expressed in HEK 293 cells by radioligand binding assay,CHEMBL1147728,KI,Br.CN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL1202298,CHEMBL2056,Dopamine D1 receptor,Ki,=,341.0,nM,CHEMBL859834,B,Inhibition of binding to human D1 receptor expressed in HEK 293 cells by radioligand binding assay,CHEMBL1147728,KI,Br.CN1CCc2ccccc2Cc2cc(O)c(O)cc2CC1
CHEMBL201525,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.5,nM,CHEMBL859834,B,Inhibition of binding to human D1 receptor expressed in HEK 293 cells by radioligand binding assay,CHEMBL1147728,KI,CN1CCc2ccccc2Cc2ccccc2CC1
CHEMBL201093,CHEMBL2056,Dopamine D1 receptor,Ki,=,10.7,nM,CHEMBL859834,B,Inhibition of binding to human D1 receptor expressed in HEK 293 cells by radioligand binding assay,CHEMBL1147728,KI,CN1CCc2ccccc2Cc2ccsc2CC1
CHEMBL201483,CHEMBL2056,Dopamine D1 receptor,Ki,=,61.0,nM,CHEMBL859834,B,Inhibition of binding to human D1 receptor expressed in HEK 293 cells by radioligand binding assay,CHEMBL1147728,KI,CN1CCc2ccccc2Cc2ccn(C)c2CC1
CHEMBL380330,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.5,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,COc1ccc2c(c1)CCN(C)CCc1ccccc1C2
CHEMBL201170,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.39,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL203689,CHEMBL2056,Dopamine D1 receptor,Ki,=,8.7,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2c(O)cccc2CC1
CHEMBL204065,CHEMBL2056,Dopamine D1 receptor,Ki,=,9.4,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,COc1ccc2c(c1)CCN(C)CCc1cc(OC)ccc1C2
CHEMBL441618,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.9,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL381936,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.0,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,CN1CCc2cc(O)ccc2Cc2ccc(O)cc2CC1
CHEMBL379662,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.6,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,COc1cccc2c1Cc1ccccc1CCN(C)CC2
CHEMBL203047,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.1,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2cc(O)c(Cl)cc2CC1
CHEMBL380464,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.46,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2c(ccc(O)c2Cl)CC1
CHEMBL203734,CHEMBL2056,Dopamine D1 receptor,Ki,=,25.3,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,COc1c(Cl)cc2c(c1Cl)Cc1ccccc1CCN(C)CC2
CHEMBL381946,CHEMBL2056,Dopamine D1 receptor,Ki,=,82.0,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,COc1ccc2c(c1)Cc1ccccc1CCN(C)CC2
CHEMBL382010,CHEMBL2056,Dopamine D1 receptor,Ki,=,8.9,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2cc(O)ccc2CC1
CHEMBL204098,CHEMBL2056,Dopamine D1 receptor,Ki,=,9.3,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2cc(N)c(O)cc2CC1
CHEMBL383451,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.2,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2cc(Cl)c(O)c(Cl)c2CC1
CHEMBL203637,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.83,nM,CHEMBL861434,B,Displacement of [3H]SCH 23390 from D1 dopamine receptor,CHEMBL1138197,KI,CN1CCc2ccccc2Cc2ccc(O)c(Cl)c2CC1
CHEMBL208847,CHEMBL2056,Dopamine D1 receptor,Ki,=,780.0,nM,CHEMBL860505,B,Displacement of [3H]SCH 23390 from D1 receptor of porcine striatal membrane,CHEMBL1148643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3c4ccc(c3o2)CCc2ccc(cc2)CC4)CC1
CHEMBL25236,CHEMBL2056,Dopamine D1 receptor,Ki,=,760.0,nM,CHEMBL860505,B,Displacement of [3H]SCH 23390 from D1 receptor of porcine striatal membrane,CHEMBL1148643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1
CHEMBL426863,CHEMBL2056,Dopamine D1 receptor,Ki,=,570.0,nM,CHEMBL860505,B,Displacement of [3H]SCH 23390 from D1 receptor of porcine striatal membrane,CHEMBL1148643,KI,O=C(NCCCCN1CCN(c2cccc(F)c2F)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL209876,CHEMBL2056,Dopamine D1 receptor,Ki,=,970.0,nM,CHEMBL860505,B,Displacement of [3H]SCH 23390 from D1 receptor of porcine striatal membrane,CHEMBL1148643,KI,COc1c(Cl)cccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1
CHEMBL210461,CHEMBL2056,Dopamine D1 receptor,Ki,=,2800.0,nM,CHEMBL860505,B,Displacement of [3H]SCH 23390 from D1 receptor of porcine striatal membrane,CHEMBL1148643,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccc1CCc1ccc(cc1)CC2
CHEMBL210567,CHEMBL2056,Dopamine D1 receptor,Ki,=,490.0,nM,CHEMBL860505,B,Displacement of [3H]SCH 23390 from D1 receptor of porcine striatal membrane,CHEMBL1148643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1
CHEMBL210567,CHEMBL2056,Dopamine D1 receptor,Ki,=,660.0,nM,CHEMBL860505,B,Displacement of [3H]SCH 23390 from D1 receptor of porcine striatal membrane,CHEMBL1148643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccc2CCc2ccc(cc2)CC3)CC1
CHEMBL210514,CHEMBL2056,Dopamine D1 receptor,Ki,=,1620.0,nM,CHEMBL853317,B,Binding affinity to human D1 receptor,CHEMBL1148507,KI,COc1nc(NCCCN2CCOCC2)nc(OC)c1NC(=O)c1ccc(Oc2cc3c(cc2C)CCC3(C)C)o1
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,132.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL214407,CHEMBL2056,Dopamine D1 receptor,Ki,=,51.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Oc3ccccc3)c3ccccc32)CC1
CHEMBL212844,CHEMBL2056,Dopamine D1 receptor,Ki,=,88.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3-n3ccnc3)c3ccccc32)CC1
CHEMBL210016,CHEMBL2056,Dopamine D1 receptor,Ki,=,237.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3N3CCN(C)CC3)c3ccccc32)CC1
CHEMBL212383,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.8,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3N3CCCCC3)c3ccccc32)CC1
CHEMBL212186,CHEMBL2056,Dopamine D1 receptor,Ki,=,62.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3NC3CCCCC3)c3ccccc32)CC1
CHEMBL213444,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cnc4ccccc4c3)c3ccccc32)CC1
CHEMBL213443,CHEMBL2056,Dopamine D1 receptor,Ki,=,10.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc4ccccc4n3)c3ccccc32)CC1
CHEMBL213278,CHEMBL2056,Dopamine D1 receptor,Ki,=,23.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3nccc4ccccc34)c3ccccc32)CC1
CHEMBL378512,CHEMBL2056,Dopamine D1 receptor,Ki,=,65.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CCOc1ccc2ccccc2c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL213882,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.4,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc4ccccc4c3)c3ccccc32)CC1
CHEMBL213834,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.8,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc4ccccc34)c3ccccc32)CC1
CHEMBL384500,CHEMBL2056,Dopamine D1 receptor,Ki,=,11.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccnc3Cl)c3ccccc32)CC1
CHEMBL405751,CHEMBL2056,Dopamine D1 receptor,Ki,=,30.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cnn(-c4ccccc4)c3C(F)(F)F)c3ccccc32)CC1
CHEMBL213372,CHEMBL2056,Dopamine D1 receptor,Ki,=,22.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccon3)c3ccccc32)CC1
CHEMBL378914,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CCOc1c(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)sc2ccccc12
CHEMBL384916,CHEMBL2056,Dopamine D1 receptor,Ki,=,39.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3sccc3-c3ccccc3)c3ccccc32)CC1
CHEMBL437112,CHEMBL2056,Dopamine D1 receptor,Ki,=,10.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CCOc1csc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)c1
CHEMBL212896,CHEMBL2056,Dopamine D1 receptor,Ki,=,9.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccsc3)c3ccccc32)CC1
CHEMBL379874,CHEMBL2056,Dopamine D1 receptor,Ki,=,14.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccs3)c3ccccc32)CC1
CHEMBL426868,CHEMBL2056,Dopamine D1 receptor,Ki,=,15.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccco3)c3ccccc32)CC1
CHEMBL377756,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3C(F)(F)F)c3ccccc32)CC1
CHEMBL213424,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.2,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,Cc1cccc(N)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL213336,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL378669,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.6,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(N)cccc3Cl)c3ccccc32)CC1
CHEMBL213492,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.5,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(F)cccc3C(F)(F)F)c3ccccc32)CC1
CHEMBL425069,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.6,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL427230,CHEMBL2056,Dopamine D1 receptor,Ki,=,24.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cc(Cl)cc(Cl)c3)c3ccccc32)CC1
CHEMBL213881,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(Cl)cc(Cl)cc3Cl)c3ccccc32)CC1
CHEMBL386122,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.4,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3c(Cl)cccc3Cl)c3ccccc32)CC1
CHEMBL212077,CHEMBL2056,Dopamine D1 receptor,Ki,=,12.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(Cl)c(Cl)c3)c3ccccc32)CC1
CHEMBL212912,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL213477,CHEMBL2056,Dopamine D1 receptor,Ki,=,12.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3F)c3ccccc32)CC1
CHEMBL377584,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.6,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(I)c3)c3ccccc32)CC1
CHEMBL213084,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(Cl)c3)c3ccccc32)CC1
CHEMBL213083,CHEMBL2056,Dopamine D1 receptor,Ki,=,47.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(F)c3)c3ccccc32)CC1
CHEMBL214016,CHEMBL2056,Dopamine D1 receptor,Ki,=,13.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,COc1cccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)c1
CHEMBL213793,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,Cc1cccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)c1
CHEMBL378886,CHEMBL2056,Dopamine D1 receptor,Ki,=,68.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(C(F)(F)F)cc3)c3ccccc32)CC1
CHEMBL215885,CHEMBL2056,Dopamine D1 receptor,Ki,=,47.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,COc1ccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc1
CHEMBL213795,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.7,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,Cc1ccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc1
CHEMBL214142,CHEMBL2056,Dopamine D1 receptor,Ki,=,35.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(Cl)cc3)c3ccccc32)CC1
CHEMBL213775,CHEMBL2056,Dopamine D1 receptor,Ki,=,14.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(Br)cc3)c3ccccc32)CC1
CHEMBL212608,CHEMBL2056,Dopamine D1 receptor,Ki,=,157.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3)c3ccccc32)CC1
CHEMBL213388,CHEMBL2056,Dopamine D1 receptor,Ki,=,42.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)C3CCCCC3)c3ccccc32)CC1
CHEMBL376928,CHEMBL2056,Dopamine D1 receptor,Ki,=,150.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)C3CCC3)c3ccccc32)CC1
CHEMBL386424,CHEMBL2056,Dopamine D1 receptor,Ki,=,103.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)/C=C/c3ccccc3)c3ccccc32)CC1
CHEMBL215950,CHEMBL2056,Dopamine D1 receptor,Ki,=,56.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,COc1ccc(CCC(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc1Cl
CHEMBL215611,CHEMBL2056,Dopamine D1 receptor,Ki,=,79.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCc3ccccc3)c3ccccc32)CC1
CHEMBL211461,CHEMBL2056,Dopamine D1 receptor,Ki,=,111.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)CCC3CCCC3)c3ccccc32)CC1
CHEMBL212597,CHEMBL2056,Dopamine D1 receptor,Ki,=,154.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CCCC(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL212486,CHEMBL2056,Dopamine D1 receptor,Ki,=,86.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)C(F)(F)F)c3ccccc32)CC1
CHEMBL379757,CHEMBL2056,Dopamine D1 receptor,Ki,=,98.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)C(C)(C)C)c3ccccc32)CC1
CHEMBL383869,CHEMBL2056,Dopamine D1 receptor,Ki,=,494.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CC(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL215140,CHEMBL2056,Dopamine D1 receptor,Ki,=,280.0,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(N)c3ccccc32)CC1
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,132.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL212807,CHEMBL2056,Dopamine D1 receptor,Ki,=,11.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21
CHEMBL212936,CHEMBL2056,Dopamine D1 receptor,Ki,=,12.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3I)c3ccc(Cl)cc32)CC1
CHEMBL379942,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1ccccc1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21
CHEMBL213110,CHEMBL2056,Dopamine D1 receptor,Ki,=,16.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3cc(Cl)ccc32)cc(OC)c1OC
CHEMBL212700,CHEMBL2056,Dopamine D1 receptor,Ki,=,130.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc4c(c3)OCO4)c3ccc(Cl)cc32)CC1
CHEMBL213466,CHEMBL2056,Dopamine D1 receptor,Ki,=,98.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cc(F)c(F)c(F)c3F)c3ccc(Cl)cc32)CC1
CHEMBL378341,CHEMBL2056,Dopamine D1 receptor,Ki,=,24.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cc(F)ccc3C(F)(F)F)c3ccc(Cl)cc32)CC1
CHEMBL384069,CHEMBL2056,Dopamine D1 receptor,Ki,=,44.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3cc(Cl)ccc32)c1
CHEMBL212402,CHEMBL2056,Dopamine D1 receptor,Ki,=,47.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(C#N)c3)c3ccc(Cl)cc32)CC1
CHEMBL378648,CHEMBL2056,Dopamine D1 receptor,Ki,=,51.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(C#N)cc3)c3ccc(Cl)cc32)CC1
CHEMBL215414,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cccc(OC)c1C(=O)NN1c2ccccc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21
CHEMBL214503,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3ccccc3N(NC(=O)c3ccccc3I)c3ccc(Cl)cc32)CC1
CHEMBL385295,CHEMBL2056,Dopamine D1 receptor,Ki,=,48.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1ccccc1C(=O)NN1c2ccccc2N=C(N2CCN(C)CC2)c2cc(Cl)ccc21
CHEMBL377420,CHEMBL2056,Dopamine D1 receptor,Ki,=,20.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cc(C(=O)NN2c3ccccc3N=C(N3CCN(C)CC3)c3cc(Cl)ccc32)cc(OC)c1OC
CHEMBL213472,CHEMBL2056,Dopamine D1 receptor,Ki,=,83.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3ccccc3N(NC(=O)c3ccc4c(c3)OCO4)c3ccc(Cl)cc32)CC1
CHEMBL213145,CHEMBL2056,Dopamine D1 receptor,Ki,=,156.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3ccccc3N(NC(=O)c3cc(F)c(F)c(F)c3F)c3ccc(Cl)cc32)CC1
CHEMBL213193,CHEMBL2056,Dopamine D1 receptor,Ki,=,22.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3ccccc3N(NC(=O)c3cc(F)ccc3C(F)(F)F)c3ccc(Cl)cc32)CC1
CHEMBL213239,CHEMBL2056,Dopamine D1 receptor,Ki,=,86.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cccc(C(=O)NN2c3ccccc3N=C(N3CCN(C)CC3)c3cc(Cl)ccc32)c1
CHEMBL213238,CHEMBL2056,Dopamine D1 receptor,Ki,=,99.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3ccccc3N(NC(=O)c3cccc(C#N)c3)c3ccc(Cl)cc32)CC1
CHEMBL213201,CHEMBL2056,Dopamine D1 receptor,Ki,=,64.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3ccccc3N(NC(=O)c3ccc(C#N)cc3)c3ccc(Cl)cc32)CC1
CHEMBL378893,CHEMBL2056,Dopamine D1 receptor,Ki,=,2568.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,O=C(NN1c2ccc(Cl)cc2N=C(N2CCN(Cc3cccc(OC(F)(F)F)c3)CC2)c2ccccc21)c1ccccc1Cl
CHEMBL379862,CHEMBL2056,Dopamine D1 receptor,Ki,=,4749.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,O=C(NN1c2ccc(Cl)cc2N=C(N2CCN(Cc3cccc4c3OC(F)(F)O4)CC2)c2ccccc21)c1ccccc1Cl
CHEMBL379286,CHEMBL2056,Dopamine D1 receptor,Ki,=,238.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,O=C(NN1c2ccc(Cl)cc2N=C(N2CCN(Cc3ccc4c(c3)OCCO4)CC2)c2ccccc21)c1ccccc1Cl
CHEMBL386336,CHEMBL2056,Dopamine D1 receptor,Ki,=,1097.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1ccc(CN2CCN(C3=Nc4cc(Cl)ccc4N(NC(=O)c4ccccc4Cl)c4ccccc43)CC2)c(C)c1
CHEMBL377043,CHEMBL2056,Dopamine D1 receptor,Ki,=,571.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,O=C(NN1c2ccc(Cl)cc2N=C(N2CCN(Cc3cccc4c3OCO4)CC2)c2ccccc21)c1ccccc1Cl
CHEMBL377564,CHEMBL2056,Dopamine D1 receptor,Ki,=,886.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,O=C(NN1c2ccc(Cl)cc2N=C(N2CCN(Cc3ccc(F)cc3F)CC2)c2ccccc21)c1ccccc1Cl
CHEMBL215669,CHEMBL2056,Dopamine D1 receptor,Ki,=,3799.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,FC(F)(F)Oc1cccc(CN2CCN(C3=Nc4cc(Cl)ccc4Nc4ccccc43)CC2)c1
CHEMBL384634,CHEMBL2056,Dopamine D1 receptor,Ki,=,3106.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,FC1(F)Oc2cccc(CN3CCN(C4=Nc5cc(Cl)ccc5Nc5ccccc54)CC3)c2O1
CHEMBL213577,CHEMBL2056,Dopamine D1 receptor,Ki,=,583.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,Clc1ccc2c(c1)N=C(N1CCN(Cc3ccc4c(c3)OCCO4)CC1)c1ccccc1N2
CHEMBL378301,CHEMBL2056,Dopamine D1 receptor,Ki,=,482.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1ccc(CN2CCN(C3=Nc4cc(Cl)ccc4Nc4ccccc43)CC2)c(C)c1
CHEMBL211915,CHEMBL2056,Dopamine D1 receptor,Ki,=,637.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,Clc1ccc2c(c1)N=C(N1CCN(Cc3cccc4c3OCO4)CC1)c1ccccc1N2
CHEMBL213200,CHEMBL2056,Dopamine D1 receptor,Ki,=,835.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,Fc1ccc(CN2CCN(C3=Nc4cc(Cl)ccc4Nc4ccccc43)CC2)c(F)c1
CHEMBL215641,CHEMBL2056,Dopamine D1 receptor,Ki,=,503.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,O=C(NN1c2ccc(Cl)cc2N=C(N2CCN(Cc3ccccc3F)CC2)c2ccccc21)c1ccccc1Cl
CHEMBL216047,CHEMBL2056,Dopamine D1 receptor,Ki,=,294.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,O=C(NN1c2ccc(Cl)cc2N=C(N2CCN(CC3CCCCC3)CC2)c2ccccc21)c1ccccc1Cl
CHEMBL212966,CHEMBL2056,Dopamine D1 receptor,Ki,=,505.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CCC(CC)CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL385590,CHEMBL2056,Dopamine D1 receptor,Ki,=,447.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CC(C)(C)CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL212950,CHEMBL2056,Dopamine D1 receptor,Ki,=,81.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CC(C)CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL379593,CHEMBL2056,Dopamine D1 receptor,Ki,=,191.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CC(C)N1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL213335,CHEMBL2056,Dopamine D1 receptor,Ki,=,26.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CCCN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL215842,CHEMBL2056,Dopamine D1 receptor,Ki,=,54.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CCN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL384248,CHEMBL2056,Dopamine D1 receptor,Ki,=,86.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccncc3)c3ccccc32)CC1
CHEMBL215997,CHEMBL2056,Dopamine D1 receptor,Ki,=,85.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccnc3)c3ccccc32)CC1
CHEMBL425069,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.6,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cccc(OC)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL213336,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1cccc(C)c1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL212438,CHEMBL2056,Dopamine D1 receptor,Ki,=,32.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cc(F)c(F)c(F)c3F)c3ccccc32)CC1
CHEMBL379875,CHEMBL2056,Dopamine D1 receptor,Ki,=,31.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1cc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc(OC)c1OC
CHEMBL437917,CHEMBL2056,Dopamine D1 receptor,Ki,=,49.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(F)cc3C(F)(F)F)c3ccccc32)CC1
CHEMBL213668,CHEMBL2056,Dopamine D1 receptor,Ki,=,56.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc4c(c3)OCO4)c3ccccc32)CC1
CHEMBL384269,CHEMBL2056,Dopamine D1 receptor,Ki,=,16.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(F)c3F)c3ccccc32)CC1
CHEMBL212912,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.1,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Cl)c3ccccc32)CC1
CHEMBL377877,CHEMBL2056,Dopamine D1 receptor,Ki,=,16.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3Br)c3ccccc32)CC1
CHEMBL380236,CHEMBL2056,Dopamine D1 receptor,Ki,=,148.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(C(F)(F)F)c3)c3ccccc32)CC1
CHEMBL212905,CHEMBL2056,Dopamine D1 receptor,Ki,=,62.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3cccc(C#N)c3)c3ccccc32)CC1
CHEMBL215885,CHEMBL2056,Dopamine D1 receptor,Ki,=,47.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1ccc(C(=O)NN2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc1
CHEMBL212334,CHEMBL2056,Dopamine D1 receptor,Ki,=,68.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccc(C#N)cc3)c3ccccc32)CC1
CHEMBL212608,CHEMBL2056,Dopamine D1 receptor,Ki,=,157.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(NC(=O)c3ccccc3)c3ccccc32)CC1
CHEMBL379560,CHEMBL2056,Dopamine D1 receptor,Ki,=,13.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1ccccc1C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL211910,CHEMBL2056,Dopamine D1 receptor,Ki,=,60.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,COc1ccccc1CNN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL212384,CHEMBL2056,Dopamine D1 receptor,Ki,=,175.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,CN1CCN(C2=Nc3cc(Cl)ccc3N(C(=O)Nc3cc(Cl)cc(Cl)c3)c3ccccc32)CC1
CHEMBL377452,CHEMBL2056,Dopamine D1 receptor,Ki,=,71.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1ccccc1S(=O)(=O)N1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL209805,CHEMBL2056,Dopamine D1 receptor,Ki,=,65.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1ccc(S(=O)(=O)N2c3ccc(Cl)cc3N=C(N3CCN(C)CC3)c3ccccc32)cc1
CHEMBL378543,CHEMBL2056,Dopamine D1 receptor,Ki,=,1232.0,nM,CHEMBL911523,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor expressed in CHO cells,CHEMBL1146903,KI,Cc1ccccc1C(=O)N1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL215581,CHEMBL2056,Dopamine D1 receptor,Ki,=,25.6,nM,CHEMBL870467,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL1146871,KI,CCCC(CCC)C(=O)NN1c2ccc(Cl)cc2N=C(N2CCN(C)CC2)c2ccccc21
CHEMBL441618,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.9,nM,CHEMBL908356,B,Displacement of [3H]SCH 23390 from human D1 dopamine receptor expressed in HEK293 cells,CHEMBL1137400,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL216258,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.2,nM,CHEMBL908356,B,Displacement of [3H]SCH 23390 from human D1 dopamine receptor expressed in HEK293 cells,CHEMBL1137400,KI,CN1CCCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL216439,CHEMBL2056,Dopamine D1 receptor,Ki,=,163.5,nM,CHEMBL908356,B,Displacement of [3H]SCH 23390 from human D1 dopamine receptor expressed in HEK293 cells,CHEMBL1137400,KI,CN1CCCc2c([nH]c3ccccc23)Cc2ccccc2CC1
CHEMBL217299,CHEMBL2056,Dopamine D1 receptor,Ki,=,98.0,nM,CHEMBL912417,B,Binding affinity to human cloned dopamine D1 receptor,CHEMBL1137342,KI,Oc1cc2c(cc1O)C1c3ccccc3CNC1CO2
CHEMBL389356,CHEMBL2056,Dopamine D1 receptor,Ki,=,13.9,nM,CHEMBL895723,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor,CHEMBL1148752,KI,CN1CCCc2cc(O)ccc2Cc2ccccc2CC1
CHEMBL397207,CHEMBL2056,Dopamine D1 receptor,Ki,=,579.0,nM,CHEMBL895723,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor,CHEMBL1148752,KI,COc1cc2c(cc1OC)Cc1ccccc1CCCN(C)CC2
CHEMBL394779,CHEMBL2056,Dopamine D1 receptor,Ki,=,70.0,nM,CHEMBL895723,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor,CHEMBL1148752,KI,CN1CCCc2ccccc2Cc2cc(O)ccc2CC1
CHEMBL231374,CHEMBL2056,Dopamine D1 receptor,Ki,=,137.0,nM,CHEMBL895723,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor,CHEMBL1148752,KI,COc1ccc2c(c1)Cc1ccccc1CCCN(C)CC2
CHEMBL396950,CHEMBL2056,Dopamine D1 receptor,Ki,=,291.0,nM,CHEMBL895723,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor,CHEMBL1148752,KI,Oc1ccc2c(c1)CCCNCCc1ccccc1C2
CHEMBL231171,CHEMBL2056,Dopamine D1 receptor,Ki,=,23.5,nM,CHEMBL895723,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor,CHEMBL1148752,KI,COc1ccc2c(c1)CCCN(C)CCCc1ccccc1C2
CHEMBL389559,CHEMBL2056,Dopamine D1 receptor,Ki,=,83.0,nM,CHEMBL895723,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor,CHEMBL1148752,KI,CN1CCCc2ccccc2Cc2ccc(O)cc2CCC1
CHEMBL276778,CHEMBL2056,Dopamine D1 receptor,Ki,=,18.5,nM,CHEMBL895723,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor,CHEMBL1148752,KI,COc1ccc2c(c1)CCN(C)CCCc1ccccc1C2
CHEMBL231070,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.2,nM,CHEMBL895723,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor,CHEMBL1148752,KI,CN1CCCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL389357,CHEMBL2056,Dopamine D1 receptor,Ki,=,29.4,nM,CHEMBL895723,B,Displacement of [3H]SCH 23390 from human dopamine D1 receptor,CHEMBL1148752,KI,COc1ccc2c(c1)CCCN(C)CCc1ccccc1C2
CHEMBL441618,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.9,nM,CHEMBL885886,B,Displacement of [3H]SCH 23390 from human cloned dopamine D1 receptor expressed in HEK 293 cells,CHEMBL1139077,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL201525,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.5,nM,CHEMBL885886,B,Displacement of [3H]SCH 23390 from human cloned dopamine D1 receptor expressed in HEK 293 cells,CHEMBL1139077,KI,CN1CCc2ccccc2Cc2ccccc2CC1
CHEMBL201170,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.39,nM,CHEMBL885886,B,Displacement of [3H]SCH 23390 from human cloned dopamine D1 receptor expressed in HEK 293 cells,CHEMBL1139077,KI,CN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL380330,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.5,nM,CHEMBL885886,B,Displacement of [3H]SCH 23390 from human cloned dopamine D1 receptor expressed in HEK 293 cells,CHEMBL1139077,KI,COc1ccc2c(c1)CCN(C)CCc1ccccc1C2
CHEMBL245764,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.0,nM,CHEMBL885886,B,Displacement of [3H]SCH 23390 from human cloned dopamine D1 receptor expressed in HEK 293 cells,CHEMBL1139077,KI,COc1ccc2c(c1)c1c(n2C)Cc2ccccc2CCN(C)CC1
CHEMBL245571,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.7,nM,CHEMBL885886,B,Displacement of [3H]SCH 23390 from human cloned dopamine D1 receptor expressed in HEK 293 cells,CHEMBL1139077,KI,CN1CCc2cc(O)ccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL396561,CHEMBL2056,Dopamine D1 receptor,Ki,=,19.0,nM,CHEMBL885886,B,Displacement of [3H]SCH 23390 from human cloned dopamine D1 receptor expressed in HEK 293 cells,CHEMBL1139077,KI,COc1ccc2c(c1)CCN(C)CCc1c([nH]c3ccccc13)C2
CHEMBL245570,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.56,nM,CHEMBL885886,B,Displacement of [3H]SCH 23390 from human cloned dopamine D1 receptor expressed in HEK 293 cells,CHEMBL1139077,KI,CN1CCc2ccccc2Cc2[nH]c3ccc(O)cc3c2CC1
CHEMBL396560,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.82,nM,CHEMBL885886,B,Displacement of [3H]SCH 23390 from human cloned dopamine D1 receptor expressed in HEK 293 cells,CHEMBL1139077,KI,COc1ccc2[nH]c3c(c2c1)CCN(C)CCc1ccccc1C3
CHEMBL431298,CHEMBL2056,Dopamine D1 receptor,Ki,=,120.0,nM,CHEMBL927707,B,Displacement of [3H]SCH-23390 from human cloned dopamine D1 receptor,CHEMBL1140794,KI,COc1ccc(NS(=O)(=O)c2sc3ccc(Cl)cc3c2C)cc1N1CCNCC1
CHEMBL404352,CHEMBL2056,Dopamine D1 receptor,Ki,=,1810.0,nM,CHEMBL927707,B,Displacement of [3H]SCH-23390 from human cloned dopamine D1 receptor,CHEMBL1140794,KI,CC1(c2cccc(O)c2)C(=O)Nc2cc(Cl)cc(Cl)c2C1=O
CHEMBL253096,CHEMBL2056,Dopamine D1 receptor,Ki,=,120.0,nM,CHEMBL927707,B,Displacement of [3H]SCH-23390 from human cloned dopamine D1 receptor,CHEMBL1140794,KI,CC1(c2cccc(OCc3ccccc3)c2)C(=O)Nc2cc(Cl)cc(Cl)c2C1=O
CHEMBL409662,CHEMBL2056,Dopamine D1 receptor,Ki,=,3360.0,nM,CHEMBL927099,B,Inhibition of dopamine D1 receptor,CHEMBL1144747,KI,CCC1(CCCCN2CCN(c3ccc(Cl)cc3)CC2)C(=O)Nc2cc(F)ccc21
CHEMBL411663,CHEMBL2056,Dopamine D1 receptor,Ki,=,1900.0,nM,CHEMBL927099,B,Inhibition of dopamine D1 receptor,CHEMBL1144747,KI,O=C1Nc2ccc(F)cc2C1CCCCN1CCN(c2ccccc2)CC1
CHEMBL260994,CHEMBL2056,Dopamine D1 receptor,Ki,=,2400.0,nM,CHEMBL927099,B,Inhibition of dopamine D1 receptor,CHEMBL1144747,KI,O=C1Nc2ccccc2C1CCCCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL3084502,CHEMBL2056,Dopamine D1 receptor,Ki,=,1220.0,nM,CHEMBL1033063,B,Displacement of [3H]SCH23390 from dopamine D1 receptor,CHEMBL1140093,KI,O[C@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12
CHEMBL445102,CHEMBL2056,Dopamine D1 receptor,Ki,=,722.0,nM,CHEMBL1033063,B,Displacement of [3H]SCH23390 from dopamine D1 receptor,CHEMBL1140093,KI,OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL3084515,CHEMBL2056,Dopamine D1 receptor,Ki,=,3930.0,nM,CHEMBL1033063,B,Displacement of [3H]SCH23390 from dopamine D1 receptor,CHEMBL1140093,KI,O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1coc2ccccc12
CHEMBL3084512,CHEMBL2056,Dopamine D1 receptor,Ki,=,3000.0,nM,CHEMBL1033063,B,Displacement of [3H]SCH23390 from dopamine D1 receptor,CHEMBL1140093,KI,O[C@@]1(c2ccc(Cl)cc2)C[C@H]2CC[C@@H](C1)N2Cc1csc2ccccc12
CHEMBL3084503,CHEMBL2056,Dopamine D1 receptor,Ki,=,1710.0,nM,CHEMBL1033063,B,Displacement of [3H]SCH23390 from dopamine D1 receptor,CHEMBL1140093,KI,O[C@@]1(c2ccc(Cl)c(Cl)c2)C[C@H]2CC[C@@H](C1)N2Cc1c[nH]c2ccccc12
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.38,nM,CHEMBL953136,B,Displacement of radiolabeled SCH 23390 from human dopamine D1 receptor,CHEMBL1140203,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL477961,CHEMBL2056,Dopamine D1 receptor,Ki,=,1698.24,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCN1CCCN1CCN(c2ccccn2)CC1
CHEMBL516270,CHEMBL2056,Dopamine D1 receptor,Ki,=,1737.8,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCN1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1
CHEMBL517349,CHEMBL2056,Dopamine D1 receptor,Ki,=,1445.44,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCN1CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL476641,CHEMBL2056,Dopamine D1 receptor,Ki,=,2511.89,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,COc1ccccc1N1CCN(CCCN2CCCc3ccccc3C2=O)CC1
CHEMBL477446,CHEMBL2056,Dopamine D1 receptor,Ki,=,4897.79,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCCN1CCCN1CCN(c2cccc(C(F)(F)F)c2)CC1
CHEMBL477055,CHEMBL2056,Dopamine D1 receptor,Ki,=,2398.83,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCCN1CCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL477434,CHEMBL2056,Dopamine D1 receptor,Ki,=,2041.74,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccn2)CC1
CHEMBL477646,CHEMBL2056,Dopamine D1 receptor,Ki,=,1778.28,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCN1CCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL514382,CHEMBL2056,Dopamine D1 receptor,Ki,=,346.74,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCN1CCCCN1CCN(c2ccccc2Cl)CC1
CHEMBL478688,CHEMBL2056,Dopamine D1 receptor,Ki,=,426.58,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,COc1cccc(N2CCN(CCCCN3CCc4ccccc4C3=O)CC2)c1
CHEMBL477206,CHEMBL2056,Dopamine D1 receptor,Ki,=,2691.53,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,COc1ccccc1N1CCN(CCCCN2CCCc3ccccc3C2=O)CC1
CHEMBL476185,CHEMBL2056,Dopamine D1 receptor,Ki,=,281.84,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCCN1CCCCN1CCN(c2ccccn2)CC1
CHEMBL476393,CHEMBL2056,Dopamine D1 receptor,Ki,=,8709.64,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCCN1CCCCN1CCN(c2ncccn2)CC1
CHEMBL476394,CHEMBL2056,Dopamine D1 receptor,Ki,=,1737.8,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,O=C1c2ccccc2CCCN1CCCCN1CCN(c2cccc(Cl)c2Cl)CC1
CHEMBL476808,CHEMBL2056,Dopamine D1 receptor,Ki,=,977.24,nM,CHEMBL993529,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1153914,KI,COc1ccccc1N1CCN(CCCCCN2CCc3ccccc3C2=O)CC1
CHEMBL402143,CHEMBL2056,Dopamine D1 receptor,Ki,=,899.0,nM,CHEMBL961042,B,Inhibition of human cloned dopamine D1 receptor by competitive binding experiment,CHEMBL1153452,KI,COc1c(OCCF)cccc1C(O)C1CCN(CCc2ccc(F)cc2)CC1
CHEMBL515472,CHEMBL2056,Dopamine D1 receptor,Ki,=,3828.0,nM,CHEMBL961042,B,Inhibition of human cloned dopamine D1 receptor by competitive binding experiment,CHEMBL1153452,KI,COc1c(OCCF)cccc1[C@H](O)C1CCN(CCc2ccc(F)cc2)CC1
CHEMBL516088,CHEMBL2056,Dopamine D1 receptor,Ki,=,1410.0,nM,CHEMBL961042,B,Inhibition of human cloned dopamine D1 receptor by competitive binding experiment,CHEMBL1153452,KI,COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(F)cc2)CC1
CHEMBL476839,CHEMBL2056,Dopamine D1 receptor,Ki,=,1759.0,nM,CHEMBL961042,B,Inhibition of human cloned dopamine D1 receptor by competitive binding experiment,CHEMBL1153452,KI,COc1c(OCCF)cccc1C(O)C1CCN(CCc2ccc(C)cc2)CC1
CHEMBL490632,CHEMBL2056,Dopamine D1 receptor,Ki,=,1930.0,nM,CHEMBL961042,B,Inhibition of human cloned dopamine D1 receptor by competitive binding experiment,CHEMBL1153452,KI,COc1c(OCCF)cccc1C(=O)C1CCN(CCc2ccc(C)cc2)CC1
CHEMBL139926,CHEMBL2056,Dopamine D1 receptor,Ki,=,2100.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL124444,CHEMBL2056,Dopamine D1 receptor,Ki,=,2000.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3o2)CC1
CHEMBL184383,CHEMBL2056,Dopamine D1 receptor,Ki,=,2920.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2cc(I)ccc2o1
CHEMBL182379,CHEMBL2056,Dopamine D1 receptor,Ki,=,900.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3cc(I)ccc3o2)CC1
CHEMBL59725,CHEMBL2056,Dopamine D1 receptor,Ki,=,1195.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,O=C(NCCCCN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL424294,CHEMBL2056,Dopamine D1 receptor,Ki,=,800.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL1627323,CHEMBL2056,Dopamine D1 receptor,Ki,=,931.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL366904,CHEMBL2056,Dopamine D1 receptor,Ki,=,1460.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2o1
CHEMBL1627324,CHEMBL2056,Dopamine D1 receptor,Ki,=,990.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc3ccccc3o2)CC1
CHEMBL175734,CHEMBL2056,Dopamine D1 receptor,Ki,=,1730.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,O=C(NC/C=C/CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2s1
CHEMBL1627304,CHEMBL2056,Dopamine D1 receptor,Ki,=,678.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,COc1ccccc1N1CCN(C/C=C/CNC(=O)c2cc3ccccc3s2)CC1
CHEMBL1627305,CHEMBL2056,Dopamine D1 receptor,Ki,=,4630.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,O=C(NCCC(O)CN1CCN(c2cccc(Cl)c2Cl)CC1)c1cc2ccccc2[nH]1
CHEMBL1627309,CHEMBL2056,Dopamine D1 receptor,Ki,=,4960.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,CCCOc1ccccc1N1CCN(CC(O)CCNC(=O)c2cc3ccccc3[nH]2)CC1
CHEMBL1627311,CHEMBL2056,Dopamine D1 receptor,Ki,=,5060.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2cc3cc(F)ccc3[nH]2)CC1
CHEMBL1627319,CHEMBL2056,Dopamine D1 receptor,Ki,=,3690.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2cc3cc(I)ccc3o2)CC1
CHEMBL1627320,CHEMBL2056,Dopamine D1 receptor,Ki,=,6650.0,nM,CHEMBL961824,B,Displacement of [3H]SCH23390 from D1 receptor,CHEMBL1153455,KI,COc1ccccc1N1CCN(CC(O)CCNC(=O)c2cc3ccccc3s2)CC1
CHEMBL479587,CHEMBL2056,Dopamine D1 receptor,Ki,=,37.3,nM,CHEMBL1013926,B,Displacement of [3H]SCH23390 from dopamine D1 receptor,CHEMBL1147348,KI,CC(C)(C)[C@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL441618,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.862,nM,CHEMBL982102,B,Displacement of [3H]SCH23390 from human cloned dopamine D1 receptor,CHEMBL1157471,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL459871,CHEMBL2056,Dopamine D1 receptor,Ki,=,63.1,nM,CHEMBL982102,B,Displacement of [3H]SCH23390 from human cloned dopamine D1 receptor,CHEMBL1157471,KI,Oc1ccc2c(c1)CCNCCc1ccccc1C2
CHEMBL389357,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.18,nM,CHEMBL982102,B,Displacement of [3H]SCH23390 from human cloned dopamine D1 receptor,CHEMBL1157471,KI,COc1ccc2c(c1)CCCN(C)CCc1ccccc1C2
CHEMBL508399,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.715,nM,CHEMBL982102,B,Displacement of [3H]SCH23390 from human cloned dopamine D1 receptor,CHEMBL1157471,KI,CCN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL276778,CHEMBL2056,Dopamine D1 receptor,Ki,=,21.88,nM,CHEMBL982102,B,Displacement of [3H]SCH23390 from human cloned dopamine D1 receptor,CHEMBL1157471,KI,COc1ccc2c(c1)CCN(C)CCCc1ccccc1C2
CHEMBL231070,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.667,nM,CHEMBL982102,B,Displacement of [3H]SCH23390 from human cloned dopamine D1 receptor,CHEMBL1157471,KI,CN1CCCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL380330,CHEMBL2056,Dopamine D1 receptor,Ki,=,22.91,nM,CHEMBL982102,B,Displacement of [3H]SCH23390 from human cloned dopamine D1 receptor,CHEMBL1157471,KI,COc1ccc2c(c1)CCN(C)CCc1ccccc1C2
CHEMBL201525,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.467,nM,CHEMBL982102,B,Displacement of [3H]SCH23390 from human cloned dopamine D1 receptor,CHEMBL1157471,KI,CN1CCc2ccccc2Cc2ccccc2CC1
CHEMBL203637,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.8128,nM,CHEMBL982102,B,Displacement of [3H]SCH23390 from human cloned dopamine D1 receptor,CHEMBL1157471,KI,CN1CCc2ccccc2Cc2ccc(O)c(Cl)c2CC1
CHEMBL201170,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.3548,nM,CHEMBL982102,B,Displacement of [3H]SCH23390 from human cloned dopamine D1 receptor,CHEMBL1157471,KI,CN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL245570,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.5623,nM,CHEMBL982102,B,Displacement of [3H]SCH23390 from human cloned dopamine D1 receptor,CHEMBL1157471,KI,CN1CCc2ccccc2Cc2[nH]c3ccc(O)cc3c2CC1
CHEMBL216439,CHEMBL2056,Dopamine D1 receptor,Ki,=,158.49,nM,CHEMBL982102,B,Displacement of [3H]SCH23390 from human cloned dopamine D1 receptor,CHEMBL1157471,KI,CN1CCCc2c([nH]c3ccccc23)Cc2ccccc2CC1
CHEMBL216258,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.042,nM,CHEMBL982102,B,Displacement of [3H]SCH23390 from human cloned dopamine D1 receptor,CHEMBL1157471,KI,CN1CCCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.8,nM,CHEMBL937843,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1155028,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL53,CHEMBL2056,Dopamine D1 receptor,Ki,=,290.0,nM,CHEMBL937843,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1155028,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL455051,CHEMBL2056,Dopamine D1 receptor,Ki,=,2920.0,nM,CHEMBL937843,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1155028,KI,CN1CCc2cc(N)cc3c2[C@H]1Cc1cccc(N)c1-3
CHEMBL506721,CHEMBL2056,Dopamine D1 receptor,Ki,=,78.0,nM,CHEMBL937843,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1155028,KI,COc1cc2c3c(c1)-c1c(N)cccc1C[C@H]3N(C)CC2
CHEMBL482276,CHEMBL2056,Dopamine D1 receptor,Ki,=,116.0,nM,CHEMBL937843,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1155028,KI,CCCCC(=O)Oc1cccc2c1-c1cc(OC)cc3c1[C@@H](C2)N(C)CC3
CHEMBL520610,CHEMBL2056,Dopamine D1 receptor,Ki,=,2520.0,nM,CHEMBL937843,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1155028,KI,CN1CCc2c3c(cc4nc(N)sc24)-c2c(ccc(O)c2O)C[C@H]31
CHEMBL505308,CHEMBL2056,Dopamine D1 receptor,Ki,=,190.0,nM,CHEMBL993383,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1142503,KI,Br.Oc1cc2c(cc1O)C(c1ccccc1)CNCC2
CHEMBL503958,CHEMBL2056,Dopamine D1 receptor,Ki,=,26.0,nM,CHEMBL993383,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1142503,KI,Br.Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2
CHEMBL520992,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.18,nM,CHEMBL993383,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1142503,KI,Br.Cc1cccc(C2CN(C)CCc3c2cc(O)c(O)c3Cl)c1
CHEMBL484352,CHEMBL2056,Dopamine D1 receptor,Ki,=,346.0,nM,CHEMBL993383,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1142503,KI,Br.Oc1cc2c(c(-c3ccccc3)c1O)CCNCC2c1ccccc1
CHEMBL484356,CHEMBL2056,Dopamine D1 receptor,Ki,=,39.0,nM,CHEMBL993383,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1142503,KI,Br.Cc1cccc(-c2c(O)c(O)cc3c2CCNCC3c2ccccc2)c1
CHEMBL485036,CHEMBL2056,Dopamine D1 receptor,Ki,=,190.0,nM,CHEMBL993383,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1142503,KI,Br.Oc1cc2c(c(-c3ccc(Cl)cc3)c1O)CCNCC2c1ccccc1
CHEMBL485041,CHEMBL2056,Dopamine D1 receptor,Ki,=,422.0,nM,CHEMBL993383,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1142503,KI,Br.Oc1cc2c(c(-c3ccc(F)cc3)c1O)CCNCC2c1ccccc1
CHEMBL485207,CHEMBL2056,Dopamine D1 receptor,Ki,=,56.0,nM,CHEMBL993383,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1142503,KI,Br.Oc1cc2c(c(-c3ccc4ccccc4c3)c1O)CCNCC2c1ccccc1
CHEMBL484538,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.81,nM,CHEMBL993383,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1142503,KI,Br.Cc1cccc(-c2c(O)c(O)cc3c2CCN(C)CC3c2cccc(C)c2)c1
CHEMBL520821,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.88,nM,CHEMBL993383,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1142503,KI,Br.Cc1cccc(C2CN(C)CCc3c2cc(O)c(O)c3-c2ccc3ccccc3c2)c1
CHEMBL27559,CHEMBL2056,Dopamine D1 receptor,Ki,=,45.0,nM,CHEMBL989749,B,Displacement of [3H]8OH-DPAT from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1144215,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3
CHEMBL516580,CHEMBL2056,Dopamine D1 receptor,Ki,=,31.0,nM,CHEMBL989749,B,Displacement of [3H]8OH-DPAT from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1144215,KI,CCCCCCC(=O)Oc1cccc2c1-c1cccc3c1[C@@H](C2)N(CCC)CC3
CHEMBL515342,CHEMBL2056,Dopamine D1 receptor,Ki,=,10.0,nM,CHEMBL989749,B,Displacement of [3H]8OH-DPAT from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1144215,KI,CCCCCC(=O)Oc1cccc2c1-c1cccc3c1[C@@H](C2)N(CCC)CC3
CHEMBL478671,CHEMBL2056,Dopamine D1 receptor,Ki,=,12.0,nM,CHEMBL989749,B,Displacement of [3H]8OH-DPAT from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1144215,KI,CCCC(=O)Oc1cccc2c1-c1cccc3c1[C@@H](C2)N(CCC)CC3
CHEMBL515187,CHEMBL2056,Dopamine D1 receptor,Ki,=,18.0,nM,CHEMBL989749,B,Displacement of [3H]8OH-DPAT from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1144215,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)CC)c1-3
CHEMBL403550,CHEMBL2056,Dopamine D1 receptor,Ki,=,23.0,nM,CHEMBL989749,B,Displacement of [3H]8OH-DPAT from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL1144215,KI,CCCCC(=O)Oc1cccc2c1-c1cccc3c1[C@@H](C2)N(CCC)CC3
CHEMBL54,CHEMBL2056,Dopamine D1 receptor,Ki,=,120.0,nM,CHEMBL992741,B,Binding affinity to human cloned dopamine D1 receptor,CHEMBL1155799,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL716,CHEMBL2056,Dopamine D1 receptor,Ki,=,1300.0,nM,CHEMBL992741,B,Binding affinity to human cloned dopamine D1 receptor,CHEMBL1155799,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL715,CHEMBL2056,Dopamine D1 receptor,Ki,=,52.0,nM,CHEMBL992741,B,Binding affinity to human cloned dopamine D1 receptor,CHEMBL1155799,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL708,CHEMBL2056,Dopamine D1 receptor,Ki,=,130.0,nM,CHEMBL992741,B,Binding affinity to human cloned dopamine D1 receptor,CHEMBL1155799,KI,O=C1Cc2cc(CCN3CCN(c4nsc5ccccc45)CC3)c(Cl)cc2N1
CHEMBL85,CHEMBL2056,Dopamine D1 receptor,Ki,=,580.0,nM,CHEMBL992741,B,Binding affinity to human cloned dopamine D1 receptor,CHEMBL1155799,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL476108,CHEMBL2056,Dopamine D1 receptor,Ki,=,162.7,nM,CHEMBL992741,B,Binding affinity to human cloned dopamine D1 receptor,CHEMBL1155799,KI,O=C(CCCN1CCCN(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,290.0,nM,CHEMBL992741,B,Binding affinity to human cloned dopamine D1 receptor,CHEMBL1155799,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL629,CHEMBL2056,Dopamine D1 receptor,Ki,=,89.0,nM,CHEMBL1030598,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL1149085,KI,CN(C)CCC=C1c2ccccc2CCc2ccccc21
CHEMBL457957,CHEMBL2056,Dopamine D1 receptor,Ki,=,879.0,nM,CHEMBL1030598,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL1149085,KI,CN(CCC=C1c2ccccc2CCc2ccccc21)C(=O)Cc1ccc(OCCCN2CCCCC2)cc1
CHEMBL459350,CHEMBL2056,Dopamine D1 receptor,Ki,=,305.0,nM,CHEMBL1030598,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL1149085,KI,CN(CCC=C1c2ccccc2CCc2ccccc21)Cc1ccc(OCCCN2CCCCC2)cc1
CHEMBL21731,CHEMBL2056,Dopamine D1 receptor,Ki,=,402.0,nM,CHEMBL1030598,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL1149085,KI,CNCCCC12CCC(c3ccccc31)c1ccccc12
CHEMBL517244,CHEMBL2056,Dopamine D1 receptor,Ki,=,203.0,nM,CHEMBL1030598,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL1149085,KI,CN(CCCC12CCC(c3ccccc31)c1ccccc12)Cc1ccc(OCCCN2CCCCC2)cc1
CHEMBL71,CHEMBL2056,Dopamine D1 receptor,Ki,=,96.0,nM,CHEMBL1030598,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL1149085,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL459373,CHEMBL2056,Dopamine D1 receptor,Ki,=,232.0,nM,CHEMBL1030598,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL1149085,KI,CN(CCCN1c2ccccc2Sc2ccc(Cl)cc21)Cc1ccc(OCCCN2CCCCC2)cc1
CHEMBL517407,CHEMBL2056,Dopamine D1 receptor,Ki,=,248.0,nM,CHEMBL1030598,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL1149085,KI,CN(CC/C=C1\c2ccccc2Sc2ccc(Cl)cc21)Cc1ccc(OCCCN2CCCCC2)cc1
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,89.0,nM,CHEMBL1030598,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL1149085,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL464811,CHEMBL2056,Dopamine D1 receptor,Ki,=,866.0,nM,CHEMBL1030598,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL1149085,KI,Clc1ccc2c(c1)N=C(N1CCN(Cc3ccc(OCCCN4CCCCC4)cc3)CC1)c1ccccc1N2
CHEMBL726,CHEMBL2056,Dopamine D1 receptor,Ki,=,179.0,nM,CHEMBL1030598,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL1149085,KI,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
CHEMBL455288,CHEMBL2056,Dopamine D1 receptor,Ki,=,203.0,nM,CHEMBL1030598,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL1149085,KI,O=C(OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1)c1ccc(OCCCN2CCCCC2)cc1
CHEMBL908,CHEMBL2056,Dopamine D1 receptor,Ki,=,18.0,nM,CHEMBL1030598,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL1149085,KI,CN(C)CC/C=C1/c2ccccc2Sc2ccc(Cl)cc21
CHEMBL59,CHEMBL2056,Dopamine D1 receptor,Ki,=,124.0,nM,CHEMBL1053912,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in Ltk deficient fibroblast cells by liquid scintillation counting,CHEMBL1152940,KI,NCCc1ccc(O)c(O)c1
CHEMBL53,CHEMBL2056,Dopamine D1 receptor,Ki,=,72.0,nM,CHEMBL1053912,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in Ltk deficient fibroblast cells by liquid scintillation counting,CHEMBL1152940,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL465054,CHEMBL2056,Dopamine D1 receptor,Ki,=,88.0,nM,CHEMBL1053912,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in Ltk deficient fibroblast cells by liquid scintillation counting,CHEMBL1152940,KI,CN1CCc2cc(-c3ccccc3)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL517028,CHEMBL2056,Dopamine D1 receptor,Ki,=,755.0,nM,CHEMBL1053912,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in Ltk deficient fibroblast cells by liquid scintillation counting,CHEMBL1152940,KI,CN1CCc2cc(-c3ccc(O)cc3)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL562460,CHEMBL2056,Dopamine D1 receptor,Ki,=,1340.0,nM,CHEMBL1053912,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in Ltk deficient fibroblast cells by liquid scintillation counting,CHEMBL1152940,KI,CCN1CCc2cc(C)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL564909,CHEMBL2056,Dopamine D1 receptor,Ki,=,31.0,nM,CHEMBL1053912,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in Ltk deficient fibroblast cells by liquid scintillation counting,CHEMBL1152940,KI,CCN1CCc2cc(-c3ccccc3)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL562935,CHEMBL2056,Dopamine D1 receptor,Ki,=,124.0,nM,CHEMBL1053912,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in Ltk deficient fibroblast cells by liquid scintillation counting,CHEMBL1152940,KI,CCN1CCc2cc(-c3ccc(O)cc3)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL550180,CHEMBL2056,Dopamine D1 receptor,Ki,=,278.0,nM,CHEMBL1053912,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in Ltk deficient fibroblast cells by liquid scintillation counting,CHEMBL1152940,KI,CCCN1CCc2cc(C)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL550792,CHEMBL2056,Dopamine D1 receptor,Ki,=,669.0,nM,CHEMBL1053912,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in Ltk deficient fibroblast cells by liquid scintillation counting,CHEMBL1152940,KI,CCCN1CCc2cc(-c3ccccc3)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL560721,CHEMBL2056,Dopamine D1 receptor,Ki,=,94.0,nM,CHEMBL1053912,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in Ltk deficient fibroblast cells by liquid scintillation counting,CHEMBL1152940,KI,CCCN1CCc2cc(-c3ccc(O)cc3)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL286080,CHEMBL2056,Dopamine D1 receptor,Ki,=,393.0,nM,CHEMBL1041329,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,Oc1cc2c(cc1O)C(c1ccccc1)CNCC2
CHEMBL574558,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.93,nM,CHEMBL1041329,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,Cc1cccc(C2CN(C)CCc3c2cc(O)c(O)c3Cl)c1
CHEMBL574595,CHEMBL2056,Dopamine D1 receptor,Ki,=,501.0,nM,CHEMBL1041329,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,COc1ccccc1N1CCN(CCCn2cc(CCCN3CCc4cc(O)c(O)cc4C(c4ccccc4C)C3)nn2)CC1
CHEMBL574627,CHEMBL2056,Dopamine D1 receptor,Ki,=,963.0,nM,CHEMBL1041329,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,Cc1cccc(C2CN(CCCc3cn(CCCN4CCN(c5ncccn5)CC4)nn3)CCc3cc(O)c(O)cc32)c1
CHEMBL585740,CHEMBL2056,Dopamine D1 receptor,Ki,=,655.0,nM,CHEMBL1041329,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,COc1ccccc1N1CCN(CCCn2cc(CCCN3CCc4cc(O)c(O)cc4C(c4cccc(C)c4)C3)nn2)CC1
CHEMBL585741,CHEMBL2056,Dopamine D1 receptor,Ki,=,221.0,nM,CHEMBL1041329,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,Cc1cccc(C2CN(CCCc3cn(CCCN4CCN(c5nsc6ccccc56)CC4)nn3)CCc3cc(O)c(O)cc32)c1
CHEMBL585742,CHEMBL2056,Dopamine D1 receptor,Ki,=,492.0,nM,CHEMBL1041329,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,COc1ccccc1N1CCN(CCCn2cc(CN3CCc4cc(O)c(O)cc4C(c4cccc(C)c4)C3)nn2)CC1
CHEMBL582945,CHEMBL2056,Dopamine D1 receptor,Ki,=,144.0,nM,CHEMBL1041329,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,COc1ccccc1N1CCN(CCCn2cc(CCCCN3CCc4cc(O)c(O)cc4C(c4cccc(C)c4)C3)nn2)CC1
CHEMBL574700,CHEMBL2056,Dopamine D1 receptor,Ki,=,551.0,nM,CHEMBL1041329,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1154108,KI,COc1ccccc1N1CCN(CCCc2cn(CCCN3CCc4cc(O)c(O)cc4C(c4ccccc4C)C3)nn2)CC1
CHEMBL572708,CHEMBL2056,Dopamine D1 receptor,Ki,=,134.9,nM,CHEMBL1059283,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1154195,KI,O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2ncncc21
CHEMBL566508,CHEMBL2056,Dopamine D1 receptor,Ki,=,33.11,nM,CHEMBL1059283,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1154195,KI,CSc1ncc2c(n1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O
CHEMBL576756,CHEMBL2056,Dopamine D1 receptor,Ki,=,42.66,nM,CHEMBL1059283,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1154195,KI,CNc1ncc2c(n1)CC(CN1CCC(c3noc4cc(F)ccc34)CC1)CC2=O
CHEMBL54,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.166,nM,CHEMBL1059283,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1154195,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,21.38,nM,CHEMBL1059283,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1154195,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL85,CHEMBL2056,Dopamine D1 receptor,Ki,=,147.91,nM,CHEMBL1059283,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1154195,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL593395,CHEMBL2056,Dopamine D1 receptor,Ki,=,2116.0,nM,CHEMBL1038852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,COc1ccc2c(c1)CCN1CCc3ccccc3C21
CHEMBL380330,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.5,nM,CHEMBL1038852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,COc1ccc2c(c1)CCN(C)CCc1ccccc1C2
CHEMBL201170,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.39,nM,CHEMBL1038852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,CN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL487387,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.9,nM,CHEMBL1038852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL596448,CHEMBL2056,Dopamine D1 receptor,Ki,=,183.0,nM,CHEMBL1038852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,COc1ccc2c(c1)CCN1Cc3ccccc3CC21
CHEMBL593897,CHEMBL2056,Dopamine D1 receptor,Ki,=,136.0,nM,CHEMBL1038852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,Oc1ccc2c(c1)CCN1Cc3ccccc3CC21
CHEMBL593394,CHEMBL2056,Dopamine D1 receptor,Ki,=,1727.0,nM,CHEMBL1038852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,COc1ccc2c(c1)CCN(C)Cc1ccccc1CC2
CHEMBL25856,CHEMBL2056,Dopamine D1 receptor,Ki,=,35.7,nM,CHEMBL1038852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2
CHEMBL594789,CHEMBL2056,Dopamine D1 receptor,Ki,=,1264.0,nM,CHEMBL1038852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,COc1ccc2c(c1)CCCN(C)Cc1ccccc1C2
CHEMBL596179,CHEMBL2056,Dopamine D1 receptor,Ki,=,2070.0,nM,CHEMBL1038852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,CN1CCCc2cc(O)ccc2Cc2ccccc2C1
CHEMBL610449,CHEMBL2056,Dopamine D1 receptor,Ki,=,4748.0,nM,CHEMBL1038852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,CN1CCCc2cc3c(cc2-c2ccccc2CC1)OCO3
CHEMBL594798,CHEMBL2056,Dopamine D1 receptor,Ki,=,3019.0,nM,CHEMBL1038852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,Cc1ccccc1CC1c2ccc(O)cc2CCN1C
CHEMBL594127,CHEMBL2056,Dopamine D1 receptor,Ki,=,2349.0,nM,CHEMBL1038852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells by scintillation counting,CHEMBL1152600,KI,COc1ccc2c(c1)CCN(C)C2Cc1ccccc1C
CHEMBL467094,CHEMBL2056,Dopamine D1 receptor,Ki,=,895.0,nM,CHEMBL1066742,B,Displacement of [3H]SCH233930 from human dopamine D1 receptor,CHEMBL1153197,KI,COc1cc2c3c(c1OC)-c1cc4c(cc1CC3N(C)CC2)OCO4
CHEMBL270426,CHEMBL2056,Dopamine D1 receptor,Ki,=,46.0,nM,CHEMBL1065706,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1159064,KI,COc1cc2c3c(c1)-c1c(O)cccc1C[C@H]3N(C)CC2
CHEMBL119455,CHEMBL2056,Dopamine D1 receptor,Ki,=,61.0,nM,CHEMBL1065706,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells by liquid scintillation counting,CHEMBL1159064,KI,CN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.4,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL596622,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.9,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CNC3CCC3)cc2)C1
CHEMBL596824,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.2,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CC(=O)N(Cc1ccc([C@H]2CN(C)CCc3cc(Cl)c(O)cc32)cc1)C1CCC1
CHEMBL599282,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.5,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CN(C3CCC3)S(C)(=O)=O)cc2)C1
CHEMBL603901,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.5,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CN(C)S(C)(=O)=O)cc2)C1
CHEMBL599487,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.6,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CN(C)S(=O)(=O)c3ccccc3)cc2)C1
CHEMBL604108,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.0,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CNc3ccccc3)cc2)C1
CHEMBL597702,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.7,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccc(CN(Cc3ccccc3)c3ccc(F)cc3F)cc2)C1
CHEMBL298406,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.2,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21
CHEMBL598515,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.0,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccc(N)cc3CC[C@@H]21
CHEMBL598516,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.3,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccc(NC(=O)C4CC4)cc3CC[C@@H]21
CHEMBL597909,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.5,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccc(NS(C)(=O)=O)cc3CC[C@@H]21
CHEMBL600986,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.7,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CCS(=O)(=O)Nc1ccc2c(c1)CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL600987,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.5,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CCNC(=O)Nc1ccc2c(c1)CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL599977,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.7,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccc(NC(=O)Nc4c(Cl)cccc4Cl)cc3CC[C@@H]21
CHEMBL603485,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.4,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CCOC(=O)Nc1ccc2c(c1)CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL591685,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.8,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(N)c3CC[C@@H]21
CHEMBL602659,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.7,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(NC(=O)C4CC4)c3CC[C@@H]21
CHEMBL604135,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.7,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(NS(C)(=O)=O)c3CC[C@@H]21
CHEMBL602052,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.8,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CCS(=O)(=O)Nc1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL604132,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.4,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CCNC(=O)Nc1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL604129,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.1,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(NC(=O)Nc4c(Cl)cccc4Cl)c3CC[C@@H]21
CHEMBL601634,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.3,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CCC(=O)Nc1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL601635,CHEMBL2056,Dopamine D1 receptor,Ki,=,152.0,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cc(CN4CCN(c5ccccn5)CC4)ccc3CC[C@@H]21
CHEMBL600998,CHEMBL2056,Dopamine D1 receptor,Ki,=,225.0,nM,CHEMBL1073807,B,Binding affinity to dopamine D1 receptor,CHEMBL1156835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cc(CN4CCCCC4)ccc3CC[C@@H]21
CHEMBL298406,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.2,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21
CHEMBL600083,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.0,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(Br)c3CC[C@@H]21
CHEMBL604316,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.6,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(C=O)c3CC[C@@H]21
CHEMBL599116,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.0,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(CO)c3CC[C@@H]21
CHEMBL604127,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.8,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(C#N)c3CC[C@@H]21
CHEMBL598730,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.3,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,COC(=O)c1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL598915,CHEMBL2056,Dopamine D1 receptor,Ki,=,38.0,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(C(=O)O)c3CC[C@@H]21
CHEMBL604314,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.6,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(O)c3CC[C@@H]21
CHEMBL598949,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.1,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(N4CCCC4=O)c3CC[C@@H]21
CHEMBL604732,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.6,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(/C=N/O)c3CC[C@@H]21
CHEMBL599134,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.4,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CO/N=C/c1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL604525,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.8,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CCO/N=C/c1cccc2c1CC[C@H]1[C@H]2c2cc(O)c(Cl)cc2CCN1C
CHEMBL599135,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.2,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(/C=N/OCc4ccccc4)c3CC[C@@H]21
CHEMBL605354,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.0,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(/C=N/Oc4ccccc4)c3CC[C@@H]21
CHEMBL599528,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.2,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4ccccc4)c3CC[C@@H]21
CHEMBL598104,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.4,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccc(F)c4)c3CC[C@@H]21
CHEMBL598105,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.6,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccc(C#N)c4)c3CC[C@@H]21
CHEMBL605339,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.6,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccc([N+](=O)[O-])c4)c3CC[C@@H]21
CHEMBL604383,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.3,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccc(OC(F)(F)F)c4)c3CC[C@H]21
CHEMBL597100,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.9,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cc(F)cc(F)c4)c3CC[C@@H]21
CHEMBL603872,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.7,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,COc1ccc(-c2cccc3c2CC[C@H]2[C@H]3c3cc(O)c(Cl)cc3CCN2C)cc1
CHEMBL597310,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.7,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN(C)c1ccc(-c2cccc3c2CC[C@H]2[C@H]3c3cc(O)c(Cl)cc3CCN2C)cc1
CHEMBL604176,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.7,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4ccc(CO)cc4)c3CC[C@@H]21
CHEMBL597900,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.9,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4cccs4)c3CC[C@@H]21
CHEMBL605127,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.3,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4ccncc4)c3CC[C@@H]21
CHEMBL597503,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.6,nM,CHEMBL1074769,B,Displacement of [3H]SCh23390 from dopamine D1 receptor expressed in mouse LTK cells by scintillation counting,CHEMBL1156846,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3cccc(-c4ccc5[nH]ccc5c4)c3CC[C@@H]21
CHEMBL1086789,CHEMBL2056,Dopamine D1 receptor,Ki,=,2101.0,nM,CHEMBL1105124,B,Displacement of [3H]SCH23390 from human recombinant dopamine D1 receptor expressed in HEK293 cells by microplate scintillation counting,CHEMBL1155427,KI,c1ccc2c(c1)CCN1CCc3[nH]c4ccccc4c3C21
CHEMBL1086790,CHEMBL2056,Dopamine D1 receptor,Ki,=,1836.0,nM,CHEMBL1105124,B,Displacement of [3H]SCH23390 from human recombinant dopamine D1 receptor expressed in HEK293 cells by microplate scintillation counting,CHEMBL1155427,KI,c1ccc2c(c1)CCN1CCc3cccc4[nH]cc(c34)C21
CHEMBL1087301,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.5,nM,CHEMBL1105124,B,Displacement of [3H]SCH23390 from human recombinant dopamine D1 receptor expressed in HEK293 cells by microplate scintillation counting,CHEMBL1155427,KI,CN1CCc2ccccc2Cc2c([nH]c3ccccc23)CC1
CHEMBL1087300,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.2,nM,CHEMBL1105124,B,Displacement of [3H]SCH23390 from human recombinant dopamine D1 receptor expressed in HEK293 cells by microplate scintillation counting,CHEMBL1155427,KI,CN1CCc2ccccc2Cc2c[nH]c3cccc(c23)CC1
CHEMBL1224527,CHEMBL2056,Dopamine D1 receptor,Ki,=,18000.0,nM,CHEMBL1225588,B,Binding affinity to dopamine D1 receptor,CHEMBL1221364,KI,Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21
CHEMBL53,CHEMBL2056,Dopamine D1 receptor,Ki,=,650.0,nM,CHEMBL1680103,B,Binding affinity to dopamine D1 receptor low binding site by radioligand displacement assay,CHEMBL1671824,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL225230,CHEMBL2056,Dopamine D1 receptor,Ki,=,490.0,nM,CHEMBL1680103,B,Binding affinity to dopamine D1 receptor low binding site by radioligand displacement assay,CHEMBL1671824,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL27559,CHEMBL2056,Dopamine D1 receptor,Ki,=,4300.0,nM,CHEMBL1680103,B,Binding affinity to dopamine D1 receptor low binding site by radioligand displacement assay,CHEMBL1671824,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(O)c1-3
CHEMBL1672308,CHEMBL2056,Dopamine D1 receptor,Ki,=,3700.0,nM,CHEMBL1680103,B,Binding affinity to dopamine D1 receptor low binding site by radioligand displacement assay,CHEMBL1671824,KI,CN1CCc2cc(OCCF)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL1672313,CHEMBL2056,Dopamine D1 receptor,Ki,=,340.0,nM,CHEMBL1680103,B,Binding affinity to dopamine D1 receptor low binding site by radioligand displacement assay,CHEMBL1671824,KI,CN1CCc2cc(OCCF)cc3c2[C@H]1Cc1cccc(O)c1-3
CHEMBL53,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.6,nM,CHEMBL1680104,B,Binding affinity to dopamine D1 receptor high binding site by radioligand displacement assay,CHEMBL1671824,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL225230,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.0,nM,CHEMBL1680104,B,Binding affinity to dopamine D1 receptor high binding site by radioligand displacement assay,CHEMBL1671824,KI,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL53294,CHEMBL2056,Dopamine D1 receptor,Ki,=,8.1,nM,CHEMBL1680104,B,Binding affinity to dopamine D1 receptor high binding site by radioligand displacement assay,CHEMBL1671824,KI,CCCN1CCc2cc(OC)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL1684128,CHEMBL2056,Dopamine D1 receptor,Ki,=,735.0,nM,CHEMBL1686532,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OCCCCN2CCN(c4ccccc4OC)CC2)c1-3
CHEMBL1684129,CHEMBL2056,Dopamine D1 receptor,Ki,=,910.0,nM,CHEMBL1686532,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OCCCN(CCCN2CCN(c4ccccc4OC)CC2)S(C)(=O)=O)c1-3
CHEMBL1684134,CHEMBL2056,Dopamine D1 receptor,Ki,=,1174.0,nM,CHEMBL1686532,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2[C@@H]1Cc1cccc(OCCCCN2CCN(c4ccccc4OC)CC2)c1-3
CHEMBL1684135,CHEMBL2056,Dopamine D1 receptor,Ki,=,1307.0,nM,CHEMBL1686532,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OCCCCN2CCN(c4ccccc4OC)CC2)c1-3
CHEMBL1684131,CHEMBL2056,Dopamine D1 receptor,Ki,=,1600.0,nM,CHEMBL1686532,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OCc2cn(CCCCN4CCN(c5ccccc5OC)CC4)nn2)c1-3
CHEMBL1684029,CHEMBL2056,Dopamine D1 receptor,Ki,=,1900.0,nM,CHEMBL1686532,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OCCCn2cc(CCCCN4CCN(c5ccccc5OC)CC4)nn2)c1-3
CHEMBL1684024,CHEMBL2056,Dopamine D1 receptor,Ki,=,2007.0,nM,CHEMBL1686532,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OCc2cn(CCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn2)c1-3
CHEMBL1684028,CHEMBL2056,Dopamine D1 receptor,Ki,=,2700.0,nM,CHEMBL1686532,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in human HEK293 cells by liquid scintillation counter,CHEMBL1681760,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OCc2cn(CCCCN4CCN(c5ccccc5OC)CC4)nn2)c1-3
CHEMBL1779058,CHEMBL2056,Dopamine D1 receptor,Ki,=,209.0,nM,CHEMBL1781412,B,Displacement of [3H]SCH233930 from human D1 receptor expressed in HEK cells,CHEMBL1777734,KI,O=C(CCCN1C2C3C4CC5C6C4C2C6C1(O)C53)c1ccc(F)cc1
CHEMBL54,CHEMBL2056,Dopamine D1 receptor,Ki,=,25.0,nM,CHEMBL1781412,B,Displacement of [3H]SCH233930 from human D1 receptor expressed in HEK cells,CHEMBL1777734,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL53,CHEMBL2056,Dopamine D1 receptor,Ki,=,72.0,nM,CHEMBL1803357,B,Displacement of [3H]SCH23390 from human D1 dopamine receptor expressed in Ltk fibroblast cells after 60 mins by liquid scintillation counter,CHEMBL1799928,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL3216980,CHEMBL2056,Dopamine D1 receptor,Ki,=,4200.0,nM,CHEMBL1803357,B,Displacement of [3H]SCH23390 from human D1 dopamine receptor expressed in Ltk fibroblast cells after 60 mins by liquid scintillation counter,CHEMBL1799928,KI,CN1CCc2cc(SC[C@H](N)C(=O)O)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl.Cl
CHEMBL3216523,CHEMBL2056,Dopamine D1 receptor,Ki,=,141.0,nM,CHEMBL1803357,B,Displacement of [3H]SCH23390 from human D1 dopamine receptor expressed in Ltk fibroblast cells after 60 mins by liquid scintillation counter,CHEMBL1799928,KI,CN1CCc2cc(SC[C@@H](N)C(=O)O)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl.Cl
CHEMBL3215641,CHEMBL2056,Dopamine D1 receptor,Ki,=,1300.0,nM,CHEMBL1803357,B,Displacement of [3H]SCH23390 from human D1 dopamine receptor expressed in Ltk fibroblast cells after 60 mins by liquid scintillation counter,CHEMBL1799928,KI,CN1CCc2cc(SCCN)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl.Cl
CHEMBL1802234,CHEMBL2056,Dopamine D1 receptor,Ki,=,2200.0,nM,CHEMBL1803357,B,Displacement of [3H]SCH23390 from human D1 dopamine receptor expressed in Ltk fibroblast cells after 60 mins by liquid scintillation counter,CHEMBL1799928,KI,CN1CCc2cc(Sc3ccccc3)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL3216759,CHEMBL2056,Dopamine D1 receptor,Ki,=,380.0,nM,CHEMBL1803357,B,Displacement of [3H]SCH23390 from human D1 dopamine receptor expressed in Ltk fibroblast cells after 60 mins by liquid scintillation counter,CHEMBL1799928,KI,COC(=O)[C@@H](N)CSc1cc2c3c(c1)-c1c(ccc(O)c1O)C[C@H]3N(C)CC2.Cl.Cl
CHEMBL1802236,CHEMBL2056,Dopamine D1 receptor,Ki,=,150.0,nM,CHEMBL1803357,B,Displacement of [3H]SCH23390 from human D1 dopamine receptor expressed in Ltk fibroblast cells after 60 mins by liquid scintillation counter,CHEMBL1799928,KI,CN1CCc2cc(SCCC(=O)O)cc3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL1802237,CHEMBL2056,Dopamine D1 receptor,Ki,=,140.0,nM,CHEMBL1803357,B,Displacement of [3H]SCH23390 from human D1 dopamine receptor expressed in Ltk fibroblast cells after 60 mins by liquid scintillation counter,CHEMBL1799928,KI,CN1CCc2c3c(cc4c2[C@H]1Cc1ccc(O)c(O)c1-4)SCCC3=O.Cl
CHEMBL1806871,CHEMBL2056,Dopamine D1 receptor,Ki,=,2400.0,nM,CHEMBL1811737,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCN1CCc2cccc3c2[C@H]1Cc1cccc(OC(=O)NCc2ccccc2)c1-3
CHEMBL1806870,CHEMBL2056,Dopamine D1 receptor,Ki,=,4200.0,nM,CHEMBL1811737,B,Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in HEK293 cells after 50 mins by beta liquid scintillation counter,CHEMBL1806354,KI,CCCN1CCc2cccc3c2C1Cc1cccc(OC(=O)NCc2ccccc2)c1-3
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.11,nM,CHEMBL1817459,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL1811872,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL270299,CHEMBL2056,Dopamine D1 receptor,Ki,=,2206.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1
CHEMBL493,CHEMBL2056,Dopamine D1 receptor,Ki,=,1444.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL508112,CHEMBL2056,Dopamine D1 receptor,Ki,=,595.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,c1ccc2sc(SSc3nc4ccccc4s3)nc2c1
CHEMBL296419,CHEMBL2056,Dopamine D1 receptor,Ki,=,2005.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1
CHEMBL1113,CHEMBL2056,Dopamine D1 receptor,Ki,=,196.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2
CHEMBL1381098,CHEMBL2056,Dopamine D1 receptor,Ki,=,13788.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,S=C=Nc1cccc2ccccc12
CHEMBL3215298,CHEMBL2056,Dopamine D1 receptor,Ki,=,3060.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O
CHEMBL633,CHEMBL2056,Dopamine D1 receptor,Ki,=,4571.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1
CHEMBL1403281,CHEMBL2056,Dopamine D1 receptor,Ki,=,202.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL629,CHEMBL2056,Dopamine D1 receptor,Ki,=,178.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN(C)CCC=C1c2ccccc2CCc2ccccc21
CHEMBL1289,CHEMBL2056,Dopamine D1 receptor,Ki,=,282.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,Clc1cc(Cl)c(OCC#CI)cc1Cl
CHEMBL305660,CHEMBL2056,Dopamine D1 receptor,Ki,=,596.5,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1
CHEMBL64894,CHEMBL2056,Dopamine D1 receptor,Ki,=,1551.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]
CHEMBL808,CHEMBL2056,Dopamine D1 receptor,Ki,=,4612.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1
CHEMBL1385840,CHEMBL2056,Dopamine D1 receptor,Ki,=,147.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12
CHEMBL30008,CHEMBL2056,Dopamine D1 receptor,Ki,=,1937.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1
CHEMBL119443,CHEMBL2056,Dopamine D1 receptor,Ki,=,2950.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL726,CHEMBL2056,Dopamine D1 receptor,Ki,=,11.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
CHEMBL442,CHEMBL2056,Dopamine D1 receptor,Ki,=,864.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL1108,CHEMBL2056,Dopamine D1 receptor,Ki,=,546.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL2056,Dopamine D1 receptor,Ki,=,55.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1626,CHEMBL2056,Dopamine D1 receptor,Ki,=,767.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1
CHEMBL7002,CHEMBL2056,Dopamine D1 receptor,Ki,=,9893.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1
CHEMBL1628227,CHEMBL2056,Dopamine D1 receptor,Ki,=,344.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN(C)CCC=C1c2ccccc2COc2ccccc21
CHEMBL1255837,CHEMBL2056,Dopamine D1 receptor,Ki,=,589.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O
CHEMBL118,CHEMBL2056,Dopamine D1 receptor,Ki,=,13997.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1
CHEMBL964,CHEMBL2056,Dopamine D1 receptor,Ki,=,1079.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CCN(CC)C(=S)SSC(=S)N(CC)CC
CHEMBL104,CHEMBL2056,Dopamine D1 receptor,Ki,=,4508.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1
CHEMBL1732,CHEMBL2056,Dopamine D1 receptor,Ki,=,1197.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL411,CHEMBL2056,Dopamine D1 receptor,Ki,=,3882.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,53.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL71,CHEMBL2056,Dopamine D1 receptor,Ki,=,112.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21
CHEMBL415,CHEMBL2056,Dopamine D1 receptor,Ki,=,557.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21
CHEMBL516,CHEMBL2056,Dopamine D1 receptor,Ki,=,79.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1
CHEMBL1479,CHEMBL2056,Dopamine D1 receptor,Ki,=,10225.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C
CHEMBL723,CHEMBL2056,Dopamine D1 receptor,Ki,=,749.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12
CHEMBL564,CHEMBL2056,Dopamine D1 receptor,Ki,=,1232.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN(C)CCCN1c2ccccc2Sc2ccccc21
CHEMBL643,CHEMBL2056,Dopamine D1 receptor,Ki,=,1372.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC(CN1c2ccccc2Sc2ccccc21)N(C)C
CHEMBL531,CHEMBL2056,Dopamine D1 receptor,Ki,=,339.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL1909072,CHEMBL2056,Dopamine D1 receptor,Ki,=,16.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL715,CHEMBL2056,Dopamine D1 receptor,Ki,=,36.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL1262,CHEMBL2056,Dopamine D1 receptor,Ki,=,2068.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL445,CHEMBL2056,Dopamine D1 receptor,Ki,=,269.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CNCCC=C1c2ccccc2CCc2ccccc21
CHEMBL716,CHEMBL2056,Dopamine D1 receptor,Ki,=,214.6,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL584,CHEMBL2056,Dopamine D1 receptor,Ki,=,6467.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C
CHEMBL728,CHEMBL2056,Dopamine D1 receptor,Ki,=,78.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1
CHEMBL1065,CHEMBL2056,Dopamine D1 receptor,Ki,=,472.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1
CHEMBL534,CHEMBL2056,Dopamine D1 receptor,Ki,=,436.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1
CHEMBL21731,CHEMBL2056,Dopamine D1 receptor,Ki,=,187.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CNCCCC12CCC(c3ccccc31)c1ccccc12
CHEMBL6437,CHEMBL2056,Dopamine D1 receptor,Ki,=,271.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN1CCN2c3ccccc3Cc3ccccc3C2C1
CHEMBL91,CHEMBL2056,Dopamine D1 receptor,Ki,=,3124.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1
CHEMBL19215,CHEMBL2056,Dopamine D1 receptor,Ki,=,37.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21
CHEMBL1200633,CHEMBL2056,Dopamine D1 receptor,Ki,=,2257.4,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@]54O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O
CHEMBL157138,CHEMBL2056,Dopamine D1 receptor,Ki,=,86.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL1909065,CHEMBL2056,Dopamine D1 receptor,Ki,=,1454.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CO[C@@H]1[C@@H](OC)[C@H](C)[C@@](O)(CC(=O)O)O[C@H]1[C@H](C)[C@H]1O[C@@]2(CC[C@@](C)([C@H]3CC[C@@](C)([C@@H]4O[C@@H]([C@H]5O[C@](C)(O)[C@H](C)C[C@@H]5C)C[C@@H]4O[C@@H]4C[C@H](OC)[C@@H](OC)[C@H](C)O4)O3)O2)C[C@H](O)[C@H]1C
CHEMBL1201356,CHEMBL2056,Dopamine D1 receptor,Ki,=,539.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL479,CHEMBL2056,Dopamine D1 receptor,Ki,=,97.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2
CHEMBL83,CHEMBL2056,Dopamine D1 receptor,Ki,=,4251.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1
CHEMBL18797,CHEMBL2056,Dopamine D1 receptor,Ki,=,13911.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1
CHEMBL85,CHEMBL2056,Dopamine D1 receptor,Ki,=,240.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL1306,CHEMBL2056,Dopamine D1 receptor,Ki,=,12740.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1
CHEMBL17157,CHEMBL2056,Dopamine D1 receptor,Ki,=,1337.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1
CHEMBL81,CHEMBL2056,Dopamine D1 receptor,Ki,=,1932.0,nM,CHEMBL1909139,B,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),CHEMBL1909046,KI,O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12
CHEMBL25856,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.2,nM,CHEMBL1936227,B,Binding affinity to dopamine D1 receptor,CHEMBL1932931,KI,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2
CHEMBL319707,CHEMBL2056,Dopamine D1 receptor,Ki,=,8.7,nM,CHEMBL1936227,B,Binding affinity to dopamine D1 receptor,CHEMBL1932931,KI,Cc1ccc2c(c1)[C@@H]1c3cc(O)c(O)cc3CC[C@H]1NC2
CHEMBL104571,CHEMBL2056,Dopamine D1 receptor,Ki,=,29.0,nM,CHEMBL1936227,B,Binding affinity to dopamine D1 receptor,CHEMBL1932931,KI,CCc1ccc2c(c1)[C@@H]1c3cc(O)c(O)cc3CC[C@H]1NC2
CHEMBL1949725,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.1,nM,CHEMBL1954776,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in human HEK293 cells,CHEMBL1949524,KI,C[C@H]1Cc2c([nH]c3ccccc23)Cc2ccccc2CCN1C
CHEMBL1949726,CHEMBL2056,Dopamine D1 receptor,Ki,=,640.0,nM,CHEMBL1954776,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in human HEK293 cells,CHEMBL1949524,KI,C[C@@H]1Cc2c([nH]c3ccccc23)Cc2ccccc2CCN1C
CHEMBL1949728,CHEMBL2056,Dopamine D1 receptor,Ki,=,10.3,nM,CHEMBL1954776,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in human HEK293 cells,CHEMBL1949524,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2C[C@@H]1CO
CHEMBL1949729,CHEMBL2056,Dopamine D1 receptor,Ki,=,114.0,nM,CHEMBL1954776,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in human HEK293 cells,CHEMBL1949524,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2C[C@H]1CO
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.24,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL487387,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.23,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL2057457,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.91,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2057456,CHEMBL2056,Dopamine D1 receptor,Ki,=,17.29,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(cc1O)[C@@H]1Cc3c(CO)c(OC)cc(OC)c3CN1CC2
CHEMBL2057455,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.53,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL2057454,CHEMBL2056,Dopamine D1 receptor,Ki,=,52.34,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(O)c(OC)c3[C@@H]1C2
CHEMBL2057453,CHEMBL2056,Dopamine D1 receptor,Ki,=,35.79,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1ccc2c(c1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL2057452,CHEMBL2056,Dopamine D1 receptor,Ki,=,1440.62,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(cc1OC)C1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2057451,CHEMBL2056,Dopamine D1 receptor,Ki,=,337.7,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2057446,CHEMBL2056,Dopamine D1 receptor,Ki,=,23.76,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(OC)c(OC)c3[C@@H]1C2
CHEMBL2057445,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.97,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)cc(OC)c3[C@@H]1C2
CHEMBL2057443,CHEMBL2056,Dopamine D1 receptor,Ki,=,74.51,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(c(OC)c1)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL2057442,CHEMBL2056,Dopamine D1 receptor,Ki,=,64.12,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(cc1OC)[C@@H]1Cc3c(CO)c(OC)cc(OC)c3CN1CC2
CHEMBL2057441,CHEMBL2056,Dopamine D1 receptor,Ki,=,106.45,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(OC)cc3[C@@H]1C2
CHEMBL2057438,CHEMBL2056,Dopamine D1 receptor,Ki,=,182.41,nM,CHEMBL2060920,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells,CHEMBL2057072,KI,COc1cc(OC)c2c(c1CO)C[C@H]1c3cc4c(cc3CCN1C2)OCO4
CHEMBL2062848,CHEMBL2056,Dopamine D1 receptor,Ki,=,42000.0,nM,CHEMBL2066739,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL2062374,KI,CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@H](c3ccccc3)[C@H]21
CHEMBL2062849,CHEMBL2056,Dopamine D1 receptor,Ki,=,22000.0,nM,CHEMBL2066739,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL2062374,KI,CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccccc3)[C@@H]21
CHEMBL2062850,CHEMBL2056,Dopamine D1 receptor,Ki,=,40800.0,nM,CHEMBL2066739,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL2062374,KI,OC[C@H]1[C@H]2CN(Cc3ccccc3)[C@H](c3ccccc3)[C@H]2[C@@H]1N1CCCC1
CHEMBL2062851,CHEMBL2056,Dopamine D1 receptor,Ki,=,22000.0,nM,CHEMBL2066739,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL2062374,KI,OC[C@@H]1[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccccc3)[C@@H]2[C@H]1N1CCCC1
CHEMBL2062856,CHEMBL2056,Dopamine D1 receptor,Ki,=,7000.0,nM,CHEMBL2066739,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL2062374,KI,CCN(CC)[C@@H]1[C@@H](CO)[C@H]2CN(Cc3ccccc3)[C@H](c3ccc(Br)cc3)[C@H]21
CHEMBL2062857,CHEMBL2056,Dopamine D1 receptor,Ki,=,8000.0,nM,CHEMBL2066739,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL2062374,KI,CCN(CC)[C@H]1[C@H](CO)[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccc(Br)cc3)[C@@H]21
CHEMBL2062860,CHEMBL2056,Dopamine D1 receptor,Ki,=,44000.0,nM,CHEMBL2066739,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL2062374,KI,OC[C@H]1[C@H]2CN(Cc3ccccc3)[C@H](c3ccccc3)[C@H]2[C@@H]1N1CCCCC1
CHEMBL2062861,CHEMBL2056,Dopamine D1 receptor,Ki,=,49000.0,nM,CHEMBL2066739,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL2062374,KI,OC[C@@H]1[C@@H]2CN(Cc3ccccc3)[C@@H](c3ccccc3)[C@@H]2[C@H]1N1CCCCC1
CHEMBL59,CHEMBL2056,Dopamine D1 receptor,Ki,=,12000.0,nM,CHEMBL2066739,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL2062374,KI,NCCc1ccc(O)c(O)c1
CHEMBL53,CHEMBL2056,Dopamine D1 receptor,Ki,=,660.0,nM,CHEMBL2066739,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL2062374,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL2158641,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.94,nM,CHEMBL2162510,B,Displacement of [3H]-SCH-23390 from human dopamine D1 receptor expressed in HEK293 cells after 30 mins by scintillation counting,CHEMBL2157876,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1.O=C(O)/C(O)=C(/O)C(=O)O
CHEMBL2158640,CHEMBL2056,Dopamine D1 receptor,Ki,=,921.0,nM,CHEMBL2162510,B,Displacement of [3H]-SCH-23390 from human dopamine D1 receptor expressed in HEK293 cells after 30 mins by scintillation counting,CHEMBL2157876,KI,Br.CCCN1C[C@H](c2ccc(O)cc2)C[C@@H]2c3cc(O)c(O)cc3CC[C@H]21
CHEMBL2158636,CHEMBL2056,Dopamine D1 receptor,Ki,=,550.0,nM,CHEMBL2162510,B,Displacement of [3H]-SCH-23390 from human dopamine D1 receptor expressed in HEK293 cells after 30 mins by scintillation counting,CHEMBL2157876,KI,Br.Oc1ccc([C@H]2CN[C@@H]3CCc4cc(O)c(O)cc4[C@H]3C2)cc1
CHEMBL1224527,CHEMBL2056,Dopamine D1 receptor,Ki,=,47.0,nM,CHEMBL2162510,B,Displacement of [3H]-SCH-23390 from human dopamine D1 receptor expressed in HEK293 cells after 30 mins by scintillation counting,CHEMBL2157876,KI,Oc1ccc2c(c1O)C[C@@H](c1ccccc1)[C@@H]1CCNC[C@@H]21
CHEMBL59,CHEMBL2056,Dopamine D1 receptor,Ki,=,4470.0,nM,CHEMBL2182834,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor expressed in LHD1 cells,CHEMBL2177058,KI,NCCc1ccc(O)c(O)c1
CHEMBL2204343,CHEMBL2056,Dopamine D1 receptor,Ki,=,162.0,nM,CHEMBL2208723,B,Inhibition of human dopamine D1 receptor,CHEMBL2203023,KI,O=C(CCCN1CC[Si](O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL54,CHEMBL2056,Dopamine D1 receptor,Ki,=,107.0,nM,CHEMBL2208723,B,Inhibition of human dopamine D1 receptor,CHEMBL2203023,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL2205836,CHEMBL2056,Dopamine D1 receptor,Ki,=,2979.0,nM,CHEMBL2210351,B,Binding affinity to D1 dopamine receptor,CHEMBL2203059,KI,COc1ccccc1CCN1C2C3C4CC5C6C4C2C6C1(O)C53
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.5,nM,CHEMBL3073107,B,Binding affinity to dopamine D1 receptor (unknown origin),CHEMBL3046886,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL183776,CHEMBL2056,Dopamine D1 receptor,Ki,=,812.83,nM,CHEMBL3073107,B,Binding affinity to dopamine D1 receptor (unknown origin),CHEMBL3046886,KI,COc1ccccc1N1CCN(CCc2ccc3[nH]nnc3c2)CC1
CHEMBL2298806,CHEMBL2056,Dopamine D1 receptor,Ki,=,3981.07,nM,CHEMBL3073107,B,Binding affinity to dopamine D1 receptor (unknown origin),CHEMBL3046886,KI,c1ccc2c(N3CCN(CCc4ccc5[nH]cnc5c4)CC3)cccc2c1
CHEMBL184770,CHEMBL2056,Dopamine D1 receptor,Ki,=,4677.35,nM,CHEMBL3073107,B,Binding affinity to dopamine D1 receptor (unknown origin),CHEMBL3046886,KI,Cc1cccc(N2CCN(CCc3ccc4[nH]nnc4c3)CC2)c1C
CHEMBL363124,CHEMBL2056,Dopamine D1 receptor,Ki,=,5754.4,nM,CHEMBL3073107,B,Binding affinity to dopamine D1 receptor (unknown origin),CHEMBL3046886,KI,c1ccc2c(N3CCN(CCc4ccc5[nH]nnc5c4)CC3)cccc2c1
CHEMBL2298832,CHEMBL2056,Dopamine D1 receptor,Ki,=,446.0,nM,CHEMBL3073107,B,Binding affinity to dopamine D1 receptor (unknown origin),CHEMBL3046886,KI,S=c1[nH]c2ccc(OCCN3CCN(c4ccccc4Cl)CC3)cc2[nH]1
CHEMBL2298800,CHEMBL2056,Dopamine D1 receptor,Ki,=,405.0,nM,CHEMBL3073107,B,Binding affinity to dopamine D1 receptor (unknown origin),CHEMBL3046886,KI,O=c1[nH]c2ccc(OCCN3CCN(c4ccccc4Cl)CC3)cc2[nH]1
CHEMBL2323582,CHEMBL2056,Dopamine D1 receptor,Ki,=,12513.0,nM,CHEMBL2328678,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL2321700,KI,CC1=CC(C)=[N+]2C1=C(c1ccc(OCCCN3CCCCC3)cc1)c1c(C)cc(C)n1[B-]2(F)F
CHEMBL2334887,CHEMBL2056,Dopamine D1 receptor,Ki,=,530.0,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)CCN1Cc3c(ccc(OC)c3O)C[C@@H]21
CHEMBL1395394,CHEMBL2056,Dopamine D1 receptor,Ki,=,529.0,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@H]1Cc3ccc(OC)c(O)c3CN1CC2
CHEMBL2334885,CHEMBL2056,Dopamine D1 receptor,Ki,=,310.0,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)CCN1Cc3c(ccc(OC)c3OC)C[C@@H]21
CHEMBL522746,CHEMBL2056,Dopamine D1 receptor,Ki,=,443.0,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(O)c3CN1CC2
CHEMBL487182,CHEMBL2056,Dopamine D1 receptor,Ki,=,231.0,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2
CHEMBL320397,CHEMBL2056,Dopamine D1 receptor,Ki,=,200.0,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)CCN1Cc3c(ccc(O)c3OC)C[C@@H]21
CHEMBL2334886,CHEMBL2056,Dopamine D1 receptor,Ki,=,1189.0,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)CCN1Cc3c(ccc(OC)c3OC)C[C@H]21
CHEMBL490533,CHEMBL2056,Dopamine D1 receptor,Ki,=,66.0,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1ccc2c(c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL2334890,CHEMBL2056,Dopamine D1 receptor,Ki,=,135.0,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL2334880,CHEMBL2056,Dopamine D1 receptor,Ki,=,565.0,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@H]1C2)OCO4
CHEMBL448891,CHEMBL2056,Dopamine D1 receptor,Ki,=,50.0,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL2314732,CHEMBL2056,Dopamine D1 receptor,Ki,=,60.0,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1ccc2c(c1O)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL1235966,CHEMBL2056,Dopamine D1 receptor,Ki,=,22.0,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(O)c3CN1CC2
CHEMBL2057457,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.9,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2057453,CHEMBL2056,Dopamine D1 receptor,Ki,=,35.8,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1ccc2c(c1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL2334882,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.5,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCC4
CHEMBL2334892,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.6,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@H]1Cc3ccc(OC)c(OC)c3CN1CC2
CHEMBL487387,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.4,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL2057456,CHEMBL2056,Dopamine D1 receptor,Ki,=,17.3,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@@H]1Cc3c(CO)c(OC)cc(OC)c3CN1CC2
CHEMBL1457510,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.3,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL2334891,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.5,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2
CHEMBL13668,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.2,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,CN1CCc2cc(Cl)c(O)cc2C(c2ccccc2)C1
CHEMBL2057455,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.5,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL2334893,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.2,nM,CHEMBL2343280,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in human HEK293 cells by liquid scintillation counter,CHEMBL2331343,KI,COc1cc2c(cc1O)[C@@H]1Cc3cc4c(cc3CN1CC2)OCO4
CHEMBL2335739,CHEMBL2056,Dopamine D1 receptor,Ki,=,3340.0,nM,CHEMBL2346211,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,CHEMBL2331372,KI,COc1ccc2c(c1)CCN1CC[C@@](O)(c3ccc(Cl)cc3)C[C@H]21
CHEMBL2335738,CHEMBL2056,Dopamine D1 receptor,Ki,=,252.0,nM,CHEMBL2346211,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,CHEMBL2331372,KI,COc1ccc2c(c1)CCN1CC[C@](O)(c3ccc(Cl)cc3)C[C@H]21
CHEMBL2335741,CHEMBL2056,Dopamine D1 receptor,Ki,=,244.0,nM,CHEMBL2346211,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,CHEMBL2331372,KI,COc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2
CHEMBL2331599,CHEMBL2056,Dopamine D1 receptor,Ki,=,45.9,nM,CHEMBL2346211,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,CHEMBL2331372,KI,Cc1cc2c(cc1O)[C@H]1C[C@](O)(c3ccc(Cl)cc3)CCN1CC2
CHEMBL2335737,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.5,nM,CHEMBL2346211,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,CHEMBL2331372,KI,Cc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(Cl)cc3)CCN1CC2
CHEMBL2335740,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.0,nM,CHEMBL2346211,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,CHEMBL2331372,KI,COc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(Cl)cc3)CCN1CC2
CHEMBL2335736,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.0,nM,CHEMBL2346211,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin) expressed in CHO cell membranes after 60 mins,CHEMBL2331372,KI,COc1cc2c(cc1O)[C@H]1C[C@@](O)(c3ccc(OC(F)(F)F)cc3)CCN1CC2
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.7,nM,CHEMBL2395275,B,Displacement of [3H]SCH23390 from human recombinant dopamine D1 receptor expressed in CHO cells after 2 hrs,CHEMBL2390918,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL1814790,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.11,nM,CHEMBL2395700,B,Binding affinity to human dopamine D1 receptor by radioligand displacement assay,CHEMBL2390830,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1.O=C(O)/C=C\C(=O)O
CHEMBL2397385,CHEMBL2056,Dopamine D1 receptor,Ki,=,437.0,nM,CHEMBL2399863,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,CN1CCc2ccc(Cc3ccc(O)c4ccccc34)c3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL3216146,CHEMBL2056,Dopamine D1 receptor,Ki,=,135.0,nM,CHEMBL2399863,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,CN(C)c1ccc(Cc2ccc3c4c2-c2c(ccc(O)c2O)C[C@H]4N(C)CC3)cc1.Cl.Cl
CHEMBL2397383,CHEMBL2056,Dopamine D1 receptor,Ki,=,40.0,nM,CHEMBL2399863,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,CN1CCc2ccc(Cc3ccc(O)cc3)c3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL2397382,CHEMBL2056,Dopamine D1 receptor,Ki,=,980.0,nM,CHEMBL2399863,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,CN1CCc2ccc(CO)c3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL2397381,CHEMBL2056,Dopamine D1 receptor,Ki,=,168.0,nM,CHEMBL2399863,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,CN1CCc2ccc(Cc3ccccc3)c3c2[C@H]1Cc1ccc(O)c(O)c1-3.Cl
CHEMBL2397380,CHEMBL2056,Dopamine D1 receptor,Ki,=,187.0,nM,CHEMBL2399863,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,Cc1ccc2c3c1-c1c(ccc(O)c1O)C[C@H]3N(C)CC2.Cl
CHEMBL53,CHEMBL2056,Dopamine D1 receptor,Ki,=,492.0,nM,CHEMBL2399863,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL59,CHEMBL2056,Dopamine D1 receptor,Ki,=,12000.0,nM,CHEMBL2399863,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by scintillation counting analysis,CHEMBL2396540,KI,NCCc1ccc(O)c(O)c1
CHEMBL481153,CHEMBL2056,Dopamine D1 receptor,Ki,=,5900.0,nM,CHEMBL2404421,B,Antagonist activity at dopamine D1 receptor (unknown origin) by PDSP assay,CHEMBL2401658,KI,O=C(OCCN1CCCC1)N1c2ccccc2Sc2ccccc21
CHEMBL1334465,CHEMBL2056,Dopamine D1 receptor,Ki,=,1780.0,nM,CHEMBL2416551,B,Binding affinity to dopamine D1 receptor (unknown origin),CHEMBL2412971,KI,Cc1cc(NC(=O)Nc2ccc(N(C)C)cc2)c2cc(F)cc(F)c2n1
CHEMBL2420777,CHEMBL2056,Dopamine D1 receptor,Ki,=,2541.0,nM,CHEMBL2423804,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor,CHEMBL2417399,KI,Clc1ccc(N2CCN(Cc3cccs3)CC2)cc1Cl
CHEMBL3115580,CHEMBL2056,Dopamine D1 receptor,Ki,=,1160.0,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1OCCCCF)CC2
CHEMBL3115580,CHEMBL2056,Dopamine D1 receptor,Ki,=,1148.15,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1OCCCCF)CC2
CHEMBL3115579,CHEMBL2056,Dopamine D1 receptor,Ki,=,6910.0,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2
CHEMBL3115579,CHEMBL2056,Dopamine D1 receptor,Ki,=,6606.93,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(OCCCCF)cc1)CC2
CHEMBL3115578,CHEMBL2056,Dopamine D1 receptor,Ki,=,3960.0,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(I)cc3)CC1)CC2
CHEMBL3115578,CHEMBL2056,Dopamine D1 receptor,Ki,=,3890.45,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCCN1CCN(c3ccc(I)cc3)CC1)CC2
CHEMBL3115577,CHEMBL2056,Dopamine D1 receptor,Ki,=,46500.0,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CN1CCN(c3ccc(I)cc3)CC1)CC2
CHEMBL3115577,CHEMBL2056,Dopamine D1 receptor,Ki,=,30199.52,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CN1CCN(c3ccc(I)cc3)CC1)CC2
CHEMBL3115576,CHEMBL2056,Dopamine D1 receptor,Ki,=,436.0,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1I)CC2
CHEMBL3115576,CHEMBL2056,Dopamine D1 receptor,Ki,=,416.87,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1I)CC2
CHEMBL3115575,CHEMBL2056,Dopamine D1 receptor,Ki,=,4290.0,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2
CHEMBL3115575,CHEMBL2056,Dopamine D1 receptor,Ki,=,3890.45,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1cccc(I)c1)CC2
CHEMBL3115574,CHEMBL2056,Dopamine D1 receptor,Ki,=,8670.0,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2
CHEMBL3115574,CHEMBL2056,Dopamine D1 receptor,Ki,=,8128.31,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccc(I)cc1)CC2
CHEMBL3115585,CHEMBL2056,Dopamine D1 receptor,Ki,=,10900.0,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1.O=C(O)C(=O)O
CHEMBL3115585,CHEMBL2056,Dopamine D1 receptor,Ki,=,10471.29,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,CCCCCCNC[C@H]1CCc2ccc(O)cc2O1.O=C(O)C(=O)O
CHEMBL134807,CHEMBL2056,Dopamine D1 receptor,Ki,=,7250.0,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2
CHEMBL134807,CHEMBL2056,Dopamine D1 receptor,Ki,=,6165.95,nM,CHEMBL3117740,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 2 hrs by scintillation counting analysis,CHEMBL3112461,KI,O=C(O)C(=O)O.Oc1ccc2c(c1)O[C@@H](CNCc1ccccc1)CC2
CHEMBL715,CHEMBL2056,Dopamine D1 receptor,Ki,=,100.0,nM,CHEMBL3226694,B,Binding affinity to dopamine D1 receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,1000.0,nM,CHEMBL3226694,B,Binding affinity to dopamine D1 receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL716,CHEMBL2056,Dopamine D1 receptor,Ki,=,1000.0,nM,CHEMBL3226694,B,Binding affinity to dopamine D1 receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1
CHEMBL1112,CHEMBL2056,Dopamine D1 receptor,Ki,=,1000.0,nM,CHEMBL3226694,B,Binding affinity to dopamine D1 receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL85,CHEMBL2056,Dopamine D1 receptor,Ki,=,1000.0,nM,CHEMBL3226694,B,Binding affinity to dopamine D1 receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2
CHEMBL3217984,CHEMBL2056,Dopamine D1 receptor,Ki,=,25.12,nM,CHEMBL3226694,B,Binding affinity to dopamine D1 receptor (unknown origin) by PDSP assay,CHEMBL3217546,KI,CN1CCC2C(C1)c1cccc3c1N2c1ccccc1CS3
CHEMBL246484,CHEMBL2056,Dopamine D1 receptor,Ki,=,38.9,nM,CHEMBL3222874,B,Binding affinity to dopamine D1 receptor (unknown origin),CHEMBL3217716,KI,O=C1CC(CN2CCC(c3noc4cc(F)ccc34)CC2)Cc2[nH]ncc21
CHEMBL3220215,CHEMBL2056,Dopamine D1 receptor,Ki,=,33.88,nM,CHEMBL3222874,B,Binding affinity to dopamine D1 receptor (unknown origin),CHEMBL3217716,KI,Cc1nc2c(o1)CC(CN1CCC(c3c[nH]c4cc(F)ccc34)CC1)CC2=O
CHEMBL3220219,CHEMBL2056,Dopamine D1 receptor,Ki,=,36.31,nM,CHEMBL3222874,B,Binding affinity to dopamine D1 receptor (unknown origin),CHEMBL3217716,KI,O=C1CC(CN2CCC(c3c[nH]c4cc(F)ccc34)CC2)Cc2nc(N3CCCC3)sc21
CHEMBL3233142,CHEMBL2056,Dopamine D1 receptor,Ki,=,52.0,nM,CHEMBL3243864,B,Inhibition of human dopamine D1 receptor,CHEMBL3232708,KI,CN1CCN2c3c(cccc31)[C@@H]1CN(CCCC(=O)c3ccc(F)cc3)CC[C@@H]12.Cc1ccc(S(=O)(=O)O)cc1
CHEMBL3233143,CHEMBL2056,Dopamine D1 receptor,Ki,=,110.0,nM,CHEMBL3243864,B,Inhibition of human dopamine D1 receptor,CHEMBL3232708,KI,O=C(CCCN1CC[C@H]2[C@@H](C1)c1cccc3c1N2CCN3)c1ccc(F)cc1
CHEMBL24077,CHEMBL2056,Dopamine D1 receptor,Ki,=,73.0,nM,CHEMBL3267826,B,Agonist activity at dopamine D1 receptor (unknown origin),CHEMBL3259567,KI,Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2
CHEMBL1940408,CHEMBL2056,Dopamine D1 receptor,Ki,=,589.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(CCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1940409,CHEMBL2056,Dopamine D1 receptor,Ki,=,52.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(SCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1940411,CHEMBL2056,Dopamine D1 receptor,Ki,=,135.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(OCCCN2CCN(c3ccc(Cl)cc3)CC2)cc1
CHEMBL1940406,CHEMBL2056,Dopamine D1 receptor,Ki,=,126.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(OCCCN2CCC(c3ccc(Cl)cc3)CC2)cc1
CHEMBL3289642,CHEMBL2056,Dopamine D1 receptor,Ki,=,641.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,O=C1c2ccc(F)cc2CC1CCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL3289642,CHEMBL2056,Dopamine D1 receptor,Ki,=,645.65,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,O=C1c2ccc(F)cc2CC1CCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL3289643,CHEMBL2056,Dopamine D1 receptor,Ki,=,1701.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,O=C1c2ccccc2CC1CCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL3289643,CHEMBL2056,Dopamine D1 receptor,Ki,=,389.05,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,O=C1c2ccccc2CC1CCN1CCN(c2ccc(Cl)cc2)CC1
CHEMBL3289644,CHEMBL2056,Dopamine D1 receptor,Ki,=,837.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc2c(c1)CC(CCN1CCN(c3ccc(Cl)cc3)CC1)C2
CHEMBL1940418,CHEMBL2056,Dopamine D1 receptor,Ki,=,238.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(CCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL1940419,CHEMBL2056,Dopamine D1 receptor,Ki,=,265.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(SCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL1940420,CHEMBL2056,Dopamine D1 receptor,Ki,=,180.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL3289645,CHEMBL2056,Dopamine D1 receptor,Ki,=,2344.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,FC(F)(F)c1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL3289646,CHEMBL2056,Dopamine D1 receptor,Ki,=,260.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Cc1ccc(N2CCN(CCCOc3ccc(F)cc3)CC2)nc1
CHEMBL3289647,CHEMBL2056,Dopamine D1 receptor,Ki,=,222.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Cc1ccc(N2CCN(CCCSc3ccc(F)cc3)CC2)nc1
CHEMBL3289648,CHEMBL2056,Dopamine D1 receptor,Ki,=,521.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Cc1ccc(N2CCN(CCCCc3ccc(F)cc3)CC2)nc1
CHEMBL1940417,CHEMBL2056,Dopamine D1 receptor,Ki,=,259.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(OCCCN2CCN(c3ncccn3)CC2)cc1
CHEMBL1940416,CHEMBL2056,Dopamine D1 receptor,Ki,=,495.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(SCCCN2CCN(c3ncccn3)CC2)cc1
CHEMBL1940415,CHEMBL2056,Dopamine D1 receptor,Ki,=,134.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Fc1ccc(CCCCN2CCN(c3ncccn3)CC2)cc1
CHEMBL2037431,CHEMBL2056,Dopamine D1 receptor,Ki,=,1897.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(CCCCc3nc4ccccc4s3)CC2)cc1
CHEMBL2037430,CHEMBL2056,Dopamine D1 receptor,Ki,=,1273.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)cc1
CHEMBL3289649,CHEMBL2056,Dopamine D1 receptor,Ki,=,7939.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(CCCCCc3nc4ccccc4o3)CC2)cc1
CHEMBL3286429,CHEMBL2056,Dopamine D1 receptor,Ki,=,1172.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(CCCc3nc4ccccc4o3)CC2)cc1
CHEMBL3289653,CHEMBL2056,Dopamine D1 receptor,Ki,=,1408.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCN(CCCc3cc4ccccc4o3)CC2)cc1
CHEMBL3289655,CHEMBL2056,Dopamine D1 receptor,Ki,=,274.0,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Clc1ccc(N2CCCN(CCCc3cc4ccccc4o3)CC2)cc1
CHEMBL3289645,CHEMBL2056,Dopamine D1 receptor,Ki,=,2344.23,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,FC(F)(F)c1ccc(OCCCN2CCN(c3ccccn3)CC2)cc1
CHEMBL3289648,CHEMBL2056,Dopamine D1 receptor,Ki,=,524.81,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Cc1ccc(N2CCN(CCCCc3ccc(F)cc3)CC2)nc1
CHEMBL3289646,CHEMBL2056,Dopamine D1 receptor,Ki,=,263.03,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Cc1ccc(N2CCN(CCCOc3ccc(F)cc3)CC2)nc1
CHEMBL3289647,CHEMBL2056,Dopamine D1 receptor,Ki,=,223.87,nM,CHEMBL3292985,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by PDSP assay,CHEMBL3286287,KI,Cc1ccc(N2CCN(CCCSc3ccc(F)cc3)CC2)nc1
CHEMBL240773,CHEMBL2056,Dopamine D1 receptor,Ki,=,87000.0,nM,CHEMBL3295079,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,CHEMBL3286313,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL1112,CHEMBL2056,Dopamine D1 receptor,Ki,=,310.0,nM,CHEMBL3295079,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,CHEMBL3286313,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2028019,CHEMBL2056,Dopamine D1 receptor,Ki,=,2100.0,nM,CHEMBL3295079,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,CHEMBL3286313,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL3287395,CHEMBL2056,Dopamine D1 receptor,Ki,=,150.0,nM,CHEMBL3295079,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,CHEMBL3286313,KI,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287396,CHEMBL2056,Dopamine D1 receptor,Ki,=,240.0,nM,CHEMBL3295079,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,CHEMBL3286313,KI,OCc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287397,CHEMBL2056,Dopamine D1 receptor,Ki,=,970.0,nM,CHEMBL3295079,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287402,CHEMBL2056,Dopamine D1 receptor,Ki,=,180.0,nM,CHEMBL3295079,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,CHEMBL3286313,KI,O=Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287403,CHEMBL2056,Dopamine D1 receptor,Ki,=,4300.0,nM,CHEMBL3295079,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,CHEMBL3286313,KI,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287403,CHEMBL2056,Dopamine D1 receptor,Ki,=,670.0,nM,CHEMBL3295079,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,CHEMBL3286313,KI,O/N=C/c1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287404,CHEMBL2056,Dopamine D1 receptor,Ki,=,260.0,nM,CHEMBL3295079,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,CHEMBL3286313,KI,O/N=C/c1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3287405,CHEMBL2056,Dopamine D1 receptor,Ki,=,930.0,nM,CHEMBL3295079,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,CHEMBL3286313,KI,N#Cc1cnn2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL3287406,CHEMBL2056,Dopamine D1 receptor,Ki,=,3500.0,nM,CHEMBL3295079,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by competitive binding assay,CHEMBL3286313,KI,N#Cc1cc2cc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)ccn2n1
CHEMBL3290012,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.3,nM,CHEMBL3297338,B,Displacement of [3H]SCH23390 from human recombinant D1 receptor expressed in CHO cells,CHEMBL3286108,KI,O=S(=O)(NCCCCN1CCC(c2noc3cc(F)ccc23)CC1)c1cc2ccccc2s1
CHEMBL1814790,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.1,nM,CHEMBL3297338,B,Displacement of [3H]SCH23390 from human recombinant D1 receptor expressed in CHO cells,CHEMBL3286108,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1.O=C(O)/C=C\C(=O)O
CHEMBL1193274,CHEMBL2056,Dopamine D1 receptor,Ki,=,207.0,nM,CHEMBL3364543,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay,CHEMBL3351966,KI,CN1CCc2ccc(O)cc2C(c2ccccc2)C1
CHEMBL3325901,CHEMBL2056,Dopamine D1 receptor,Ki,=,334.0,nM,CHEMBL3364543,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay,CHEMBL3351966,KI,CN1CCc2cc(N)c(O)cc2C(c2ccccc2)C1
CHEMBL3325903,CHEMBL2056,Dopamine D1 receptor,Ki,=,351.0,nM,CHEMBL3364543,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay,CHEMBL3351966,KI,CN1CCc2cc(O)c(N)cc2C(c2ccccc2)C1
CHEMBL3325904,CHEMBL2056,Dopamine D1 receptor,Ki,=,665.0,nM,CHEMBL3364543,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay,CHEMBL3351966,KI,CN1CCc2cc(NCc3ccccc3)c(O)cc2C(c2ccccc2)C1
CHEMBL3325905,CHEMBL2056,Dopamine D1 receptor,Ki,=,277.0,nM,CHEMBL3364543,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay,CHEMBL3351966,KI,CN1CCc2cc(NCc3cccc(Cl)c3)c(O)cc2C(c2ccccc2)C1
CHEMBL3325906,CHEMBL2056,Dopamine D1 receptor,Ki,=,370.0,nM,CHEMBL3364543,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay,CHEMBL3351966,KI,Cc1cccc(CNc2cc3c(cc2O)C(c2ccccc2)CN(C)CC3)c1
CHEMBL3325907,CHEMBL2056,Dopamine D1 receptor,Ki,=,292.0,nM,CHEMBL3364543,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay,CHEMBL3351966,KI,Cc1ccccc1CNc1cc2c(cc1O)C(c1ccccc1)CN(C)CC2
CHEMBL3325908,CHEMBL2056,Dopamine D1 receptor,Ki,=,756.0,nM,CHEMBL3364543,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay,CHEMBL3351966,KI,Cc1ccc(CNc2cc3c(cc2O)C(c2ccccc2)CN(C)CC3)cc1
CHEMBL3325913,CHEMBL2056,Dopamine D1 receptor,Ki,=,216.0,nM,CHEMBL3364543,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay,CHEMBL3351966,KI,Cc1cccc(-c2cc3c(cc2O)C(c2ccccc2)CN(C)CC3)c1
CHEMBL3325914,CHEMBL2056,Dopamine D1 receptor,Ki,=,912.0,nM,CHEMBL3364543,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay,CHEMBL3351966,KI,Cc1ccccc1-c1cc2c(cc1O)C(c1ccccc1)CN(C)CC2
CHEMBL3325916,CHEMBL2056,Dopamine D1 receptor,Ki,=,349.0,nM,CHEMBL3364543,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay,CHEMBL3351966,KI,CN1CCc2cc(-c3ccc(O)cc3)c(O)cc2C(c2ccccc2)C1
CHEMBL3325920,CHEMBL2056,Dopamine D1 receptor,Ki,=,583.0,nM,CHEMBL3364543,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay,CHEMBL3351966,KI,CN1CCc2ccc(N)cc2C(c2ccccc2)C1
CHEMBL286080,CHEMBL2056,Dopamine D1 receptor,Ki,=,393.0,nM,CHEMBL3364543,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes by liquid scintillation counting based competition binding assay,CHEMBL3351966,KI,Oc1cc2c(cc1O)C(c1ccccc1)CNCC2
CHEMBL54,CHEMBL2056,Dopamine D1 receptor,Ki,=,120.0,nM,CHEMBL3366155,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by liquid scintillation counting,CHEMBL3352364,KI,O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1
CHEMBL1940402,CHEMBL2056,Dopamine D1 receptor,Ki,=,130.0,nM,CHEMBL3366155,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by liquid scintillation counting,CHEMBL3352364,KI,OC1(c2ccc(Cl)cc2)CCN(CCCCc2ccc(F)cc2)CC1
CHEMBL1940404,CHEMBL2056,Dopamine D1 receptor,Ki,=,22.0,nM,CHEMBL3366155,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by liquid scintillation counting,CHEMBL3352364,KI,OC1(c2ccc(Cl)cc2)CCN(CCCOc2ccc(F)cc2)CC1
CHEMBL1940403,CHEMBL2056,Dopamine D1 receptor,Ki,=,27.0,nM,CHEMBL3366155,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by liquid scintillation counting,CHEMBL3352364,KI,OC1(c2ccc(Cl)cc2)CCN(CCCSc2ccc(F)cc2)CC1
CHEMBL3321790,CHEMBL2056,Dopamine D1 receptor,Ki,=,347.0,nM,CHEMBL3366155,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by liquid scintillation counting,CHEMBL3352364,KI,OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCSc1ccc(F)cc1
CHEMBL3321792,CHEMBL2056,Dopamine D1 receptor,Ki,=,4093.0,nM,CHEMBL3366155,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by liquid scintillation counting,CHEMBL3352364,KI,OC1(c2ccc(Cl)cc2)CC2CCC(C1)N2CCCSc1ccccc1F
CHEMBL715,CHEMBL2056,Dopamine D1 receptor,Ki,=,52.0,nM,CHEMBL3366155,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor by liquid scintillation counting,CHEMBL3352364,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL3344356,CHEMBL2056,Dopamine D1 receptor,Ki,=,86.98,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sccc3CN1CC2
CHEMBL3344456,CHEMBL2056,Dopamine D1 receptor,Ki,=,26.33,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,CCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL3344457,CHEMBL2056,Dopamine D1 receptor,Ki,=,61.75,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,CCCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL3344458,CHEMBL2056,Dopamine D1 receptor,Ki,=,62.19,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,CCCCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL3344459,CHEMBL2056,Dopamine D1 receptor,Ki,=,128.14,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CC(C)C)cc3CN1CC2
CHEMBL3344460,CHEMBL2056,Dopamine D1 receptor,Ki,=,133.05,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,CCCCCc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL3344462,CHEMBL2056,Dopamine D1 receptor,Ki,=,403.42,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,CCC(C)Cc1cc2c(s1)C[C@H]1c3cc(O)c(OC)cc3CCN1C2
CHEMBL3344463,CHEMBL2056,Dopamine D1 receptor,Ki,=,633.79,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CC(C)(C)C)cc3CN1CC2
CHEMBL3344465,CHEMBL2056,Dopamine D1 receptor,Ki,=,379.28,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CC4CCC4)cc3CN1CC2
CHEMBL3344466,CHEMBL2056,Dopamine D1 receptor,Ki,=,66.21,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CC4CC4)cc3CN1CC2
CHEMBL3344467,CHEMBL2056,Dopamine D1 receptor,Ki,=,16.43,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CCCl)cc3CN1CC2
CHEMBL3344468,CHEMBL2056,Dopamine D1 receptor,Ki,=,77.0,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CCCCl)cc3CN1CC2
CHEMBL3344469,CHEMBL2056,Dopamine D1 receptor,Ki,=,45.82,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CC(C)Cl)cc3CN1CC2
CHEMBL3344470,CHEMBL2056,Dopamine D1 receptor,Ki,=,718.74,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3sc(CCCCCl)cc3CN1CC2
CHEMBL487387,CHEMBL2056,Dopamine D1 receptor,Ki,=,12.29,nM,CHEMBL3387734,B,Displacement of [3H]SCH23390 from D1 receptor (unknown origin) transfected in HEK293T cells after 50 mins by liquid scintillation counting analysis,CHEMBL3351714,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL1814790,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.1,nM,CHEMBL3413560,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in CHO cells,CHEMBL3407464,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1.O=C(O)/C=C\C(=O)O
CHEMBL240773,CHEMBL2056,Dopamine D1 receptor,Ki,=,8700.0,nM,CHEMBL3578852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL2397389,CHEMBL2056,Dopamine D1 receptor,Ki,=,18000.0,nM,CHEMBL3578852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL2396663,CHEMBL2056,Dopamine D1 receptor,Ki,=,13000.0,nM,CHEMBL3578852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(-c3ccccc3)cc2)CC1
CHEMBL3577342,CHEMBL2056,Dopamine D1 receptor,Ki,=,2600.0,nM,CHEMBL3578852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,C#CC1=CC[C@@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1
CHEMBL3577343,CHEMBL2056,Dopamine D1 receptor,Ki,=,3900.0,nM,CHEMBL3578852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,C#CC1=CC[C@H](N(CCC)CCCCNC(=O)c2ccc(OCCCc3cn(CCCC)nn3)c(OC)c2)CO1
CHEMBL3577344,CHEMBL2056,Dopamine D1 receptor,Ki,=,4600.0,nM,CHEMBL3578852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)CCc3ccc(O)c4[nH]c(=O)ccc34)cc2OC)nn1
CHEMBL3577345,CHEMBL2056,Dopamine D1 receptor,Ki,=,23000.0,nM,CHEMBL3578852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@@H]3CCc4c(O)cccc4C3)cc2OC)nn1
CHEMBL3577346,CHEMBL2056,Dopamine D1 receptor,Ki,=,2900.0,nM,CHEMBL3578852,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor transfected in HEK293 cells after 1 hr by scintillation counting analysis,CHEMBL3576771,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN(CCC)[C@H]3CCc4c(O)cccc4C3)cc2OC)nn1
CHEMBL464099,CHEMBL2056,Dopamine D1 receptor,Ki,=,373.0,nM,CHEMBL3584687,B,Displacement of [3H]SCH23390 from human recombinant dopamine D1 receptor expressed in HEKT cell membranes by radioligand binding assay,CHEMBL3580564,KI,COc1cc2c(cc1O)C[C@H]1c3c(cc(OC)c(OC)c3-2)CCN1C
CHEMBL589,CHEMBL2056,Dopamine D1 receptor,Ki,=,32500.0,nM,CHEMBL3587540,B,Binding affinity to human dopamine D1 receptor,CHEMBL3585327,KI,CCCN(CCC)CCc1cccc2c1CC(=O)N2
CHEMBL3590077,CHEMBL2056,Dopamine D1 receptor,Ki,=,1300.0,nM,CHEMBL3592691,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes,CHEMBL3588764,KI,COc1ccccc1N1CCN(CCCCNC(=O)/N=N/c2ccc(F)cc2)CC1
CHEMBL3590080,CHEMBL2056,Dopamine D1 receptor,Ki,=,1300.0,nM,CHEMBL3592691,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes,CHEMBL3588764,KI,CCCN(CCCCNC(=O)/C=C/c1ccc(F)cc1)C1Cc2ccccc2C1
CHEMBL3590081,CHEMBL2056,Dopamine D1 receptor,Ki,=,3300.0,nM,CHEMBL3592691,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes,CHEMBL3588764,KI,CCCN(CCCCNC(=O)/N=N/c1ccc(F)cc1)C1Cc2ccccc2C1
CHEMBL3590084,CHEMBL2056,Dopamine D1 receptor,Ki,=,2200.0,nM,CHEMBL3592691,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes,CHEMBL3588764,KI,CCCN(CCNC(=O)/C=C/c1ccc(F)cc1)C1Cc2ccccc2C1
CHEMBL3589577,CHEMBL2056,Dopamine D1 receptor,Ki,=,2600.0,nM,CHEMBL3592691,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cell membranes,CHEMBL3588764,KI,CCCN(CCNC(=O)/N=N/c1cc(F)c(F)c(F)c1)C1Cc2ccccc2C1
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.69,nM,CHEMBL3610649,B,Displacement of [3H]-SCH-23390 from dopamine D1 receptor (unknown origin) expressed in HEK293 cell membranes incubated for 15 mins by liquid scintillation spectrometry,CHEMBL3608303,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL3613880,CHEMBL2056,Dopamine D1 receptor,Ki,=,110.0,nM,CHEMBL3614289,B,Displacement of [3H]SCH23990 from human dopamine D1 receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,Clc1cccc(N2CCN(CCCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl
CHEMBL3613879,CHEMBL2056,Dopamine D1 receptor,Ki,=,110.0,nM,CHEMBL3614289,B,Displacement of [3H]SCH23990 from human dopamine D1 receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,Clc1cccc(N2CCN(CCCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl
CHEMBL3613878,CHEMBL2056,Dopamine D1 receptor,Ki,=,120.0,nM,CHEMBL3614289,B,Displacement of [3H]SCH23990 from human dopamine D1 receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,Clc1cccc(N2CCN(CCc3cn(-c4ccn5nccc5c4)nn3)CC2)c1Cl
CHEMBL3613877,CHEMBL2056,Dopamine D1 receptor,Ki,=,620.0,nM,CHEMBL3614289,B,Displacement of [3H]SCH23990 from human dopamine D1 receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCc2cn(-c3ccn4ncc(C=O)c4c3)nn2)CC1
CHEMBL3613876,CHEMBL2056,Dopamine D1 receptor,Ki,=,160.0,nM,CHEMBL3614289,B,Displacement of [3H]SCH23990 from human dopamine D1 receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,O=Cc1cnn2ccc(-n3cc(CCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12
CHEMBL3613875,CHEMBL2056,Dopamine D1 receptor,Ki,=,1500.0,nM,CHEMBL3614289,B,Displacement of [3H]SCH23990 from human dopamine D1 receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,O=Cc1cnn2ccc(-n3cc(CCCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12
CHEMBL3613874,CHEMBL2056,Dopamine D1 receptor,Ki,=,210.0,nM,CHEMBL3614289,B,Displacement of [3H]SCH23990 from human dopamine D1 receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,O=Cc1cnn2ccc(-n3cc(CCCN4CCN(c5cccc(Cl)c5Cl)CC4)nn3)cc12
CHEMBL3613873,CHEMBL2056,Dopamine D1 receptor,Ki,=,1700.0,nM,CHEMBL3614289,B,Displacement of [3H]SCH23990 from human dopamine D1 receptor expressed in CHO cell membranes by radioligand competition binding assay,CHEMBL3612016,KI,COc1ccccc1N1CCN(CCCc2cn(-c3ccn4nccc4c3)nn2)CC1
CHEMBL3622099,CHEMBL2056,Dopamine D1 receptor,Ki,=,250.0,nM,CHEMBL3626476,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL3621057,KI,CCCN(CCN1CCN(CCc2c[nH]c3ccccc23)CC1)c1ccc(Br)cc1
CHEMBL3622097,CHEMBL2056,Dopamine D1 receptor,Ki,=,480.0,nM,CHEMBL3626476,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK cells,CHEMBL3621057,KI,Brc1ccc(NCCN2CCN(CCc3c[nH]c4ccccc34)CC2)cc1
CHEMBL3735756,CHEMBL2056,Dopamine D1 receptor,Ki,=,1682.0,nM,CHEMBL3736705,B,Displacement of [3H]SCH23390 from human recombinant dopamine D1 receptor expressed in HEKT cell membrane after 90 mins by scintillation counting method,CHEMBL3734659,KI,COc1ccc(CCN(CCCc2ccccc2)CCc2ccc3c(c2)OCO3)cc1OC
CHEMBL3752512,CHEMBL2056,Dopamine D1 receptor,Ki,=,60.0,nM,CHEMBL3757878,B,Displacement of [3H]SCH-23390 from human cloned D1 dopamine receptor incubated for 90 mins by radioligand binding assay,CHEMBL3751719,KI,CN1CCc2ccccc2Cc2sccc2CC1
CHEMBL201093,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.0,nM,CHEMBL3757878,B,Displacement of [3H]SCH-23390 from human cloned D1 dopamine receptor incubated for 90 mins by radioligand binding assay,CHEMBL3751719,KI,CN1CCc2ccccc2Cc2ccsc2CC1
CHEMBL3753266,CHEMBL2056,Dopamine D1 receptor,Ki,=,40.0,nM,CHEMBL3757878,B,Displacement of [3H]SCH-23390 from human cloned D1 dopamine receptor incubated for 90 mins by radioligand binding assay,CHEMBL3751719,KI,CN1CCc2ccccc2Cc2sc3ccccc3c2CC1
CHEMBL441618,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.9,nM,CHEMBL3757878,B,Displacement of [3H]SCH-23390 from human cloned D1 dopamine receptor incubated for 90 mins by radioligand binding assay,CHEMBL3751719,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL201525,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.5,nM,CHEMBL3757878,B,Displacement of [3H]SCH-23390 from human cloned D1 dopamine receptor incubated for 90 mins by radioligand binding assay,CHEMBL3751719,KI,CN1CCc2ccccc2Cc2ccccc2CC1
CHEMBL201170,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.4,nM,CHEMBL3757878,B,Displacement of [3H]SCH-23390 from human cloned D1 dopamine receptor incubated for 90 mins by radioligand binding assay,CHEMBL3751719,KI,CN1CCc2ccccc2Cc2ccc(O)cc2CC1
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,189.0,nM,CHEMBL3757884,B,Displacement of [3H]SCH-23390 from human cloned D1 dopamine receptor expressed in HEKT cells incubated for 90 mins by scintillation counting based radioligand binding assay,CHEMBL3751719,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL715,CHEMBL2056,Dopamine D1 receptor,Ki,=,70.0,nM,CHEMBL3757884,B,Displacement of [3H]SCH-23390 from human cloned D1 dopamine receptor expressed in HEKT cells incubated for 90 mins by scintillation counting based radioligand binding assay,CHEMBL3751719,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL3187365,CHEMBL2056,Dopamine D1 receptor,Ki,=,8.9,nM,CHEMBL3757884,B,Displacement of [3H]SCH-23390 from human cloned D1 dopamine receptor expressed in HEKT cells incubated for 90 mins by scintillation counting based radioligand binding assay,CHEMBL3751719,KI,CN1CC2c3ccccc3Oc3ccc(Cl)cc3C2C1
CHEMBL8514,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.3,nM,CHEMBL3783164,B,Displacement of [3H]SCH2390 from human dopamine D1 receptor by PDSP assay,CHEMBL3779868,KI,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
CHEMBL3780438,CHEMBL2056,Dopamine D1 receptor,Ki,=,3111.0,nM,CHEMBL3783164,B,Displacement of [3H]SCH2390 from human dopamine D1 receptor by PDSP assay,CHEMBL3779868,KI,COc1cc(CCN(C)Cc2cccc(O)c2OC)ccc1O
CHEMBL3780975,CHEMBL2056,Dopamine D1 receptor,Ki,=,833.0,nM,CHEMBL3783164,B,Displacement of [3H]SCH2390 from human dopamine D1 receptor by PDSP assay,CHEMBL3779868,KI,COc1cc2c(cc1O)C(C)N(Cc1cccc(O)c1OC)CC2
CHEMBL3780184,CHEMBL2056,Dopamine D1 receptor,Ki,=,12.0,nM,CHEMBL3783164,B,Displacement of [3H]SCH2390 from human dopamine D1 receptor by PDSP assay,CHEMBL3779868,KI,COc1cc2c(cc1O)C1Cc3ccc(OCC4CC4)c(OC)c3CN1CC2
CHEMBL3780268,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.7,nM,CHEMBL3783164,B,Displacement of [3H]SCH2390 from human dopamine D1 receptor by PDSP assay,CHEMBL3779868,KI,COc1cc2c(cc1O)C1Cc3ccc(OCCCO)c(OC)c3CN1CC2
CHEMBL3781035,CHEMBL2056,Dopamine D1 receptor,Ki,=,40.0,nM,CHEMBL3783164,B,Displacement of [3H]SCH2390 from human dopamine D1 receptor by PDSP assay,CHEMBL3779868,KI,CCCCCCOc1ccc2c(c1OC)CN1CCc3cc(OC)c(O)cc3C1C2
CHEMBL3780140,CHEMBL2056,Dopamine D1 receptor,Ki,=,19.0,nM,CHEMBL3783164,B,Displacement of [3H]SCH2390 from human dopamine D1 receptor by PDSP assay,CHEMBL3779868,KI,CCCCCOc1ccc2c(c1OC)CN1CCc3cc(OC)c(O)cc3C1C2
CHEMBL3781840,CHEMBL2056,Dopamine D1 receptor,Ki,=,11.0,nM,CHEMBL3783164,B,Displacement of [3H]SCH2390 from human dopamine D1 receptor by PDSP assay,CHEMBL3779868,KI,CCCCOc1ccc2c(c1OC)CN1CCc3cc(OC)c(O)cc3C1C2
CHEMBL3780506,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.8,nM,CHEMBL3783164,B,Displacement of [3H]SCH2390 from human dopamine D1 receptor by PDSP assay,CHEMBL3779868,KI,CCCOc1ccc2c(c1OC)CN1CCc3cc(OC)c(O)cc3C1C2
CHEMBL3779928,CHEMBL2056,Dopamine D1 receptor,Ki,=,12.4,nM,CHEMBL3783164,B,Displacement of [3H]SCH2390 from human dopamine D1 receptor by PDSP assay,CHEMBL3779868,KI,CCOc1ccc2c(c1OC)CN1CCc3cc(OC)c(O)cc3C1C2
CHEMBL3780481,CHEMBL2056,Dopamine D1 receptor,Ki,=,15.0,nM,CHEMBL3783164,B,Displacement of [3H]SCH2390 from human dopamine D1 receptor by PDSP assay,CHEMBL3779868,KI,COc1cc2c(cc1O)C1Cc3ccc(OC)c(OC)c3CN1CC2
CHEMBL595489,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.6,nM,CHEMBL3783164,B,Displacement of [3H]SCH2390 from human dopamine D1 receptor by PDSP assay,CHEMBL3779868,KI,COc1cc2c(cc1O)C1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL3800400,CHEMBL2056,Dopamine D1 receptor,Ki,=,11000.0,nM,CHEMBL3801475,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL3797035,KI,COc1cc(CCNC[C@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1
CHEMBL3800468,CHEMBL2056,Dopamine D1 receptor,Ki,=,6800.0,nM,CHEMBL3801475,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL3797035,KI,COc1cc(CCNC[C@@H](O)c2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1
CHEMBL3799455,CHEMBL2056,Dopamine D1 receptor,Ki,=,2800.0,nM,CHEMBL3801475,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL3797035,KI,COc1cc(CCNCCc2ccc(O)c3[nH]c(=O)ccc23)ccc1OCCCc1ccccc1
CHEMBL3800303,CHEMBL2056,Dopamine D1 receptor,Ki,=,430.0,nM,CHEMBL3801475,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL3797035,KI,COc1cc(CCNC[C@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1
CHEMBL3799427,CHEMBL2056,Dopamine D1 receptor,Ki,=,2900.0,nM,CHEMBL3801475,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL3797035,KI,COc1cc(CCNC[C@@H](O)c2ccc(O)c(O)c2)ccc1OCCCc1ccccc1
CHEMBL3800636,CHEMBL2056,Dopamine D1 receptor,Ki,=,860.0,nM,CHEMBL3801475,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL3797035,KI,COc1cc(CCNCCc2ccc(O)c(O)c2)ccc1OCCCc1ccccc1
CHEMBL3798748,CHEMBL2056,Dopamine D1 receptor,Ki,=,4500.0,nM,CHEMBL3801475,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL3797035,KI,COc1cc(CCNC[C@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1
CHEMBL3797205,CHEMBL2056,Dopamine D1 receptor,Ki,=,2800.0,nM,CHEMBL3801475,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL3797035,KI,COc1cc(CCNC[C@@H](O)c2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1
CHEMBL3800341,CHEMBL2056,Dopamine D1 receptor,Ki,=,960.0,nM,CHEMBL3801475,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL3797035,KI,COc1cc(CCNCCc2ccc(O)c3c2OCC(=O)N3)ccc1OCCCc1ccccc1
CHEMBL3797876,CHEMBL2056,Dopamine D1 receptor,Ki,=,890.0,nM,CHEMBL3801475,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL3797035,KI,COc1ccccc1OCCNC[C@H](O)c1ccc(O)c(O)c1
CHEMBL3799593,CHEMBL2056,Dopamine D1 receptor,Ki,=,430.0,nM,CHEMBL3801475,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL3797035,KI,COc1ccccc1OCCNC[C@@H](O)c1ccc(O)c(O)c1
CHEMBL3797758,CHEMBL2056,Dopamine D1 receptor,Ki,=,210.0,nM,CHEMBL3801475,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL3797035,KI,COc1ccccc1OCCNCCc1ccc(O)c(O)c1
CHEMBL240773,CHEMBL2056,Dopamine D1 receptor,Ki,=,8700.0,nM,CHEMBL3801475,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells,CHEMBL3797035,KI,CCCN1CCC[C@@H]2Cc3[nH]ncc3C[C@H]21
CHEMBL3921278,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.3,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,CCOc1c(O)cc(Br)c2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL3976659,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.2,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,CCCOc1c(O)cc(Br)c2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL3905947,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.3,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,CCCCOc1c(O)cc(Br)c2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL3964242,CHEMBL2056,Dopamine D1 receptor,Ki,=,32.0,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,CCCCCOc1c(O)cc(Br)c2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL3963862,CHEMBL2056,Dopamine D1 receptor,Ki,=,68.0,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,CCCCCCOc1c(O)cc(Br)c2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL3894329,CHEMBL2056,Dopamine D1 receptor,Ki,=,9.7,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,CCC(C)Oc1c(O)cc(Br)c2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL3945691,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.2,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,COCCOc1c(O)cc(Br)c2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL3961827,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.3,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,CCOc1c(O)ccc2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL3954556,CHEMBL2056,Dopamine D1 receptor,Ki,=,12.0,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,CCCOc1c(O)ccc2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL3975220,CHEMBL2056,Dopamine D1 receptor,Ki,=,11.0,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,CCCCOc1c(O)ccc2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL3945856,CHEMBL2056,Dopamine D1 receptor,Ki,=,31.0,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,CCCCCOc1c(O)ccc2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL3966718,CHEMBL2056,Dopamine D1 receptor,Ki,=,77.0,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,CCCCCCOc1c(O)ccc2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL3936976,CHEMBL2056,Dopamine D1 receptor,Ki,=,65.0,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,CCC(C)Oc1c(O)ccc2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL3982215,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.7,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,COCCOc1c(O)ccc2c1CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL487387,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.9,nM,CHEMBL3877883,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in HEKT cell membranes after 90 mins by microbeta scintillation counting method,CHEMBL3877260,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL3671272,CHEMBL2056,Dopamine D1 receptor,Ki,=,30.3,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncnc(C)c1-c1ccc(Oc2nccc3[nH]ccc23)cc1F
CHEMBL3671273,CHEMBL2056,Dopamine D1 receptor,Ki,=,34.8,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3[nH]ccc23)ccc1-c1c(C)cnn1C
CHEMBL3671274,CHEMBL2056,Dopamine D1 receptor,Ki,=,9.76,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3n[nH]cc23)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3671274,CHEMBL2056,Dopamine D1 receptor,Ki,=,10.4,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3n[nH]cc23)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3671275,CHEMBL2056,Dopamine D1 receptor,Ki,=,13.0,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3[nH]ccc23)ccc1-c1c(C)ncnc1C
CHEMBL3671276,CHEMBL2056,Dopamine D1 receptor,Ki,=,113.0,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3n[nH]cc23)ccc1-c1c(C)ncnc1C
CHEMBL3671277,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.12,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1n[nH]c(=O)c(C)c1-c1ccc(Oc2nccc3[nH]ccc23)cc1
CHEMBL3671278,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.83,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3n[nH]cc23)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3671279,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.87,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3[nH]ccc23)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3671279,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.04,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3[nH]ccc23)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3671280,CHEMBL2056,Dopamine D1 receptor,Ki,=,14.1,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3[nH]ccc23)ccc1-c1c(C)cnnc1C
CHEMBL3671280,CHEMBL2056,Dopamine D1 receptor,Ki,=,88.3,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3[nH]ccc23)ccc1-c1c(C)cnnc1C
CHEMBL3671281,CHEMBL2056,Dopamine D1 receptor,Ki,=,93.1,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3n[nH]cc23)ccc1-c1c(C)nc[n+]([O-])c1C
CHEMBL3671282,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.98,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3[nH]ccc23)ccc1-c1c(C)ncc2nccn12
CHEMBL3671283,CHEMBL2056,Dopamine D1 receptor,Ki,=,97.5,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3[nH]ccc23)ccc1-c1cncc2nccn12
CHEMBL3671284,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.3,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncnc(C#N)c1-c1ccc(Oc2nccc3[nH]ccc23)cc1F
CHEMBL3671285,CHEMBL2056,Dopamine D1 receptor,Ki,=,39.2,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3[nH]ccc23)ccc1-c1c(C)ncnc1C#N
CHEMBL3671286,CHEMBL2056,Dopamine D1 receptor,Ki,=,29.4,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncc2nccn2c1-c1ccc(Oc2nccc3[nH]ccc23)cc1F
CHEMBL3671287,CHEMBL2056,Dopamine D1 receptor,Ki,=,15.9,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncc2nccn2c1-c1ccc(Oc2nccc3[nH]ccc23)cc1
CHEMBL3671288,CHEMBL2056,Dopamine D1 receptor,Ki,=,44.3,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncnc(C)c1-c1ccc(Oc2nccc3[nH]ccc23)cc1
CHEMBL3671289,CHEMBL2056,Dopamine D1 receptor,Ki,=,102.0,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncnc(C)c1-c1ccc(Oc2nccc3[nH]ccc23)cc1C#N
CHEMBL3671290,CHEMBL2056,Dopamine D1 receptor,Ki,=,54.8,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncnc(C)c1-c1cc(F)c(Oc2nccc3[nH]ccc23)cc1F
CHEMBL3639701,CHEMBL2056,Dopamine D1 receptor,Ki,=,53.8,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncnc(C)c1-c1ccc(Oc2nccc3[nH]ccc23)c(F)c1F
CHEMBL3671291,CHEMBL2056,Dopamine D1 receptor,Ki,=,9.84,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncnc(C)c1-c1ccc(Oc2nccc3[nH]ccc23)cc1Cl
CHEMBL3671292,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.09,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncnc(N2CC(F)C2)c1-c1ccc(Oc2nccc3[nH]ccc23)cc1F
CHEMBL3671293,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.56,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3[nH]ccc23)ccc1-c1c(C)ncc(=O)n1C
CHEMBL3671293,CHEMBL2056,Dopamine D1 receptor,Ki,=,10.6,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3[nH]ccc23)ccc1-c1c(C)ncc(=O)n1C
CHEMBL3671294,CHEMBL2056,Dopamine D1 receptor,Ki,=,35.7,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3[nH]ccc23)ccc1-c1cn[nH]c(=O)c1C
CHEMBL3671295,CHEMBL2056,Dopamine D1 receptor,Ki,=,67.9,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3[nH]ccc23)ccc1-c1cc(=O)[nH]nc1C
CHEMBL3671296,CHEMBL2056,Dopamine D1 receptor,Ki,=,268.0,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3n[nH]cc23)ccc1-n1c(C)nc2cnccc21
CHEMBL3671297,CHEMBL2056,Dopamine D1 receptor,Ki,=,287.0,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3n[nH]cc23)ccc1-c1cc(=O)[nH]nc1C
CHEMBL3671298,CHEMBL2056,Dopamine D1 receptor,Ki,=,72.3,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncnc(C)c1-c1ccc(Oc2nccc3n[nH]cc23)cc1F
CHEMBL3671299,CHEMBL2056,Dopamine D1 receptor,Ki,=,124.0,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,COc1cc(Oc2nccc3n[nH]cc23)ccc1-c1c(C)ncnc1C
CHEMBL3671300,CHEMBL2056,Dopamine D1 receptor,Ki,=,391.0,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncnc(C)c1-c1ccc(Oc2nccc3n[nH]cc23)cc1C#N
CHEMBL3671301,CHEMBL2056,Dopamine D1 receptor,Ki,=,69.6,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncnc(C#N)c1-c1ccc(Oc2nccc3n[nH]cc23)cc1F
CHEMBL3671302,CHEMBL2056,Dopamine D1 receptor,Ki,=,118.0,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3n[nH]cc23)c(F)cc1-c1c(C)ncnc1C
CHEMBL3671303,CHEMBL2056,Dopamine D1 receptor,Ki,=,52.3,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncnc(C)c1-c1ccc(Oc2nccc3n[nH]cc23)cc1Cl
CHEMBL3671304,CHEMBL2056,Dopamine D1 receptor,Ki,=,129.0,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1ncnc(C)c1-c1ccc(Oc2nccc3n[nH]cc23)cc1
CHEMBL3671305,CHEMBL2056,Dopamine D1 receptor,Ki,=,41.8,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3n[nH]cc23)ccc1-c1c(C)ncc(=O)n1C
CHEMBL3671305,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.1,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3n[nH]cc23)ccc1-c1c(C)ncc(=O)n1C
CHEMBL3671306,CHEMBL2056,Dopamine D1 receptor,Ki,=,40.9,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1n[nH]c(=O)c(C)c1-c1ccc(Oc2nccc3n[nH]cc23)cc1
CHEMBL3671307,CHEMBL2056,Dopamine D1 receptor,Ki,=,123.0,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc(Oc2nccc3n[nH]cc23)ccc1-c1cn[nH]c(=O)c1C
CHEMBL3671308,CHEMBL2056,Dopamine D1 receptor,Ki,=,17.5,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1c(-c2ccc(Oc3nccc4n[nH]cc34)cc2)n(C)c(=O)[nH]c1=O
CHEMBL3671268,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.6,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,[C-]#[N+]c1c[nH]c2ccnc(Oc3ccc(-c4c(C)ncnc4C)c(C)c3)c12
CHEMBL3671269,CHEMBL2056,Dopamine D1 receptor,Ki,=,10.3,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1n[nH]c(=O)c(C)c1-c1ccc(Oc2nccc3n[nH]c(C)c23)cc1
CHEMBL3671270,CHEMBL2056,Dopamine D1 receptor,Ki,=,24.7,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,Cc1cc2n[nH]cc2c(Oc2ccc(-c3c(C)n[nH]c(=O)c3C)cc2)n1
CHEMBL3671271,CHEMBL2056,Dopamine D1 receptor,Ki,=,695.0,nM,CHEMBL3705955,B,"Receptor Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor. D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium condition.",CHEMBL3638412,KI,COc1cnc(Oc2ccc(-c3c(C)n[nH]c(=O)c3C)cc2)c2c[nH]nc12
CHEMBL3697613,CHEMBL2056,Dopamine D1 receptor,Ki,=,15.3,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C2CC2)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697613,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.11,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C2CC2)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697614,CHEMBL2056,Dopamine D1 receptor,Ki,=,40.6,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncc(F)cc2Cl)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697614,CHEMBL2056,Dopamine D1 receptor,Ki,=,118.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncc(F)cc2Cl)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697615,CHEMBL2056,Dopamine D1 receptor,Ki,=,58.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,CCn1c(-c2ccc(Oc3ncccc3Cl)cc2C)c(C)c(=O)[nH]c1=O
CHEMBL3697616,CHEMBL2056,Dopamine D1 receptor,Ki,=,33.1,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,CCc1c(-c2ccc(Oc3ncccc3Cl)cc2C)n(C)c(=O)[nH]c1=O
CHEMBL3697617,CHEMBL2056,Dopamine D1 receptor,Ki,=,8.54,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C(F)(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697617,CHEMBL2056,Dopamine D1 receptor,Ki,=,21.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C(F)(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697618,CHEMBL2056,Dopamine D1 receptor,Ki,=,120.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cnc(Oc2ccc(-c3c(C)c(=O)[nH]c(=O)n3C)c(C)c2)c(Cl)c1
CHEMBL3697618,CHEMBL2056,Dopamine D1 receptor,Ki,=,82.3,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cnc(Oc2ccc(-c3c(C)c(=O)[nH]c(=O)n3C)c(C)c2)c(Cl)c1
CHEMBL3697619,CHEMBL2056,Dopamine D1 receptor,Ki,=,10.9,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1ccnc(Oc2ccc(-c3c(C)c(=O)[nH]c(=O)n3C)cc2)c1Cl
CHEMBL3697620,CHEMBL2056,Dopamine D1 receptor,Ki,=,55.1,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,CCn1c(-c2ccc(Oc3ncccc3C(F)F)cc2C)c(C)c(=O)[nH]c1=O
CHEMBL3697578,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.91,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2OC(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697621,CHEMBL2056,Dopamine D1 receptor,Ki,=,17.5,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697621,CHEMBL2056,Dopamine D1 receptor,Ki,=,54.7,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697622,CHEMBL2056,Dopamine D1 receptor,Ki,=,44.3,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C(F)F)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697622,CHEMBL2056,Dopamine D1 receptor,Ki,=,59.1,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C(F)F)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697623,CHEMBL2056,Dopamine D1 receptor,Ki,=,35.7,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Sc2ncccc2Cl)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697624,CHEMBL2056,Dopamine D1 receptor,Ki,=,12.9,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1c(-c2ccc(Oc3ncccc3C(F)(F)F)c3[nH]ccc23)n(C)c(=O)[nH]c1=O
CHEMBL3697553,CHEMBL2056,Dopamine D1 receptor,Ki,=,52.7,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,CCc1cccnc1Oc1ccc(-c2c(C)c(=O)[nH]c(=O)n2C)c(C)c1
CHEMBL3697554,CHEMBL2056,Dopamine D1 receptor,Ki,=,314.2,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,CCn1c(-c2ccc(Oc3ncccc3Cl)cc2)c(C)c(=O)[nH]c1=O
CHEMBL3697555,CHEMBL2056,Dopamine D1 receptor,Ki,=,82.7,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,CCc1c(-c2ccc(Oc3ncccc3Cl)cc2)n(C)c(=O)[nH]c1=O
CHEMBL3697556,CHEMBL2056,Dopamine D1 receptor,Ki,=,45.9,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,[C-]#[N+]c1c(C)ccnc1Oc1ccc(-c2c(C)c(=O)[nH]c(=O)n2C)c(C)c1
CHEMBL3697557,CHEMBL2056,Dopamine D1 receptor,Ki,=,92.1,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncc(Cl)cc2C)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697558,CHEMBL2056,Dopamine D1 receptor,Ki,=,38.5,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncc(Cl)c(C)c2Cl)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697559,CHEMBL2056,Dopamine D1 receptor,Ki,=,117.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncc(Cl)cc2C(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697560,CHEMBL2056,Dopamine D1 receptor,Ki,=,36.2,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2nccc(C)c2F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697561,CHEMBL2056,Dopamine D1 receptor,Ki,=,88.9,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncc(Cl)cc2Cl)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697562,CHEMBL2056,Dopamine D1 receptor,Ki,=,489.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697563,CHEMBL2056,Dopamine D1 receptor,Ki,=,156.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ccccn2)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697564,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.61,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2nccc(C)c2Cl)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697565,CHEMBL2056,Dopamine D1 receptor,Ki,=,650.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2N2CC(F)C2)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697566,CHEMBL2056,Dopamine D1 receptor,Ki,=,224.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2OC2CC2)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697567,CHEMBL2056,Dopamine D1 receptor,Ki,=,120.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,COc1cc(Oc2ccc(-c3c(C)c(=O)[nH]c(=O)n3C)c(C)c2)ncc1F
CHEMBL3697568,CHEMBL2056,Dopamine D1 receptor,Ki,=,246.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2N2CCC2)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697569,CHEMBL2056,Dopamine D1 receptor,Ki,=,826.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2N2CC(F)(F)C2)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697570,CHEMBL2056,Dopamine D1 receptor,Ki,=,8.42,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,C=C(C)c1cccnc1Oc1ccc(-c2c(C)c(=O)[nH]c(=O)n2C)c(C)c1
CHEMBL3697571,CHEMBL2056,Dopamine D1 receptor,Ki,=,31.1,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C(C)C)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697572,CHEMBL2056,Dopamine D1 receptor,Ki,=,15.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2cc(C3CC3)ccn2)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697573,CHEMBL2056,Dopamine D1 receptor,Ki,=,82.7,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2O)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697574,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.41,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2nccc(C)c2Cl)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697575,CHEMBL2056,Dopamine D1 receptor,Ki,=,187.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,COc1cc(Oc2ccc(-c3c(C)c(=O)[nH]c(=O)n3C)c(C)c2)ncc1C
CHEMBL3697576,CHEMBL2056,Dopamine D1 receptor,Ki,=,9.65,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2Br)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697577,CHEMBL2056,Dopamine D1 receptor,Ki,=,87.3,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1c(-c2ccc(Oc3ncccc3Cl)cc2)n(C)c(=O)[nH]c1=O
CHEMBL3697578,CHEMBL2056,Dopamine D1 receptor,Ki,=,18.6,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2OC(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697579,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.66,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C2CC2)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697580,CHEMBL2056,Dopamine D1 receptor,Ki,=,82.3,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,CCc1c(-c2ccc(Oc3ncccc3C(F)F)cc2C)n(C)c(=O)[nH]c1=O
CHEMBL3697581,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.571,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2I)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697582,CHEMBL2056,Dopamine D1 receptor,Ki,=,288.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C2COC2)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697583,CHEMBL2056,Dopamine D1 receptor,Ki,=,10.1,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2nccc(C)c2OC(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697584,CHEMBL2056,Dopamine D1 receptor,Ki,=,94.9,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2OC(F)(F)F)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697585,CHEMBL2056,Dopamine D1 receptor,Ki,=,63.1,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2OC(F)(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697586,CHEMBL2056,Dopamine D1 receptor,Ki,=,109.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1c(-c2ccc(Oc3ncccc3OC(F)F)cc2)n(C)c(=O)[nH]c1=O
CHEMBL3697587,CHEMBL2056,Dopamine D1 receptor,Ki,=,9.33,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2Cl)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697587,CHEMBL2056,Dopamine D1 receptor,Ki,=,24.2,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2Cl)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697588,CHEMBL2056,Dopamine D1 receptor,Ki,=,428.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1c(-c2ccc(Oc3ncccc3C(F)F)cc2C#N)n(C)c(=O)[nH]c1=O
CHEMBL3697589,CHEMBL2056,Dopamine D1 receptor,Ki,=,30.5,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2Cl)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697590,CHEMBL2056,Dopamine D1 receptor,Ki,=,86.2,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2OC(F)F)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697591,CHEMBL2056,Dopamine D1 receptor,Ki,=,1220.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C(N)=O)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697592,CHEMBL2056,Dopamine D1 receptor,Ki,=,767.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,COC(=O)c1cccnc1Oc1ccc(-c2c(C)n[nH]c(=O)c2C)c(C)c1
CHEMBL3697593,CHEMBL2056,Dopamine D1 receptor,Ki,=,23.8,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,COc1ccnc(Oc2ccc(-c3c(C)n[nH]c(=O)c3C)c(C)c2)c1C
CHEMBL3697594,CHEMBL2056,Dopamine D1 receptor,Ki,=,12.1,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2nccc(C)c2C(F)(F)F)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697595,CHEMBL2056,Dopamine D1 receptor,Ki,=,13.4,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,COc1ccnc(Oc2ccc(-c3c(C)n[nH]c(=O)c3C)c(C)c2)c1C(F)F
CHEMBL3697596,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.17,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,COc1ccnc(Oc2ccc(-c3c(C)n[nH]c(=O)c3C)c(C)c2)c1C(F)(F)F
CHEMBL3697597,CHEMBL2056,Dopamine D1 receptor,Ki,=,34.4,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C(F)(F)F)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697597,CHEMBL2056,Dopamine D1 receptor,Ki,=,26.9,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C(F)(F)F)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697598,CHEMBL2056,Dopamine D1 receptor,Ki,=,345.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1ccnc(Oc2ccc(-c3c(C)n[nH]c(=O)c3C)cc2)c1
CHEMBL3697599,CHEMBL2056,Dopamine D1 receptor,Ki,=,16.9,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Sc2ncccc2C(F)(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697600,CHEMBL2056,Dopamine D1 receptor,Ki,=,38.3,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1c(-c2ccc(Oc3ncccc3C3CC3)cc2)n(C)c(=O)[nH]c1=O
CHEMBL3697601,CHEMBL2056,Dopamine D1 receptor,Ki,=,138.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncc(F)cc2C)ccc1-c1c(C)n[nH]c(=O)c1C
CHEMBL3697602,CHEMBL2056,Dopamine D1 receptor,Ki,=,216.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C2CC2)ccc1-c1c(C)ncc(=O)n1C
CHEMBL3697603,CHEMBL2056,Dopamine D1 receptor,Ki,=,227.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncc(Cl)c(C)c2Cl)ccc1-c1c(C)ncc(=O)n1C
CHEMBL3697604,CHEMBL2056,Dopamine D1 receptor,Ki,=,43.4,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2nccc(C)c2Cl)ccc1-c1c(C)ncc(=O)n1C
CHEMBL3697605,CHEMBL2056,Dopamine D1 receptor,Ki,=,381.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2Cl)ccc1-c1c(C)ncc(=O)n1C
CHEMBL3697606,CHEMBL2056,Dopamine D1 receptor,Ki,=,87.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2OC(F)F)ccc1-c1c(C)ncc(=O)n1C
CHEMBL3697607,CHEMBL2056,Dopamine D1 receptor,Ki,=,354.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncc(Cl)c(C)c2Cl)ccc1-c1c(C)cnc(=O)n1C
CHEMBL3697608,CHEMBL2056,Dopamine D1 receptor,Ki,=,337.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C(F)(F)F)ccc1-c1c(C)cnc(=O)n1C
CHEMBL3697609,CHEMBL2056,Dopamine D1 receptor,Ki,=,32.3,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2nccc(C)c2Cl)ccc1-c1c(C)cnc(=O)n1C
CHEMBL3697610,CHEMBL2056,Dopamine D1 receptor,Ki,=,109.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C2CC2)ccc1-c1c(C)cnc(=O)n1C
CHEMBL3697611,CHEMBL2056,Dopamine D1 receptor,Ki,=,349.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2Cl)ccc1-c1c(C)cnc(=O)n1C
CHEMBL3697612,CHEMBL2056,Dopamine D1 receptor,Ki,=,58.0,nM,CHEMBL3706100,B,"Competition Binding Assay: The affinity of the compounds described herein was determined by competition binding assays similar to those described in Ryman-Rasmussen et al., Differential activation of adenylate cyclase and receptor internalization by novel dopamine D1 receptor agonists, Molecular Pharmacology 68(4):1039-1048 (2005). This radioligand binding assay used [3H]-SCH23390, a radiolabeled D1 ligand, to evaluate the ability of a test compound to compete with the radioligand when binding to a D1 receptor.D1 binding assays were performed using over-expressing LTK human cell lines. To determine basic assay parameters, ligand concentrations were determined from saturation binding studies where the Kd for [3H]-SCH23390 was found to be 1.3 nM. From tissue concentration curve studies, the optimal amount of tissue was determined to be 1.75 mg/mL per 96 well plate using 0.5 nM of [3H]-SCH23390. These ligand and tissue concentrations were used in time course studies to determine linearity and equilibrium.",CHEMBL3638419,KI,Cc1cc(Oc2ncccc2C(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C1CC1
CHEMBL1112,CHEMBL2056,Dopamine D1 receptor,Ki,=,895.0,nM,CHEMBL3887363,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165119,CHEMBL2056,Dopamine D1 receptor,Ki,=,1040.0,nM,CHEMBL3887363,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)nc2N1
CHEMBL2165126,CHEMBL2056,Dopamine D1 receptor,Ki,=,825.0,nM,CHEMBL3887363,B,"Radioligand Binding Assay: Membranes prepared as above were resuspended to 1 ug protein/ul (measured by Bradford assay using BSA as standard), and 50 ul were added to each well of a polypropylene 96-well plate containing (per well): 50 ul of buffer (20 mM HEPES, 10 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 100 mM N-methyl-D-gluconate, pH 7.4), 50 ul of 1.5 nM [3H]N-methylspiperone (final concentration 0.3 nM) and reference or D2 test ligand at various concentrations ranging from 50 uM to 50 uM (final concentrations ranging from 10 uM to 10 uM, triplicate determinations for each concentration of D2 test ligand). After a 1.5-hr incubation in the dark at room temperature, the reactions were harvested onto 0.3% PEI-soaked Filtermax GF/A filters (Wallac) and washed three times with ice-cold 50 mM Tris, pH 7.4 using a Perkin-Elmer Filtermate 96-well harvester. The filters were subsequently dried, placed on a hot plate (100° C.), and Melitilex-A (Wallac) scintillant was applied.",CHEMBL3886292,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL3927835,CHEMBL2056,Dopamine D1 receptor,Ki,=,246.86,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1OC)C1Cc3c(OC)ccc(OC)c3CN1CC2
CHEMBL3955446,CHEMBL2056,Dopamine D1 receptor,Ki,=,320.11,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1OC)[C@@H]1Cc3cc(OC)c(OC)c(OC)c3CN1CC2
CHEMBL3896617,CHEMBL2056,Dopamine D1 receptor,Ki,=,1003.72,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1ccc2c(c1)CCN1Cc3c(cc(OC)c(OC)c3OC)CC21
CHEMBL3982119,CHEMBL2056,Dopamine D1 receptor,Ki,=,50.07,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1OC)[C@@H]1Cc3c(OC)ccc(OC)c3CN1CC2
CHEMBL3903297,CHEMBL2056,Dopamine D1 receptor,Ki,=,147.91,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,c1c2c(cc3c1OCO3)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL3897805,CHEMBL2056,Dopamine D1 receptor,Ki,=,23.65,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4
CHEMBL3921127,CHEMBL2056,Dopamine D1 receptor,Ki,=,376.83,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(c(OC)c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL2057451,CHEMBL2056,Dopamine D1 receptor,Ki,=,337.78,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1OC)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL2057452,CHEMBL2056,Dopamine D1 receptor,Ki,=,1440.62,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1OC)C1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL3912178,CHEMBL2056,Dopamine D1 receptor,Ki,=,497.87,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1OC)C1Cc3cc(O)c(O)cc3CN1CC2
CHEMBL3906676,CHEMBL2056,Dopamine D1 receptor,Ki,=,740.67,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1OC)CN1CCc3cc(O)c(O)cc3C1C2
CHEMBL3912606,CHEMBL2056,Dopamine D1 receptor,Ki,=,522.03,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(c(OC)c1OC)CN1CCc3cc(O)c(O)cc3C1C2
CHEMBL2334893,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.2,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1O)[C@@H]1Cc3cc4c(cc3CN1CC2)OCO4
CHEMBL3913343,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.7,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1O)[C@@H]1Cc3c(OC)ccc(OC)c3CN1CC2
CHEMBL2057457,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.91,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL3986624,CHEMBL2056,Dopamine D1 receptor,Ki,=,25.25,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCCO4
CHEMBL3896731,CHEMBL2056,Dopamine D1 receptor,Ki,=,208.21,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,Cc1ccc(C)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4
CHEMBL3897805,CHEMBL2056,Dopamine D1 receptor,Ki,=,248.04,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4
CHEMBL3917753,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.72,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1ccc(OC)c2c1C[C@H]1c3cc(O)c(O)cc3CCN1C2
CHEMBL2334881,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.51,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCCO4
CHEMBL2057441,CHEMBL2056,Dopamine D1 receptor,Ki,=,64.12,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(OC)cc3[C@@H]1C2
CHEMBL2057438,CHEMBL2056,Dopamine D1 receptor,Ki,=,182.41,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc(OC)c2c(c1CO)C[C@H]1c3cc4c(cc3CCN1C2)OCO4
CHEMBL2057443,CHEMBL2056,Dopamine D1 receptor,Ki,=,74.5,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(c(OC)c1)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL2057455,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.18,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL13668,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.24,nM,CHEMBL3888597,B,"Reception Binding Assay: Different concentrations (10^−5 M-10^−11 M) of the compound of the invention and corresponding isotope receptor ligand as well as receptor protein were loaded into the reaction tube and incubated in 30° C. water bath for 60 minutes. The reaction was terminated in a refrigerator. The reaction mixture was put in a Millipore filter (millipore) cell sample collector, filtered through suction filtration using GF/C glass fiber filter paper, and dried. The resulting sample was placed into 0.5 mL tube. 500 μL liquid scintillation fluid was added and intensity of radioactivity was determined by counting. For dopamine D1 receptor: isotope receptor ligands [3H] SCH23390 (85.0 Ci/mmol) (D1-selective, purchased from Amersham Corporation), D1 receptor protein expressed in HEK-293 cells; For D2 dopamine receptor: isotope receptor ligands [3H] Spiperone (77.0 Ci/mmol) (D2-selective, purchased from Amersham Corporation); D2 receptor protein expressed in HEK-293 cells; For 5-HT1A receptor: isotope receptor ligands [3H] 8-OH-DPAT; 5-HT1A receptor protein expressed in HEK-293 cells; For 5-HT2A receptor: isotope receptor ligands [3H]-Ketanserin; 5-HT2A receptor protein expressed in HEK-293 cells.",CHEMBL3886775,KI,CN1CCc2cc(Cl)c(O)cc2C(c2ccccc2)C1
CHEMBL2057443,CHEMBL2056,Dopamine D1 receptor,Ki,=,64.12,nM,CHEMBL3888602,B,"Radioligand Binding Assay: The affinity of compounds to D1 and D2 dopamine receptors were determined by competition binding assays. Membrane homogenates of HEK293T cells were stably transfected with D1, or D2 receptors. Duplicated tubes were incubated at 30° C. for 50 mins (for D1, and D2) with increasing concentrations of respective compound and with [3H]SCH23390 (for D1 dopamine receptors), or [3H]Spiperone (for dopamine D2 receptor) in a final volume of 200 μL binding buffer containing 50 mM Tris, 4 mM MgCl2, pH 7.4. Nonspecific binding was determined by parallel incubations with either 10 μM SCH23390 for D1, or Spiperone for D2 receptors respectively. The reaction was started by addition of membranes (15 ng/tube) and stopped by rapid filtration through Whatman GF/B glassfiber filter and subsequently washed with cold buffer (50 mM Tris, 5 mM EDTA, pH 7.4) using a Brandel 24-well cell harvester. Scintillation cocktail was added and the radioactivity was determined in a MicroBeta liquid scintillation counter.",CHEMBL3886775,KI,COc1cc2c(c(OC)c1)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL3987156,CHEMBL2056,Dopamine D1 receptor,Ki,=,74.51,nM,CHEMBL3888602,B,"Radioligand Binding Assay: The affinity of compounds to D1 and D2 dopamine receptors were determined by competition binding assays. Membrane homogenates of HEK293T cells were stably transfected with D1, or D2 receptors. Duplicated tubes were incubated at 30° C. for 50 mins (for D1, and D2) with increasing concentrations of respective compound and with [3H]SCH23390 (for D1 dopamine receptors), or [3H]Spiperone (for dopamine D2 receptor) in a final volume of 200 μL binding buffer containing 50 mM Tris, 4 mM MgCl2, pH 7.4. Nonspecific binding was determined by parallel incubations with either 10 μM SCH23390 for D1, or Spiperone for D2 receptors respectively. The reaction was started by addition of membranes (15 ng/tube) and stopped by rapid filtration through Whatman GF/B glassfiber filter and subsequently washed with cold buffer (50 mM Tris, 5 mM EDTA, pH 7.4) using a Brandel 24-well cell harvester. Scintillation cocktail was added and the radioactivity was determined in a MicroBeta liquid scintillation counter.",CHEMBL3886775,KI,COc1cc2c(cc1OC)C1Cc3c(c(OC)cc(OC)c3OC)CN1CC2
CHEMBL2057455,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.53,nM,CHEMBL3888602,B,"Radioligand Binding Assay: The affinity of compounds to D1 and D2 dopamine receptors were determined by competition binding assays. Membrane homogenates of HEK293T cells were stably transfected with D1, or D2 receptors. Duplicated tubes were incubated at 30° C. for 50 mins (for D1, and D2) with increasing concentrations of respective compound and with [3H]SCH23390 (for D1 dopamine receptors), or [3H]Spiperone (for dopamine D2 receptor) in a final volume of 200 μL binding buffer containing 50 mM Tris, 4 mM MgCl2, pH 7.4. Nonspecific binding was determined by parallel incubations with either 10 μM SCH23390 for D1, or Spiperone for D2 receptors respectively. The reaction was started by addition of membranes (15 ng/tube) and stopped by rapid filtration through Whatman GF/B glassfiber filter and subsequently washed with cold buffer (50 mM Tris, 5 mM EDTA, pH 7.4) using a Brandel 24-well cell harvester. Scintillation cocktail was added and the radioactivity was determined in a MicroBeta liquid scintillation counter.",CHEMBL3886775,KI,COc1cc2c(c(OC)c1)CN1CCc3cc(OC)c(O)cc3[C@@H]1C2
CHEMBL2334882,CHEMBL2056,Dopamine D1 receptor,Ki,=,17.29,nM,CHEMBL3888602,B,"Radioligand Binding Assay: The affinity of compounds to D1 and D2 dopamine receptors were determined by competition binding assays. Membrane homogenates of HEK293T cells were stably transfected with D1, or D2 receptors. Duplicated tubes were incubated at 30° C. for 50 mins (for D1, and D2) with increasing concentrations of respective compound and with [3H]SCH23390 (for D1 dopamine receptors), or [3H]Spiperone (for dopamine D2 receptor) in a final volume of 200 μL binding buffer containing 50 mM Tris, 4 mM MgCl2, pH 7.4. Nonspecific binding was determined by parallel incubations with either 10 μM SCH23390 for D1, or Spiperone for D2 receptors respectively. The reaction was started by addition of membranes (15 ng/tube) and stopped by rapid filtration through Whatman GF/B glassfiber filter and subsequently washed with cold buffer (50 mM Tris, 5 mM EDTA, pH 7.4) using a Brandel 24-well cell harvester. Scintillation cocktail was added and the radioactivity was determined in a MicroBeta liquid scintillation counter.",CHEMBL3886775,KI,COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCC4
CHEMBL2057457,CHEMBL2056,Dopamine D1 receptor,Ki,=,28.91,nM,CHEMBL3888602,B,"Radioligand Binding Assay: The affinity of compounds to D1 and D2 dopamine receptors were determined by competition binding assays. Membrane homogenates of HEK293T cells were stably transfected with D1, or D2 receptors. Duplicated tubes were incubated at 30° C. for 50 mins (for D1, and D2) with increasing concentrations of respective compound and with [3H]SCH23390 (for D1 dopamine receptors), or [3H]Spiperone (for dopamine D2 receptor) in a final volume of 200 μL binding buffer containing 50 mM Tris, 4 mM MgCl2, pH 7.4. Nonspecific binding was determined by parallel incubations with either 10 μM SCH23390 for D1, or Spiperone for D2 receptors respectively. The reaction was started by addition of membranes (15 ng/tube) and stopped by rapid filtration through Whatman GF/B glassfiber filter and subsequently washed with cold buffer (50 mM Tris, 5 mM EDTA, pH 7.4) using a Brandel 24-well cell harvester. Scintillation cocktail was added and the radioactivity was determined in a MicroBeta liquid scintillation counter.",CHEMBL3886775,KI,COc1cc2c(cc1O)[C@@H]1Cc3cc(C)cc(C)c3CN1CC2
CHEMBL3897805,CHEMBL2056,Dopamine D1 receptor,Ki,=,23.65,nM,CHEMBL3888602,B,"Radioligand Binding Assay: The affinity of compounds to D1 and D2 dopamine receptors were determined by competition binding assays. Membrane homogenates of HEK293T cells were stably transfected with D1, or D2 receptors. Duplicated tubes were incubated at 30° C. for 50 mins (for D1, and D2) with increasing concentrations of respective compound and with [3H]SCH23390 (for D1 dopamine receptors), or [3H]Spiperone (for dopamine D2 receptor) in a final volume of 200 μL binding buffer containing 50 mM Tris, 4 mM MgCl2, pH 7.4. Nonspecific binding was determined by parallel incubations with either 10 μM SCH23390 for D1, or Spiperone for D2 receptors respectively. The reaction was started by addition of membranes (15 ng/tube) and stopped by rapid filtration through Whatman GF/B glassfiber filter and subsequently washed with cold buffer (50 mM Tris, 5 mM EDTA, pH 7.4) using a Brandel 24-well cell harvester. Scintillation cocktail was added and the radioactivity was determined in a MicroBeta liquid scintillation counter.",CHEMBL3886775,KI,COc1ccc(OC)c2c1C[C@H]1c3cc4c(cc3CCN1C2)OCO4
CHEMBL3913343,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.7,nM,CHEMBL3888602,B,"Radioligand Binding Assay: The affinity of compounds to D1 and D2 dopamine receptors were determined by competition binding assays. Membrane homogenates of HEK293T cells were stably transfected with D1, or D2 receptors. Duplicated tubes were incubated at 30° C. for 50 mins (for D1, and D2) with increasing concentrations of respective compound and with [3H]SCH23390 (for D1 dopamine receptors), or [3H]Spiperone (for dopamine D2 receptor) in a final volume of 200 μL binding buffer containing 50 mM Tris, 4 mM MgCl2, pH 7.4. Nonspecific binding was determined by parallel incubations with either 10 μM SCH23390 for D1, or Spiperone for D2 receptors respectively. The reaction was started by addition of membranes (15 ng/tube) and stopped by rapid filtration through Whatman GF/B glassfiber filter and subsequently washed with cold buffer (50 mM Tris, 5 mM EDTA, pH 7.4) using a Brandel 24-well cell harvester. Scintillation cocktail was added and the radioactivity was determined in a MicroBeta liquid scintillation counter.",CHEMBL3886775,KI,COc1cc2c(cc1O)[C@@H]1Cc3c(OC)ccc(OC)c3CN1CC2
CHEMBL3917753,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.72,nM,CHEMBL3888602,B,"Radioligand Binding Assay: The affinity of compounds to D1 and D2 dopamine receptors were determined by competition binding assays. Membrane homogenates of HEK293T cells were stably transfected with D1, or D2 receptors. Duplicated tubes were incubated at 30° C. for 50 mins (for D1, and D2) with increasing concentrations of respective compound and with [3H]SCH23390 (for D1 dopamine receptors), or [3H]Spiperone (for dopamine D2 receptor) in a final volume of 200 μL binding buffer containing 50 mM Tris, 4 mM MgCl2, pH 7.4. Nonspecific binding was determined by parallel incubations with either 10 μM SCH23390 for D1, or Spiperone for D2 receptors respectively. The reaction was started by addition of membranes (15 ng/tube) and stopped by rapid filtration through Whatman GF/B glassfiber filter and subsequently washed with cold buffer (50 mM Tris, 5 mM EDTA, pH 7.4) using a Brandel 24-well cell harvester. Scintillation cocktail was added and the radioactivity was determined in a MicroBeta liquid scintillation counter.",CHEMBL3886775,KI,COc1ccc(OC)c2c1C[C@H]1c3cc(O)c(O)cc3CCN1C2
CHEMBL3899169,CHEMBL2056,Dopamine D1 receptor,Ki,=,592.0,nM,CHEMBL3889273,B,"Binding Assay or Functional Activity Assay: Further, the compounds of the invention may be tested in binding assays and functional activity assays by well known methods for other physiologically important receptors such as, but not limited to, the hERG channel, other serotonin receptors (specifically 5-HT1B, 5-HT1D, receptors, lack of agonist activity at 5-HT2B receptors, 5-HT2C, 5-HT5, 5-HT6, and 5-HT7 receptors), dopaminergic receptors (specifically D1, D2, and D3), GABAA receptors, adrenergic receptors and monoamine transporters.",CHEMBL3887018,KI,Cc1ccc2c(c1)Oc1sc(Cl)cc1C(N1CCN(CC(C)(C)C(=O)O)CC1)=N2
CHEMBL1457510,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.5,nM,CHEMBL3999638,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor after 1 hr,CHEMBL3997822,KI,COc1c(O)ccc2c1CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL490533,CHEMBL2056,Dopamine D1 receptor,Ki,=,48.6,nM,CHEMBL3999638,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor after 1 hr,CHEMBL3997822,KI,COc1ccc2c(c1OC)CN1CCc3cc4c(cc3[C@@H]1C2)OCO4
CHEMBL448891,CHEMBL2056,Dopamine D1 receptor,Ki,=,107.0,nM,CHEMBL3999638,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor after 1 hr,CHEMBL3997822,KI,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL2334885,CHEMBL2056,Dopamine D1 receptor,Ki,=,199.0,nM,CHEMBL3999638,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor after 1 hr,CHEMBL3997822,KI,COc1cc2c(cc1O)CCN1Cc3c(ccc(OC)c3OC)C[C@@H]21
CHEMBL487182,CHEMBL2056,Dopamine D1 receptor,Ki,=,153.0,nM,CHEMBL3999643,B,Displacement of [3H]SCH23390 from human 3HA-tagged dopamine D1 receptor expressed in HEK293 cells after 1 hr,CHEMBL3997822,KI,COc1cc2c(cc1OC)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2
CHEMBL2334891,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.2,nM,CHEMBL3999643,B,Displacement of [3H]SCH23390 from human 3HA-tagged dopamine D1 receptor expressed in HEK293 cells after 1 hr,CHEMBL3997822,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(OC)c(OC)c3CN1CC2
CHEMBL4099711,CHEMBL2056,Dopamine D1 receptor,Ki,=,920.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nc(CO)cc3c2)CC1
CHEMBL4080762,CHEMBL2056,Dopamine D1 receptor,Ki,=,2800.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nccc3c2)CC1
CHEMBL4072821,CHEMBL2056,Dopamine D1 receptor,Ki,=,410.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCOC(=O)c1cc2cc(OCCCCN3CCN(c4ccccc4OC)CC3)ccn2n1
CHEMBL4098803,CHEMBL2056,Dopamine D1 receptor,Ki,=,1100.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccc3ccnn3c2)CC1
CHEMBL4070091,CHEMBL2056,Dopamine D1 receptor,Ki,=,860.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C#N)c3c2)CC1
CHEMBL4091064,CHEMBL2056,Dopamine D1 receptor,Ki,=,250.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,N#Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL4096353,CHEMBL2056,Dopamine D1 receptor,Ki,=,900.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(/C=N\O)c3c2)CC1
CHEMBL4069091,CHEMBL2056,Dopamine D1 receptor,Ki,=,2900.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2ncc(/C=N\O)c2c1
CHEMBL4088639,CHEMBL2056,Dopamine D1 receptor,Ki,=,1200.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3ncc(C=O)c3c2)CC1
CHEMBL4060403,CHEMBL2056,Dopamine D1 receptor,Ki,=,210.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,O=Cc1cnn2ccc(NC(=O)CCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc12
CHEMBL4063282,CHEMBL2056,Dopamine D1 receptor,Ki,=,1700.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCC(=O)Nc2ccn3nccc3c2)CC1
CHEMBL4091155,CHEMBL2056,Dopamine D1 receptor,Ki,=,240.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,O=C(CCCN1CCN(c2cccc(Cl)c2Cl)CC1)Nc1ccn2nccc2c1
CHEMBL1112,CHEMBL2056,Dopamine D1 receptor,Ki,=,310.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4069145,CHEMBL2056,Dopamine D1 receptor,Ki,=,1000.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccc3c(/C=N/O)cnn3c2)CC1
CHEMBL4060461,CHEMBL2056,Dopamine D1 receptor,Ki,=,710.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4060461,CHEMBL2056,Dopamine D1 receptor,Ki,=,860.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(/C=N/O)c3c2)CC1
CHEMBL4071868,CHEMBL2056,Dopamine D1 receptor,Ki,=,600.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccc2c(/C=N/O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4098859,CHEMBL2056,Dopamine D1 receptor,Ki,=,1800.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccn2ncc(/C=N\O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4063235,CHEMBL2056,Dopamine D1 receptor,Ki,=,210.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C#N)c3c2)CC1
CHEMBL4090208,CHEMBL2056,Dopamine D1 receptor,Ki,=,1300.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccn2ncc(C=O)c2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4071185,CHEMBL2056,Dopamine D1 receptor,Ki,=,1400.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccc2c(C=O)cnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4098236,CHEMBL2056,Dopamine D1 receptor,Ki,=,430.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3ncc(C=O)c3c2)CC1
CHEMBL4067439,CHEMBL2056,Dopamine D1 receptor,Ki,=,1400.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccc3c(C=O)cnn3c2)CC1
CHEMBL4094869,CHEMBL2056,Dopamine D1 receptor,Ki,=,3700.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccn2nccc2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4078348,CHEMBL2056,Dopamine D1 receptor,Ki,=,800.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccn2nccc2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4102616,CHEMBL2056,Dopamine D1 receptor,Ki,=,8600.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccc2ccnn2c1)[C@@H]1CCc2c(O)cccc2C1
CHEMBL4097330,CHEMBL2056,Dopamine D1 receptor,Ki,=,2100.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,CCCN(CCCCOc1ccc2ccnn2c1)[C@H]1CCc2c(O)cccc2C1
CHEMBL4079301,CHEMBL2056,Dopamine D1 receptor,Ki,=,280.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C#N)cc3c2)CC1
CHEMBL4105030,CHEMBL2056,Dopamine D1 receptor,Ki,=,440.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nc(/C=N/O)cc3c2)CC1
CHEMBL4087187,CHEMBL2056,Dopamine D1 receptor,Ki,=,470.0,nM,CHEMBL4010154,B,Displacement of [3H]SCH23390 from human Dopamine D1 receptor expressed in HEK293T cell membranes after 2 hrs by scintillation counting analysis,CHEMBL4007455,KI,COc1ccccc1N1CCN(CCCCOc2ccn3nc(C=O)cc3c2)CC1
CHEMBL4083239,CHEMBL2056,Dopamine D1 receptor,Ki,=,5400.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1
CHEMBL4072780,CHEMBL2056,Dopamine D1 receptor,Ki,=,12000.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1
CHEMBL4091933,CHEMBL2056,Dopamine D1 receptor,Ki,=,4500.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc2N1
CHEMBL4064186,CHEMBL2056,Dopamine D1 receptor,Ki,=,1500.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4ccc(O)c5ncccc45)CC3)cc2N1
CHEMBL4102628,CHEMBL2056,Dopamine D1 receptor,Ki,=,11000.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2N1
CHEMBL4064742,CHEMBL2056,Dopamine D1 receptor,Ki,=,2700.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc2N1
CHEMBL4092441,CHEMBL2056,Dopamine D1 receptor,Ki,=,4700.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=c1ccc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1
CHEMBL4100183,CHEMBL2056,Dopamine D1 receptor,Ki,=,2300.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1COc2c(N3CCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2N1
CHEMBL4083727,CHEMBL2056,Dopamine D1 receptor,Ki,=,5300.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c2c1OCCO2
CHEMBL4061986,CHEMBL2056,Dopamine D1 receptor,Ki,=,1100.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,Oc1ccc(N2CCN(CCCCOc3ccn4nccc4c3)CC2)c2cccnc12
CHEMBL4091507,CHEMBL2056,Dopamine D1 receptor,Ki,=,13000.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=c1ccc2c(N3CCCN(CCCCOc4ccn5nccc5c4)CC3)ccc(O)c2[nH]1
CHEMBL4070604,CHEMBL2056,Dopamine D1 receptor,Ki,=,17000.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2OC)nn1
CHEMBL4068702,CHEMBL2056,Dopamine D1 receptor,Ki,=,4000.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,CCCCn1cc(CCCOc2ccc(C(=O)NCCCCN3CCCN(c4ccc(O)c5[nH]c(=O)ccc45)CC3)cc2OC)nn1
CHEMBL1112,CHEMBL2056,Dopamine D1 receptor,Ki,=,310.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2165126,CHEMBL2056,Dopamine D1 receptor,Ki,=,340.0,nM,CHEMBL4015805,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4014323,KI,O=C1CCc2ccc(OCCCCN3CCCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL7927,CHEMBL2056,Dopamine D1 receptor,Ki,=,12000.0,nM,CHEMBL4039162,B,Inhibition of human dopamine D1 receptor,CHEMBL4038300,KI,Clc1ccc(N2CCN(Cc3cnn4ccccc34)CC2)cc1
CHEMBL310843,CHEMBL2056,Dopamine D1 receptor,Ki,=,5500.0,nM,CHEMBL4039162,B,Inhibition of human dopamine D1 receptor,CHEMBL4038300,KI,Clc1ccc(N2CCN(Cc3cc4ccccn4n3)CC2)cc1
CHEMBL81330,CHEMBL2056,Dopamine D1 receptor,Ki,=,411.0,nM,CHEMBL4039162,B,Inhibition of human dopamine D1 receptor,CHEMBL4038300,KI,Fc1ccc(N2CCN(CCC3OCCc4ccccc43)CC2)cc1
CHEMBL4096543,CHEMBL2056,Dopamine D1 receptor,Ki,=,2830.0,nM,CHEMBL4039162,B,Inhibition of human dopamine D1 receptor,CHEMBL4038300,KI,CC(C)Oc1cccnc1N(C)C1CCN(Cc2ccc(I)cc2)CC1
CHEMBL4065797,CHEMBL2056,Dopamine D1 receptor,Ki,=,8800.0,nM,CHEMBL4046972,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes,CHEMBL4043213,KI,CCCN1CCCN(c2ccc(O)c3c2OCC(=O)N3)CC1
CHEMBL4064759,CHEMBL2056,Dopamine D1 receptor,Ki,=,7700.0,nM,CHEMBL4046972,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes,CHEMBL4043213,KI,CN1CCN(c2ccc(O)c3c2OCCO3)CC1
CHEMBL4066916,CHEMBL2056,Dopamine D1 receptor,Ki,=,6000.0,nM,CHEMBL4046972,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes,CHEMBL4043213,KI,Oc1ccc(N2CCNCC2)c2c1OCCO2
CHEMBL4063145,CHEMBL2056,Dopamine D1 receptor,Ki,=,3800.0,nM,CHEMBL4046972,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes,CHEMBL4043213,KI,O=C1COc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2N1
CHEMBL4063145,CHEMBL2056,Dopamine D1 receptor,Ki,=,4800.0,nM,CHEMBL4046972,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes,CHEMBL4043213,KI,O=C1COc2c(N3CCN(CCCCOc4ccn5ncc(/C=N/O)c5c4)CC3)ccc(O)c2N1
CHEMBL4095881,CHEMBL2056,Dopamine D1 receptor,Ki,=,11000.0,nM,CHEMBL4046972,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes,CHEMBL4043213,KI,O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCCO5)CC3)cc12
CHEMBL4079375,CHEMBL2056,Dopamine D1 receptor,Ki,=,12000.0,nM,CHEMBL4046972,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes,CHEMBL4043213,KI,O=Cc1cnn2ccc(OCCCCN3CCN(c4ccc(O)c5c4OCC(=O)N5)CC3)cc12
CHEMBL1112,CHEMBL2056,Dopamine D1 receptor,Ki,=,310.0,nM,CHEMBL4046972,B,Displacement of [3H]SCH23390 from human D1R expressed in HEK293T cell membranes,CHEMBL4043213,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL2028019,CHEMBL2056,Dopamine D1 receptor,Ki,=,2100.0,nM,CHEMBL4054775,B,Displacement of [3H]SCH23990 from human D1 receptor expressed in HEK293T cell membranes,CHEMBL4052643,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL142020,CHEMBL2056,Dopamine D1 receptor,Ki,=,1600.0,nM,CHEMBL4054775,B,Displacement of [3H]SCH23990 from human D1 receptor expressed in HEK293T cell membranes,CHEMBL4052643,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2cc3ccccn3n2)CC1
CHEMBL4064974,CHEMBL2056,Dopamine D1 receptor,Ki,=,860.0,nM,CHEMBL4054775,B,Displacement of [3H]SCH23990 from human D1 receptor expressed in HEK293T cell membranes,CHEMBL4052643,KI,O=C(NCCCCN1CCN(c2ccccc2OCCF)CC1)c1cc2ccccn2n1
CHEMBL4085920,CHEMBL2056,Dopamine D1 receptor,Ki,=,7500.0,nM,CHEMBL4054775,B,Displacement of [3H]SCH23990 from human D1 receptor expressed in HEK293T cell membranes,CHEMBL4052643,KI,CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cc4ccccn4n3)CC2)cc(C(F)(F)F)n1
CHEMBL4060837,CHEMBL2056,Dopamine D1 receptor,Ki,=,5700.0,nM,CHEMBL4054775,B,Displacement of [3H]SCH23990 from human D1 receptor expressed in HEK293T cell membranes,CHEMBL4052643,KI,Cc1ccc(S(=O)(=O)[O-])cc1.O=C(NCCCCN1CC[N+]2(CCOc3ccccc32)CC1)c1cc2ccccn2n1
CHEMBL4163428,CHEMBL2056,Dopamine D1 receptor,Ki,=,1804.0,nM,CHEMBL4153408,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in HEKT cells after 90 mins by microbeta scintillation counting method,CHEMBL4152214,KI,CN1CCN(c2ccc3c(c2)CN(C(=O)OCc2ccccc2)C3)CC1
CHEMBL4208744,CHEMBL2056,Dopamine D1 receptor,Ki,=,610.0,nM,CHEMBL4179171,B,Displacement of [3H]SCH-23390 from human recombinant dopamine D1 receptor expressed in CHO cells,CHEMBL4177580,KI,O=C(NCCN1CCN(c2ccc(Cl)c(Cl)c2)CC1)c1ccccn1
CHEMBL4216870,CHEMBL2056,Dopamine D1 receptor,Ki,=,7600.0,nM,CHEMBL4189961,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cell membranes after 90 mins by scintillation counting method,CHEMBL4184336,KI,NCCCCCCn1cc(CCCCN2CCC(c3ccc(-c4cc(C(=O)O)cc5cc(-c6ccc(C(F)(F)F)cc6)ccc45)cc3)CC2)nn1
CHEMBL4225830,CHEMBL2056,Dopamine D1 receptor,Ki,=,861.0,nM,CHEMBL4223411,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4228054,CHEMBL2056,Dopamine D1 receptor,Ki,=,542.0,nM,CHEMBL4223411,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4227192,CHEMBL2056,Dopamine D1 receptor,Ki,=,1278.0,nM,CHEMBL4223411,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4226336,CHEMBL2056,Dopamine D1 receptor,Ki,=,597.0,nM,CHEMBL4223411,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4224763,CHEMBL2056,Dopamine D1 receptor,Ki,=,170.0,nM,CHEMBL4223411,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4225278,CHEMBL2056,Dopamine D1 receptor,Ki,=,174.0,nM,CHEMBL4223411,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4229178,CHEMBL2056,Dopamine D1 receptor,Ki,=,128.0,nM,CHEMBL4223411,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCCCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4225278,CHEMBL2056,Dopamine D1 receptor,Ki,=,181.0,nM,CHEMBL4223411,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4219212,KI,CCCCCCCCCN1CCC(c2cccc(O)c2)C1
CHEMBL4226226,CHEMBL2056,Dopamine D1 receptor,Ki,=,831.0,nM,CHEMBL4223411,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4219212,KI,CN(C)c1ccc(C(=O)NCCCCN2CCC(c3cccc(O)c3)C2)cc1
CHEMBL4226226,CHEMBL2056,Dopamine D1 receptor,Ki,=,4589.0,nM,CHEMBL4223411,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4219212,KI,CN(C)c1ccc(C(=O)NCCCCN2CCC(c3cccc(O)c3)C2)cc1
CHEMBL4291048,CHEMBL2056,Dopamine D1 receptor,Ki,=,300.0,nM,CHEMBL4260834,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cells by radioligand binding assay,CHEMBL4257579,KI,OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCN(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL4278465,CHEMBL2056,Dopamine D1 receptor,Ki,=,10000.0,nM,CHEMBL4260834,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cells by radioligand binding assay,CHEMBL4257579,KI,OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCCN(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL1644978,CHEMBL2056,Dopamine D1 receptor,Ki,=,798.0,nM,CHEMBL4260834,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cells by radioligand binding assay,CHEMBL4257579,KI,OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL1644980,CHEMBL2056,Dopamine D1 receptor,Ki,=,135.0,nM,CHEMBL4260834,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cells by radioligand binding assay,CHEMBL4257579,KI,OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccccc2)c2ccccc2)CC1
CHEMBL4293307,CHEMBL2056,Dopamine D1 receptor,Ki,=,10000.0,nM,CHEMBL4260834,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cells by radioligand binding assay,CHEMBL4257579,KI,COc1ccc(N(CCCCN2CCC(O)(c3ccc(Cl)c(C(F)(F)F)c3)CC2)c2ccc(OC)cc2)cc1
CHEMBL47050,CHEMBL2056,Dopamine D1 receptor,Ki,=,147.0,nM,CHEMBL4260834,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cells by radioligand binding assay,CHEMBL4257579,KI,OC1(c2ccc(Cl)c(C(F)(F)F)c2)CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL59,CHEMBL2056,Dopamine D1 receptor,Ki,=,243.0,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,NCCc1ccc(O)c(O)c1
CHEMBL4282096,CHEMBL2056,Dopamine D1 receptor,Ki,=,2242.0,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,Cn1nccc1-c1ccc(Oc2nccc3occc23)cc1
CHEMBL4293356,CHEMBL2056,Dopamine D1 receptor,Ki,=,254.0,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,Cc1cc(Oc2nccc3occc23)ccc1-c1ccnn1C
CHEMBL4285528,CHEMBL2056,Dopamine D1 receptor,Ki,=,1680.0,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,CC(C)(C)n1nccc1-c1ccc(Oc2nccc3occc23)cc1
CHEMBL4283176,CHEMBL2056,Dopamine D1 receptor,Ki,=,563.0,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,Cc1cc(Oc2nccc3occc23)ccc1-c1ccnn1C(C)(C)C
CHEMBL4293757,CHEMBL2056,Dopamine D1 receptor,Ki,=,121.0,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)cnn1C(C)(C)C
CHEMBL4289538,CHEMBL2056,Dopamine D1 receptor,Ki,=,376.0,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,Cc1nc2cnccc2n1-c1ccc(Oc2nccc3occc23)cc1
CHEMBL4278861,CHEMBL2056,Dopamine D1 receptor,Ki,=,244.0,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,Cc1cc(Oc2nccc3occc23)ccc1-n1c(C)nc2cnccc21
CHEMBL4286110,CHEMBL2056,Dopamine D1 receptor,Ki,=,56.3,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,COc1ccc2cnccc2c1-c1ccc(Oc2nccc3occc23)cc1
CHEMBL4294009,CHEMBL2056,Dopamine D1 receptor,Ki,=,98.9,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,c1cc(-c2ccc(Oc3nccc4occc34)cc2)n2ccnc2c1
CHEMBL4294397,CHEMBL2056,Dopamine D1 receptor,Ki,=,38.1,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,Cc1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12
CHEMBL4286177,CHEMBL2056,Dopamine D1 receptor,Ki,=,8.5,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,Cc1ccc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1
CHEMBL4279267,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.8,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ccc2nccn12
CHEMBL4287192,CHEMBL2056,Dopamine D1 receptor,Ki,=,2346.0,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,Cc1cc(Oc2nccc3occc23)ccc1-c1cncc2ncnn12
CHEMBL4277264,CHEMBL2056,Dopamine D1 receptor,Ki,=,8.9,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12
CHEMBL4277264,CHEMBL2056,Dopamine D1 receptor,Ki,=,21.6,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12
CHEMBL4277264,CHEMBL2056,Dopamine D1 receptor,Ki,=,11.9,nM,CHEMBL4260960,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in LTK cell membranes after 30 mins by liquid scintillation counting,CHEMBL4257582,KI,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12
CHEMBL4280542,CHEMBL2056,Dopamine D1 receptor,Ki,=,1600.0,nM,CHEMBL4269465,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEKT cell membranes,CHEMBL4266003,KI,COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccc(I)cc1)CC2
CHEMBL4291172,CHEMBL2056,Dopamine D1 receptor,Ki,=,500.0,nM,CHEMBL4269465,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEKT cell membranes,CHEMBL4266003,KI,COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccc(Br)cc1)CC2
CHEMBL4283982,CHEMBL2056,Dopamine D1 receptor,Ki,=,680.0,nM,CHEMBL4269465,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEKT cell membranes,CHEMBL4266003,KI,COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccc(Cl)cc1)CC2
CHEMBL4279136,CHEMBL2056,Dopamine D1 receptor,Ki,=,1810.0,nM,CHEMBL4269465,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEKT cell membranes,CHEMBL4266003,KI,COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccnc3ccccc13)CC2
CHEMBL4287062,CHEMBL2056,Dopamine D1 receptor,Ki,=,800.0,nM,CHEMBL4269465,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEKT cell membranes,CHEMBL4266003,KI,COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccc3ccccc3c1)CC2
CHEMBL4287471,CHEMBL2056,Dopamine D1 receptor,Ki,=,800.0,nM,CHEMBL4269465,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEKT cell membranes,CHEMBL4266003,KI,COc1cc2c(cc1O)CN(CCCCNC(=O)c1ccc(-c3ccccc3)cc1)CC2
CHEMBL4442460,CHEMBL2056,Dopamine D1 receptor,Ki,=,200.0,nM,CHEMBL4323485,B,Displacement of [3H] SCH23390 from D1 receptor (unknown origin),CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccccc2)c2ccccc2)CC1
CHEMBL4544086,CHEMBL2056,Dopamine D1 receptor,Ki,=,360.0,nM,CHEMBL4323485,B,Displacement of [3H] SCH23390 from D1 receptor (unknown origin),CHEMBL4321823,KI,COc1ccccc1N1CCN(CCCNC(=O)NN(Cc2ccc(F)cc2)c2ccccc2)CC1
CHEMBL4463034,CHEMBL2056,Dopamine D1 receptor,Ki,=,148.0,nM,CHEMBL4368217,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in commercial cell membranes,CHEMBL4364325,KI,COc1ccc2[nH]cc(C3=CCN(Cc4cc(=O)[nH]c5ccccc45)CC3)c2c1
CHEMBL4593728,CHEMBL2056,Dopamine D1 receptor,Ki,=,5110.0,nM,CHEMBL4369174,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cell membranes by radioligand binding assay,CHEMBL4368860,KI,CCNc1nc(C#Cc2ccc(Cl)s2)nc2[nH]cnc12
CHEMBL3697617,CHEMBL2056,Dopamine D1 receptor,Ki,=,8.54,nM,CHEMBL4372467,B,Partial agonist activity at human D1R,CHEMBL4371045,KI,Cc1cc(Oc2ncccc2C(F)(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3671276,CHEMBL2056,Dopamine D1 receptor,Ki,=,113.0,nM,CHEMBL4372467,B,Partial agonist activity at human D1R,CHEMBL4371045,KI,Cc1cc(Oc2nccc3n[nH]cc23)ccc1-c1c(C)ncnc1C
CHEMBL4277264,CHEMBL2056,Dopamine D1 receptor,Ki,=,110.0,nM,CHEMBL4392129,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cells measured after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12
CHEMBL4572614,CHEMBL2056,Dopamine D1 receptor,Ki,=,140.0,nM,CHEMBL4392129,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cells measured after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F
CHEMBL4469848,CHEMBL2056,Dopamine D1 receptor,Ki,=,150.0,nM,CHEMBL4392129,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cells measured after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12
CHEMBL4466483,CHEMBL2056,Dopamine D1 receptor,Ki,=,130.0,nM,CHEMBL4392129,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cells measured after 90 mins by microbeta scintillation counting method,CHEMBL4390674,KI,FC(F)(F)c1cc(Oc2nccc3ccsc23)ccc1-c1cccc2nccn12
CHEMBL4522558,CHEMBL2056,Dopamine D1 receptor,Ki,=,2344.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)C[C@H]1C[C@@H]1c1cccc(Cl)c1Cl.Cl
CHEMBL4443039,CHEMBL2056,Dopamine D1 receptor,Ki,=,1349.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)C[C@@H]1C[C@H]1c1cccc(Cl)c1Cl.Cl
CHEMBL4586582,CHEMBL2056,Dopamine D1 receptor,Ki,=,1122.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)C[C@H]1C[C@@H]1c1cccc(Cl)c1Cl.Cl
CHEMBL4439544,CHEMBL2056,Dopamine D1 receptor,Ki,=,1380.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)C[C@@H]1C[C@H]1c1cccc(Cl)c1Cl.Cl
CHEMBL4580817,CHEMBL2056,Dopamine D1 receptor,Ki,=,1047.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)C[C@H]1C[C@@H]1c1cccc(Cl)c1Cl.Cl
CHEMBL4454380,CHEMBL2056,Dopamine D1 receptor,Ki,=,1288.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)C[C@@H]1C[C@H]1c1cccc(Cl)c1Cl.Cl
CHEMBL4593394,CHEMBL2056,Dopamine D1 receptor,Ki,=,1071.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)C[C@H]1C[C@@H]1c1cc(F)ccc1OC.Cl
CHEMBL4475406,CHEMBL2056,Dopamine D1 receptor,Ki,=,4898.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)C[C@@H]1C[C@H]1c1cc(F)ccc1OC.Cl
CHEMBL4527244,CHEMBL2056,Dopamine D1 receptor,Ki,=,1647.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)CC1CC1c1cccc(Cl)c1Cl.Cl
CHEMBL4456007,CHEMBL2056,Dopamine D1 receptor,Ki,=,891.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cccc(Cl)c1Cl.Cl
CHEMBL4590211,CHEMBL2056,Dopamine D1 receptor,Ki,=,891.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cccc(Cl)c1Cl.Cl
CHEMBL4470439,CHEMBL2056,Dopamine D1 receptor,Ki,=,1423.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)CC1CC1c1ccc(C(F)(F)F)cc1.Cl
CHEMBL4584481,CHEMBL2056,Dopamine D1 receptor,Ki,=,1278.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1ccc(C(F)(F)F)cc1.Cl
CHEMBL4444691,CHEMBL2056,Dopamine D1 receptor,Ki,=,1711.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1ccc(C(F)(F)F)cc1.Cl
CHEMBL4543870,CHEMBL2056,Dopamine D1 receptor,Ki,=,1308.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)CC1CC1c1ccc(Cl)cc1.Cl
CHEMBL4472900,CHEMBL2056,Dopamine D1 receptor,Ki,=,649.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1ccc(Cl)cc1.Cl
CHEMBL4469584,CHEMBL2056,Dopamine D1 receptor,Ki,=,509.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1ccc(Cl)cc1.Cl
CHEMBL4467486,CHEMBL2056,Dopamine D1 receptor,Ki,=,3631.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)CC1CC1c1ccc(F)cc1.Cl
CHEMBL4569006,CHEMBL2056,Dopamine D1 receptor,Ki,=,1457.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1ccc(F)cc1.Cl
CHEMBL4550187,CHEMBL2056,Dopamine D1 receptor,Ki,=,992.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1ccc(F)cc1.Cl
CHEMBL4568916,CHEMBL2056,Dopamine D1 receptor,Ki,=,832.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)CC1CC1c1cccc(Cl)c1.Cl
CHEMBL4453478,CHEMBL2056,Dopamine D1 receptor,Ki,=,992.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cccc(Cl)c1.Cl
CHEMBL4525624,CHEMBL2056,Dopamine D1 receptor,Ki,=,940.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cccc(Cl)c1.Cl
CHEMBL4452329,CHEMBL2056,Dopamine D1 receptor,Ki,=,2906.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)CC1CC1c1cccc(F)c1.Cl
CHEMBL4590839,CHEMBL2056,Dopamine D1 receptor,Ki,=,1105.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cccc(F)c1.Cl
CHEMBL4439535,CHEMBL2056,Dopamine D1 receptor,Ki,=,1308.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cccc(F)c1.Cl
CHEMBL4577162,CHEMBL2056,Dopamine D1 receptor,Ki,=,818.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cc(Cl)ccc1OC.Cl
CHEMBL4456964,CHEMBL2056,Dopamine D1 receptor,Ki,=,930.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cc(Cl)ccc1OC.Cl
CHEMBL4541924,CHEMBL2056,Dopamine D1 receptor,Ki,=,1981.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cc(Cl)ccc1OC.Cl
CHEMBL4442408,CHEMBL2056,Dopamine D1 receptor,Ki,=,1758.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc(-c2ccccn2)cc1)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL4531363,CHEMBL2056,Dopamine D1 receptor,Ki,=,871.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL4561808,CHEMBL2056,Dopamine D1 receptor,Ki,=,1084.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCN(CCCCNC(=O)c1cc2ccccc2[nH]1)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL4454872,CHEMBL2056,Dopamine D1 receptor,Ki,=,967.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL4452683,CHEMBL2056,Dopamine D1 receptor,Ki,=,986.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCN(CCCCNC(=O)c1ccc2ccccc2c1)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL540612,CHEMBL2056,Dopamine D1 receptor,Ki,=,1132.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1.Cl
CHEMBL4475699,CHEMBL2056,Dopamine D1 receptor,Ki,=,636.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,COc1ccc(Cl)cc1C1CC1CN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1.Cl
CHEMBL4584372,CHEMBL2056,Dopamine D1 receptor,Ki,=,1918.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(Cl)ccc1OC.Cl
CHEMBL4578364,CHEMBL2056,Dopamine D1 receptor,Ki,=,1509.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(Cl)ccc1OC.Cl
CHEMBL4440698,CHEMBL2056,Dopamine D1 receptor,Ki,=,1078.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,COc1ccc(F)cc1C1CC1CN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1.Cl
CHEMBL4442936,CHEMBL2056,Dopamine D1 receptor,Ki,=,1668.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL4590966,CHEMBL2056,Dopamine D1 receptor,Ki,=,1724.6,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(F)ccc1OC.Cl
CHEMBL4514800,CHEMBL2056,Dopamine D1 receptor,Ki,=,794.3,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,COc1ccc(F)cc1C1CC1CN(C)CCCSc1nnc(-c2ccccc2)n1C.Cl
CHEMBL4514586,CHEMBL2056,Dopamine D1 receptor,Ki,=,631.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,COc1ccc(F)cc1C1CC1CNCCCSc1nnc(-c2ccccc2)n1C.Cl
CHEMBL4450429,CHEMBL2056,Dopamine D1 receptor,Ki,=,1148.2,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCOc1ccc(F)cc1C1CC1CN(CC)CCCSc1nnc(-c2ccccc2)n1C.Cl
CHEMBL4467528,CHEMBL2056,Dopamine D1 receptor,Ki,=,1122.0,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCOc1ccc(F)cc1C1CC1CN(C)CCCSc1nnc(-c2ccccc2)n1C.Cl
CHEMBL4590356,CHEMBL2056,Dopamine D1 receptor,Ki,=,295.1,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCOc1ccc(F)cc1C1CC1CNCCCSc1nnc(-c2ccccc2)n1C.Cl
CHEMBL4448853,CHEMBL2056,Dopamine D1 receptor,Ki,=,584.3,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CCN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(F)ccc1OCCF.Cl
CHEMBL4585289,CHEMBL2056,Dopamine D1 receptor,Ki,=,1467.8,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,CN(CCCSc1nnc(-c2ccccc2)n1C)CC1CC1c1cc(F)ccc1OCCF.Cl
CHEMBL4546749,CHEMBL2056,Dopamine D1 receptor,Ki,=,368.7,nM,CHEMBL4406060,B,Displacement of [3H]-SCH23390 from recombinant human D1 receptor transiently expressed in HEKT cell membranes measured after 90 mins by microbeta scintillation counting method,CHEMBL4402598,KI,Cl.Cn1c(SCCCNCC2CC2c2cc(F)ccc2OCCF)nnc1-c1ccccc1
CHEMBL353335,CHEMBL2056,Dopamine D1 receptor,Ki,=,15.0,nM,CHEMBL4433967,B,Displacement of [3H]-SCH23390 from wild type human D1R expressed in HEK293 cell membranes incubated for 90 mins by scintillation counting based competition radioligand binding assay,CHEMBL4433225,KI,Oc1cc2c(c(Cl)c1O)CCNCC2c1ccccc1
CHEMBL4469983,CHEMBL2056,Dopamine D1 receptor,Ki,=,51.0,nM,CHEMBL4433967,B,Displacement of [3H]-SCH23390 from wild type human D1R expressed in HEK293 cell membranes incubated for 90 mins by scintillation counting based competition radioligand binding assay,CHEMBL4433225,KI,Cc1n[nH]c(=O)c(C)c1-c1ccc(Oc2nccc3occc23)cc1F
CHEMBL4453318,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.4,nM,CHEMBL4433967,B,Displacement of [3H]-SCH23390 from wild type human D1R expressed in HEK293 cell membranes incubated for 90 mins by scintillation counting based competition radioligand binding assay,CHEMBL4433225,KI,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL3697578,CHEMBL2056,Dopamine D1 receptor,Ki,=,51.0,nM,CHEMBL4433967,B,Displacement of [3H]-SCH23390 from wild type human D1R expressed in HEK293 cell membranes incubated for 90 mins by scintillation counting based competition radioligand binding assay,CHEMBL4433225,KI,Cc1cc(Oc2ncccc2OC(F)F)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.2,nM,CHEMBL4625235,B,Antagonist activity at dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL24077,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.0,nM,CHEMBL4625237,B,Agonist activity at dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2
CHEMBL4642805,CHEMBL2056,Dopamine D1 receptor,Ki,=,126.4,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,COc1cc2c(cc1O)C(c1ccccc1)CNCC2
CHEMBL4635423,CHEMBL2056,Dopamine D1 receptor,Ki,=,147.4,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,COc1cc2c(cc1O)C(c1ccccc1Cl)CNCC2
CHEMBL4640497,CHEMBL2056,Dopamine D1 receptor,Ki,=,76.1,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,COc1cc2c(cc1O)C(c1c(Cl)cccc1Cl)CNCC2
CHEMBL4636741,CHEMBL2056,Dopamine D1 receptor,Ki,=,72.0,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,COc1cc2c(cc1O)C(c1ccccc1Br)CNCC2
CHEMBL4635277,CHEMBL2056,Dopamine D1 receptor,Ki,=,26.0,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,Oc1cc2c(cc1O)C(c1ccccc1Br)CNCC2
CHEMBL4643069,CHEMBL2056,Dopamine D1 receptor,Ki,=,14.0,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,COc1cc2c(cc1O)C(c1ccccc1Cl)CN(C)CC2
CHEMBL4633950,CHEMBL2056,Dopamine D1 receptor,Ki,=,144.6,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,COc1cc2c(cc1O)C(c1c(Cl)cccc1Cl)CN(C)CC2
CHEMBL4643426,CHEMBL2056,Dopamine D1 receptor,Ki,=,16.0,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,COc1cc2c(cc1O)C(c1ccccc1Br)CN(C)CC2
CHEMBL4643886,CHEMBL2056,Dopamine D1 receptor,Ki,=,48.3,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,C=CCN1CCc2cc(OC)c(O)cc2C(c2ccccc2Cl)C1
CHEMBL4645139,CHEMBL2056,Dopamine D1 receptor,Ki,=,1044.0,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,C=CCN1CCc2cc(OC)c(O)cc2C(c2c(Cl)cccc2Cl)C1
CHEMBL4649012,CHEMBL2056,Dopamine D1 receptor,Ki,=,41.0,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,C=CCN1CCc2cc(OC)c(O)cc2C(c2ccccc2Br)C1
CHEMBL4647167,CHEMBL2056,Dopamine D1 receptor,Ki,=,59.4,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,CN1CCc2cc(O)c(O)cc2C(c2ccccc2Br)C1
CHEMBL4637938,CHEMBL2056,Dopamine D1 receptor,Ki,=,132.9,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,C=CCN1CCc2cc(O)c(O)cc2C(c2ccccc2Br)C1
CHEMBL8514,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.04,nM,CHEMBL4625239,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4622940,KI,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
CHEMBL4641502,CHEMBL2056,Dopamine D1 receptor,Ki,=,1150.0,nM,CHEMBL4625525,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in HEKT cells incubated for 90 mins by microbeta counting method,CHEMBL4622954,KI,CN1CCc2cccc3c2C1Cc1ccc2nc(N)sc2c1-3
CHEMBL8514,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.3,nM,CHEMBL4625525,B,Displacement of [3H]-SCH23390 from human dopamine D1 receptor expressed in HEKT cells incubated for 90 mins by microbeta counting method,CHEMBL4622954,KI,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
CHEMBL8514,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.0,nM,CHEMBL4628380,B,Binding affinity to human D1 receptor,CHEMBL4627308,KI,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
CHEMBL4633772,CHEMBL2056,Dopamine D1 receptor,Ki,=,58.0,nM,CHEMBL4628380,B,Binding affinity to human D1 receptor,CHEMBL4627308,KI,C#CCOc1c(OC)cc2c3c1-c1cc(NC(C)=O)ccc1CC3N(C)CC2
CHEMBL4645375,CHEMBL2056,Dopamine D1 receptor,Ki,=,155.0,nM,CHEMBL4628380,B,Binding affinity to human D1 receptor,CHEMBL4627308,KI,C=CCOc1c(OC)cc2c3c1-c1cc(NC(C)=O)ccc1CC3N(C)CC2
CHEMBL4637673,CHEMBL2056,Dopamine D1 receptor,Ki,=,756.0,nM,CHEMBL4628380,B,Binding affinity to human D1 receptor,CHEMBL4627308,KI,COc1cc2c3c(c1OC)-c1cc(NC(C)=O)ccc1CC3N(C)CC2
CHEMBL4636589,CHEMBL2056,Dopamine D1 receptor,Ki,=,709.0,nM,CHEMBL4628380,B,Binding affinity to human D1 receptor,CHEMBL4627308,KI,C#CCOc1c(OC)cc2c3c1-c1cc(N)ccc1CC3N(C)CC2
CHEMBL4649785,CHEMBL2056,Dopamine D1 receptor,Ki,=,830.0,nM,CHEMBL4628380,B,Binding affinity to human D1 receptor,CHEMBL4627308,KI,C=CCOc1c(OC)cc2c3c1-c1cc(N)ccc1CC3N(C)CC2
CHEMBL4636318,CHEMBL2056,Dopamine D1 receptor,Ki,=,1111.0,nM,CHEMBL4628380,B,Binding affinity to human D1 receptor,CHEMBL4627308,KI,COc1cc2c3c(c1OC1CC1)-c1cc(N)ccc1CC3N(C)CC2
CHEMBL4639398,CHEMBL2056,Dopamine D1 receptor,Ki,=,691.0,nM,CHEMBL4628380,B,Binding affinity to human D1 receptor,CHEMBL4627308,KI,COc1cc2c3c(c1OC)-c1cc(N)ccc1CC3N(C)CC2
CHEMBL4637246,CHEMBL2056,Dopamine D1 receptor,Ki,=,301.0,nM,CHEMBL4628380,B,Binding affinity to human D1 receptor,CHEMBL4627308,KI,COc1cc2c3c(c1O)-c1cc(N)ccc1CC3N(C)CC2
CHEMBL4638749,CHEMBL2056,Dopamine D1 receptor,Ki,=,536.0,nM,CHEMBL4628380,B,Binding affinity to human D1 receptor,CHEMBL4627308,KI,C#CCOc1c(OC)cc2c3c1-c1cc([N+](=O)[O-])ccc1CC3N(C)CC2
CHEMBL4646927,CHEMBL2056,Dopamine D1 receptor,Ki,=,726.0,nM,CHEMBL4628380,B,Binding affinity to human D1 receptor,CHEMBL4627308,KI,COc1cc2c3c(c1OC)-c1cc([N+](=O)[O-])ccc1CC3N(C)CC2
CHEMBL4636948,CHEMBL2056,Dopamine D1 receptor,Ki,=,316.0,nM,CHEMBL4628380,B,Binding affinity to human D1 receptor,CHEMBL4627308,KI,COc1cc2c3c(c1O)-c1cc([N+](=O)[O-])ccc1CC3N(C)CC2
CHEMBL4636242,CHEMBL2056,Dopamine D1 receptor,Ki,=,928.0,nM,CHEMBL4628380,B,Binding affinity to human D1 receptor,CHEMBL4627308,KI,CN1CCc2cccc3c2C1Cc1ccc([N+](=O)[O-])cc1-3
CHEMBL53,CHEMBL2056,Dopamine D1 receptor,Ki,=,372.0,nM,CHEMBL4628390,B,Displacement of [3H]SCH23390 from human D1 receptor expressed in L cells incubated for 60 mins by radio ligand binding assay,CHEMBL4627308,KI,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL42,CHEMBL2056,Dopamine D1 receptor,Ki,=,44.0,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL715,CHEMBL2056,Dopamine D1 receptor,Ki,=,47.0,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1
CHEMBL3039528,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.13,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,CN1CCN([C@@H]2C[C@@H](c3ccccc3)c3ccc(Cl)cc32)CC1(C)C
CHEMBL298406,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.9,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,CN1CCc2cc(Cl)c(O)cc2[C@H]2c3ccccc3CC[C@@H]21
CHEMBL4748915,CHEMBL2056,Dopamine D1 receptor,Ki,=,380.0,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,CN1CC=C(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1
CHEMBL4782694,CHEMBL2056,Dopamine D1 receptor,Ki,=,55.0,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,CN1CCC(C2=Nc3cc(Cl)ccc3Nc3ccccc32)=CC1(C)C
CHEMBL4779001,CHEMBL2056,Dopamine D1 receptor,Ki,=,51.0,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CCN1C
CHEMBL4753299,CHEMBL2056,Dopamine D1 receptor,Ki,=,780.0,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,C[C@@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CCN1C
CHEMBL4745124,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.3,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,Cc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1cc(Cl)ccc1N2
CHEMBL4760903,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.4,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,CCc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1cc(Cl)ccc1N2
CHEMBL4757297,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.0,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,COc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1cc(Cl)ccc1N2
CHEMBL4758966,CHEMBL2056,Dopamine D1 receptor,Ki,=,3.7,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,CCOc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1cc(Cl)ccc1N2
CHEMBL4745489,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.0,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccc(OC(F)(F)F)cc32)CCN1C
CHEMBL4758723,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.2,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccc(F)cc32)CCN1C
CHEMBL4795230,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.9,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccc(Cl)cc32)CCN1C
CHEMBL4742056,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.1,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,C[C@H]1C=C(C2=Nc3cc(Cl)ccc3Nc3ccc(C#N)cc32)CCN1C
CHEMBL4797375,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.4,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,Cc1ccc2c(c1)N=C(C1=C[C@H](C)N(C)CC1)c1cc(OC(F)(F)F)ccc1N2
CHEMBL4776090,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.5,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,Cc1ccc2c(c1)N=C(C1=C[C@H](C)N(C)CC1)c1cc(F)ccc1N2
CHEMBL4756254,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.48,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,Cc1ccc2c(c1)N=C(C1=C[C@H](C)N(C)CC1)c1cc(Cl)ccc1N2
CHEMBL4793813,CHEMBL2056,Dopamine D1 receptor,Ki,=,7.9,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,Cc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1ccccc1N2
CHEMBL4756987,CHEMBL2056,Dopamine D1 receptor,Ki,=,4.0,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,CCc1ccc2c(c1)C(C1=C[C@H](C)N(C)CC1)=Nc1ccccc1N2
CHEMBL4740880,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.6,nM,CHEMBL4671578,B,Binding affinity to human dopamine D1 receptor,CHEMBL4665835,KI,C[C@H]1C=C(C2=Nc3ccccc3Nc3ccc(Cl)cc32)CCN1C
CHEMBL190461,CHEMBL2056,Dopamine D1 receptor,Ki,=,2700.0,nM,CHEMBL4687694,B,Inhibition of D1 dopamine receptor (unknown origin),CHEMBL4680278,KI,C=C(C)[C@@H]1CCC(C)=C[C@H]1c1c(O)cc(CCCCC)cc1O
CHEMBL4551160,CHEMBL2056,Dopamine D1 receptor,Ki,=,5630.0,nM,CHEMBL4731083,B,Displacement of [3H]-SCH23390 from human D1 receptor expressed in HEK293 cells after 60 mins by microbeta counting based assay,CHEMBL4725442,KI,C[C@H]1CO[C@@H](c2ccc(N)nc2)CN1C[C@H]1C[C@@H]1CCNC(=O)c1cc2ccccc2[nH]1
CHEMBL4642592,CHEMBL2056,Dopamine D1 receptor,Ki,=,1390.0,nM,CHEMBL4808699,B,Binding affinity to D1 receptor (unknown origin),CHEMBL4808172,KI,CC(=O)N1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1
CHEMBL4848380,CHEMBL2056,Dopamine D1 receptor,Ki,=,520.0,nM,CHEMBL4808699,B,Binding affinity to D1 receptor (unknown origin),CHEMBL4808172,KI,O=CN1CCC(c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)CC1
CHEMBL4857492,CHEMBL2056,Dopamine D1 receptor,Ki,=,1100.0,nM,CHEMBL4818338,B,Inhibition of dopamine D1 receptor (unknown origin),CHEMBL4814049,KI,O=C(O)c1ccc(C#Cc2ccc3c(c2)C=C([N+](=O)[O-])C(C(F)(F)F)O3)cc1
CHEMBL4876260,CHEMBL2056,Dopamine D1 receptor,Ki,=,91.0,nM,CHEMBL4822006,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4819092,KI,O=C(NCc1ccccc1CN1CCc2cc(O)c(O)cc2C1)c1cccc(Br)c1
CHEMBL1255588,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.84,nM,CHEMBL4822006,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4819092,KI,CC(C)(C)[C@@]1(O)CCN2C[C@@H]3c4ccccc4CCc4cccc(c43)[C@H]2C1
CHEMBL4855891,CHEMBL2056,Dopamine D1 receptor,Ki,=,1970.0,nM,CHEMBL4822006,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1O)CN(Cc1ccccc1CNC(=O)c1ccc(I)c(OC)c1)CC2
CHEMBL4846574,CHEMBL2056,Dopamine D1 receptor,Ki,=,510.0,nM,CHEMBL4822006,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1OC)CN(Cc1ccccc1CNC(=O)c1cccc(C#N)c1)CC2
CHEMBL4878587,CHEMBL2056,Dopamine D1 receptor,Ki,=,58.0,nM,CHEMBL4822006,B,Displacement of [3H]SCH23390 from dopamine D1 receptor (unknown origin),CHEMBL4819092,KI,COc1cc2c(cc1OC)CN(Cc1ccccc1CNC(=O)c1ccc(C#N)cc1)CC2
CHEMBL2028019,CHEMBL2056,Dopamine D1 receptor,Ki,=,3414.0,nM,CHEMBL4842097,B,Displacement of [3H]-SCH23390 from D1 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL2028019,CHEMBL2056,Dopamine D1 receptor,Ki,=,3388.44,nM,CHEMBL4842097,B,Displacement of [3H]-SCH23390 from D1 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL441618,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.93,nM,CHEMBL4842097,B,Displacement of [3H]-SCH23390 from D1 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL441618,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.951,nM,CHEMBL4842097,B,Displacement of [3H]-SCH23390 from D1 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,CN1CCc2ccccc2Cc2[nH]c3ccccc3c2CC1
CHEMBL1112,CHEMBL2056,Dopamine D1 receptor,Ki,=,1146.0,nM,CHEMBL4842097,B,Displacement of [3H]-SCH23390 from D1 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL1112,CHEMBL2056,Dopamine D1 receptor,Ki,=,1148.15,nM,CHEMBL4842097,B,Displacement of [3H]-SCH23390 from D1 receptor (unknown origin) expressed in HEK293T cell membranes measured after 2 hrs by microbeta scintillation counting method,CHEMBL4840367,KI,O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
CHEMBL4564312,CHEMBL2056,Dopamine D1 receptor,Ki,=,10000.0,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507266,KI,O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1
CHEMBL4564312,CHEMBL2056,Dopamine D1 receptor,Ki,=,10000.0,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507266,KI,O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1
CHEMBL4535474,CHEMBL2056,Dopamine D1 receptor,Ki,=,1266.19,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507273,KI,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL4535474,CHEMBL2056,Dopamine D1 receptor,Ki,=,1258.93,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507273,KI,CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL4520788,CHEMBL2056,Dopamine D1 receptor,Ki,=,717.65,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507273,KI,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL4520788,CHEMBL2056,Dopamine D1 receptor,Ki,=,562.34,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507273,KI,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL1800685,CHEMBL2056,Dopamine D1 receptor,Ki,=,10000.0,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507292,KI,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1
CHEMBL1800685,CHEMBL2056,Dopamine D1 receptor,Ki,=,10000.0,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507292,KI,O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1
CHEMBL4566600,CHEMBL2056,Dopamine D1 receptor,Ki,=,2150.8,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507292,KI,Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12
CHEMBL4566600,CHEMBL2056,Dopamine D1 receptor,Ki,=,2137.96,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507292,KI,Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12
CHEMBL3480577,CHEMBL2056,Dopamine D1 receptor,Ki,=,3415.0,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507309,KI,Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1
CHEMBL3480577,CHEMBL2056,Dopamine D1 receptor,Ki,=,3162.28,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507309,KI,Cc1ccc2nc(CNCCCOc3ccccc3)cc(O)c2c1
CHEMBL4580220,CHEMBL2056,Dopamine D1 receptor,Ki,=,634.31,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507319,KI,CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12
CHEMBL4580220,CHEMBL2056,Dopamine D1 receptor,Ki,=,630.96,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507319,KI,CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12
CHEMBL4552554,CHEMBL2056,Dopamine D1 receptor,Ki,=,10000.0,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507298,KI,O=C(c1ccc(F)cc1)N1CC(COc2ccc(Br)cc2)(C(=O)O)C1
CHEMBL4552554,CHEMBL2056,Dopamine D1 receptor,Ki,=,10000.0,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507298,KI,O=C(c1ccc(F)cc1)N1CC(COc2ccc(Br)cc2)(C(=O)O)C1
CHEMBL3137331,CHEMBL2056,Dopamine D1 receptor,Ki,=,10000.0,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507299,KI,CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1
CHEMBL3137331,CHEMBL2056,Dopamine D1 receptor,Ki,=,10000.0,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507299,KI,CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1
CHEMBL5074765,CHEMBL2056,Dopamine D1 receptor,Ki,=,1400.0,nM,CHEMBL5045607,B,Inhibition of dopamine D1 receptor (unknown origin) assessed as binding constant,CHEMBL5042543,KI,O=C(O)c1cc(-c2ccc([C@@H]3C[C@@H]4C[C@H]3CN4)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1
CHEMBL5079653,CHEMBL2056,Dopamine D1 receptor,Ki,=,1400.0,nM,CHEMBL5045607,B,Inhibition of dopamine D1 receptor (unknown origin) assessed as binding constant,CHEMBL5042543,KI,O=C(O)c1cc(-c2ccc([C@H]3C[C@H]4C[C@@H]3NC4=O)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1
CHEMBL5085145,CHEMBL2056,Dopamine D1 receptor,Ki,=,1400.0,nM,CHEMBL5045607,B,Inhibition of dopamine D1 receptor (unknown origin) assessed as binding constant,CHEMBL5042543,KI,N[C@H]1C[C@@H](CO)[C@H](c2ccc(-c3cc(C(=O)O)cc4cc(-c5ccc(C(F)(F)F)cc5)ccc34)cc2)C1
CHEMBL5087121,CHEMBL2056,Dopamine D1 receptor,Ki,=,1400.0,nM,CHEMBL5045607,B,Inhibition of dopamine D1 receptor (unknown origin) assessed as binding constant,CHEMBL5042543,KI,CN(C)C(=O)COC(=O)c1cc(-c2ccc([C@H]3C[C@H]4C[C@@H]3CN4)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1
CHEMBL5191141,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.56,nM,CHEMBL5117892,B,Displacement of [3H]SCH 23390 from recombinant human D1 receptor measured after 60 mins by scintillation counting analysis,CHEMBL5113485,KI,[2H]c1c([2H])c([2H])c([C@@H]2C[C@@H](N3CCN(C([2H])([2H])[2H])C(C)(C)C3)c3cc(Cl)ccc32)c([2H])c1[2H]
CHEMBL5201983,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.0,nM,CHEMBL5117892,B,Displacement of [3H]SCH 23390 from recombinant human D1 receptor measured after 60 mins by scintillation counting analysis,CHEMBL5113485,KI,[2H]c1c([2H])c([2H])c([C@@H]2C[C@@H](N3CCNC(C)(C)C3)c3cc(Cl)ccc32)c([2H])c1[2H]
CHEMBL5193761,CHEMBL2056,Dopamine D1 receptor,Ki,=,1192.3,nM,CHEMBL5145662,B,Displacement of [3H]-SCH23390 from human D1 receptor expressed in HEK293 cell membrane by competitive inhibition based analysis,CHEMBL5143585,KI,FC(F)(F)c1cccc(COC2CCN(Cc3cc4ccc(Cl)cc4[nH]3)CC2)c1
CHEMBL4860528,CHEMBL2056,Dopamine D1 receptor,Ki,=,257.04,nM,CHEMBL5151485,B,Displacement of [3H]SCH23390 from human D1 receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 60 mins by scintillation counting analysis,CHEMBL5149991,KI,CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C
CHEMBL5207281,CHEMBL2056,Dopamine D1 receptor,Ki,=,2454.71,nM,CHEMBL5151485,B,Displacement of [3H]SCH23390 from human D1 receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 60 mins by scintillation counting analysis,CHEMBL5149991,KI,CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5206565,CHEMBL2056,Dopamine D1 receptor,Ki,=,1380.38,nM,CHEMBL5151485,B,Displacement of [3H]SCH23390 from human D1 receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 60 mins by scintillation counting analysis,CHEMBL5149991,KI,N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5201074,CHEMBL2056,Dopamine D1 receptor,Ki,=,2187.76,nM,CHEMBL5151485,B,Displacement of [3H]SCH23390 from human D1 receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 60 mins by scintillation counting analysis,CHEMBL5149991,KI,C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1.Cl.Cl
CHEMBL4520788,CHEMBL2056,Dopamine D1 receptor,Ki,=,717.65,nM,CHEMBL5213954,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000743a DRD1,CHEMBL5212743,KI,CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1
CHEMBL4745071,CHEMBL2056,Dopamine D1 receptor,Ki,=,2151.0,nM,CHEMBL5214345,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000337aCl DRD1,CHEMBL5212743,KI,Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12.Cl
CHEMBL4576555,CHEMBL2056,Dopamine D1 receptor,Ki,=,1497.0,nM,CHEMBL5213381,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000705a DRD1,CHEMBL5212743,KI,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1
CHEMBL5289958,CHEMBL2056,Dopamine D1 receptor,Ki,=,1527.0,nM,CHEMBL5250282,B,Displacement of [3H]SCH23390 from D1 receptor in HEK293 cell membrane assessed as inhibition constant,CHEMBL5247621,KI,Fc1ccc(CN2CCCC3(CCN(Cc4cc5ccc(Cl)cc5[nH]4)C3)C2)cc1F
CHEMBL5274285,CHEMBL2056,Dopamine D1 receptor,Ki,=,2373.0,nM,CHEMBL5250282,B,Displacement of [3H]SCH23390 from D1 receptor in HEK293 cell membrane assessed as inhibition constant,CHEMBL5247621,KI,Fc1ccc(CN2CCCC23CCN(Cc2cc4ccc(Cl)cc4[nH]2)C3)cc1F
CHEMBL4576555,CHEMBL2056,Dopamine D1 receptor,Ki,=,1496.83,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507307,KI,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1
CHEMBL4576555,CHEMBL2056,Dopamine D1 receptor,Ki,=,1288.25,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4507307,KI,CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1
CHEMBL4802048,CHEMBL2056,Dopamine D1 receptor,Ki,=,9479.82,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4800729,KI,CC[C@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O
CHEMBL4802048,CHEMBL2056,Dopamine D1 receptor,Ki,=,9549.93,nM,CHEMBL4880034,B,GPCRScan assay: inhibition of D1,CHEMBL4800729,KI,CC[C@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O
CHEMBL5395401,CHEMBL2056,Dopamine D1 receptor,Ki,=,1443.0,nM,CHEMBL5319323,B,Binding affinity to dopamine D1 receptor (unknown origin) assessed as inhibition constant,CHEMBL5316327,KI,CCN(CC)CCCC(C)Nc1cnc(C(=O)Nc2ccc(Cl)c3cccnc23)cn1
CHEMBL5431371,CHEMBL2056,Dopamine D1 receptor,Ki,=,5474.0,nM,CHEMBL5319323,B,Binding affinity to dopamine D1 receptor (unknown origin) assessed as inhibition constant,CHEMBL5316327,KI,CCN(CC)CCCC(C)Nc1cnc(C(=O)Nc2cc(F)cc3cccnc23)cn1
CHEMBL5400876,CHEMBL2056,Dopamine D1 receptor,Ki,=,2736.0,nM,CHEMBL5325008,B,Binding affinity to D1 receptor (unknown origin) assessed as inhibition constant,CHEMBL5321291,KI,c1ccc(N2CCN(CCCc3nc4ccccc4s3)CC2)nc1
CHEMBL5433001,CHEMBL2056,Dopamine D1 receptor,Ki,=,17.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL5410387,CHEMBL2056,Dopamine D1 receptor,Ki,=,15.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL5399166,CHEMBL2056,Dopamine D1 receptor,Ki,=,53.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL5399568,CHEMBL2056,Dopamine D1 receptor,Ki,=,31.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL5410716,CHEMBL2056,Dopamine D1 receptor,Ki,=,42.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL5428803,CHEMBL2056,Dopamine D1 receptor,Ki,=,34.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,COc1c(O)ccc2c1CN1CCc3cc(OCCF)c(O)cc3[C@@H]1C2
CHEMBL487387,CHEMBL2056,Dopamine D1 receptor,Ki,=,5.9,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,COc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OC)c3CN1CC2
CHEMBL5435602,CHEMBL2056,Dopamine D1 receptor,Ki,=,6.5,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCOc1cc2c(cc1O)[C@@H]1Cc3c(Br)cc(O)c(OCC)c3CN1CC2
CHEMBL5402269,CHEMBL2056,Dopamine D1 receptor,Ki,=,20.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCOc1cc2c(cc1O)[C@@H]1Cc3c(Br)cc(O)c(OCCC)c3CN1CC2
CHEMBL5416700,CHEMBL2056,Dopamine D1 receptor,Ki,=,31.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCOc1c(O)cc(Br)c2c1CN1CCc3cc(OCCC)c(O)cc3[C@@H]1C2
CHEMBL5423880,CHEMBL2056,Dopamine D1 receptor,Ki,=,79.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCOc1c(O)cc(Br)c2c1CN1CCc3cc(OCCC)c(O)cc3[C@@H]1C2
CHEMBL5398357,CHEMBL2056,Dopamine D1 receptor,Ki,=,111.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1c(O)cc(Br)c2c1CN1CCc3cc(OCCC)c(O)cc3[C@@H]1C2
CHEMBL5420387,CHEMBL2056,Dopamine D1 receptor,Ki,=,91.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCOc1cc2c(cc1O)[C@@H]1Cc3c(Br)cc(O)c(OCCOCC)c3CN1CC2
CHEMBL5395272,CHEMBL2056,Dopamine D1 receptor,Ki,=,44.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OCC)c3CN1CC2
CHEMBL5438487,CHEMBL2056,Dopamine D1 receptor,Ki,=,58.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OCCC)c3CN1CC2
CHEMBL5425375,CHEMBL2056,Dopamine D1 receptor,Ki,=,68.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCOc1c(O)ccc2c1CN1CCc3cc(OCCC)c(O)cc3[C@@H]1C2
CHEMBL5409939,CHEMBL2056,Dopamine D1 receptor,Ki,=,683.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCOc1c(O)ccc2c1CN1CCc3cc(OCCC)c(O)cc3[C@@H]1C2
CHEMBL5420515,CHEMBL2056,Dopamine D1 receptor,Ki,=,820.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1c(O)ccc2c1CN1CCc3cc(OCCC)c(O)cc3[C@@H]1C2
CHEMBL5396616,CHEMBL2056,Dopamine D1 receptor,Ki,=,154.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OCCOCC)c3CN1CC2
CHEMBL5436253,CHEMBL2056,Dopamine D1 receptor,Ki,=,19.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1cc2c(cc1O)[C@@H]1Cc3c(Br)cc(O)c(OCC)c3CN1CC2
CHEMBL5399393,CHEMBL2056,Dopamine D1 receptor,Ki,=,147.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1cc2c(cc1O)[C@@H]1Cc3c(Br)cc(O)c(OCCC)c3CN1CC2
CHEMBL5412881,CHEMBL2056,Dopamine D1 receptor,Ki,=,108.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1cc2c(cc1O)[C@@H]1Cc3c(Br)cc(O)c(OCCCC)c3CN1CC2
CHEMBL5423775,CHEMBL2056,Dopamine D1 receptor,Ki,=,447.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1cc2c(cc1O)[C@@H]1Cc3c(Br)cc(O)c(OCCCCC)c3CN1CC2
CHEMBL5439661,CHEMBL2056,Dopamine D1 receptor,Ki,=,664.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1cc2c(cc1O)[C@@H]1Cc3c(Br)cc(O)c(OCCCCCC)c3CN1CC2
CHEMBL5394838,CHEMBL2056,Dopamine D1 receptor,Ki,=,85.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1cc2c(cc1O)[C@@H]1Cc3c(Br)cc(O)c(OCCOCC)c3CN1CC2
CHEMBL5439212,CHEMBL2056,Dopamine D1 receptor,Ki,=,11.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OCC)c3CN1CC2
CHEMBL5399422,CHEMBL2056,Dopamine D1 receptor,Ki,=,87.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OCCC)c3CN1CC2
CHEMBL5437148,CHEMBL2056,Dopamine D1 receptor,Ki,=,465.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OCCCCC)c3CN1CC2
CHEMBL5399933,CHEMBL2056,Dopamine D1 receptor,Ki,=,1014.0,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CCCCCCOc1cc2c(cc1O)[C@@H]1Cc3ccc(O)c(OCCCCCC)c3CN1CC2
CHEMBL8514,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.3,nM,CHEMBL5335367,B,Displacement of [3H]SCH-23390 from human dopamine D1 receptor assessed as inhibition constant,CHEMBL5331137,KI,CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc4cccc(c43)[C@@H]2C1
CHEMBL5403404,CHEMBL2056,Dopamine D1 receptor,Ki,=,690.0,nM,CHEMBL5339613,B,Binding affinity to human dopamine D1 receptor assessed as inhibition constant,CHEMBL5338720,KI,CCCN1CCN(c2ccc3c(c2)C(N(C)C(=O)OCc2ccccc2)CCC3)CC1
CHEMBL1201087,CHEMBL2056,Dopamine D1 receptor,Ki,=,1.4,nM,CHEMBL5346622,B,Binding affinity to dopamine D1 receptor (unknown origin) assessed as inhibition constant,CHEMBL5344475,KI,C=CCN1C[C@H](C(=O)N(CCCN(C)C)C(=O)NCC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL157138,CHEMBL2056,Dopamine D1 receptor,Ki,=,0.34,nM,CHEMBL5346622,B,Binding affinity to dopamine D1 receptor (unknown origin) assessed as inhibition constant,CHEMBL5344475,KI,CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1
CHEMBL5400232,CHEMBL2056,Dopamine D1 receptor,Ki,=,730.0,nM,CHEMBL5351452,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cells assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccccc2)CC1
CHEMBL5422870,CHEMBL2056,Dopamine D1 receptor,Ki,=,22.0,nM,CHEMBL5351452,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cells assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COCCOCCOc1ccc(NC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c(-c2ccccc2)c1
CHEMBL5394229,CHEMBL2056,Dopamine D1 receptor,Ki,=,16.0,nM,CHEMBL5351452,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cells assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)Nc2ccccc2-c2ccc(-c3ccccc3)cc2)CC1
CHEMBL5425252,CHEMBL2056,Dopamine D1 receptor,Ki,=,480.0,nM,CHEMBL5351452,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cells assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccccc1N1CCN(CCCNC(=O)NCc2ccccc2-c2ccccc2)CC1
CHEMBL5403204,CHEMBL2056,Dopamine D1 receptor,Ki,=,280.0,nM,CHEMBL5351452,B,Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293T cells assessed as inhibition constant by competition binding assay,CHEMBL5346968,KI,COc1ccc(-c2ccccc2)c(CNC(=O)NCCCN2CCN(c3ccccc3OC)CC2)c1
CHEMBL1423,CHEMBL2056,Dopamine D1 receptor,Ki,=,588.0,nM,CHEMBL5353629,B,Binding affinity to dopamine D1 receptor (unknown origin) assessed as inhibition constant,CHEMBL5352414,KI,O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL2028019,CHEMBL2056,Dopamine D1 receptor,Ki,=,2920.0,nM,CHEMBL5381018,B,Displacement of [3H]-SCH23390 from D1 receptor in HEK293 cell membranes by scintillation counting method,CHEMBL5380776,KI,CN(C)C(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5431103,CHEMBL2056,Dopamine D1 receptor,Ki,=,4600.0,nM,CHEMBL5381018,B,Displacement of [3H]-SCH23390 from D1 receptor in HEK293 cell membranes by scintillation counting method,CHEMBL5380776,KI,COCCC(=O)N[C@H]1CC[C@H](CCN2CCN(c3cccc(Cl)c3Cl)CC2)CC1
CHEMBL5404054,CHEMBL2056,Dopamine D1 receptor,Ki,=,5390.0,nM,CHEMBL5381018,B,Displacement of [3H]-SCH23390 from D1 receptor in HEK293 cell membranes by scintillation counting method,CHEMBL5380776,KI,CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)c4ccnc5ccccc45)CC3)CC2)c1Cl
CHEMBL5408223,CHEMBL2056,Dopamine D1 receptor,Ki,=,6800.0,nM,CHEMBL5381018,B,Displacement of [3H]-SCH23390 from D1 receptor in HEK293 cell membranes by scintillation counting method,CHEMBL5380776,KI,CCc1cccc(N2CCN(CC[C@H]3CC[C@H](NC(=O)COC)CC3)CC2)c1Cl
CHEMBL5437660,CHEMBL2056,Dopamine D1 receptor,Ki,=,8000.0,nM,CHEMBL5381018,B,Displacement of [3H]-SCH23390 from D1 receptor in HEK293 cell membranes by scintillation counting method,CHEMBL5380776,KI,CCc1cc(Cl)c(OC)c(N2CCN(CC[C@H]3CC[C@H](NC(=O)NC)CC3)CC2)c1
CHEMBL5426242,CHEMBL2056,Dopamine D1 receptor,Ki,=,188.5,nM,CHEMBL5385551,B,Displacement of [3H]-SCH23390 from Dopamine D1 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC3
CHEMBL5409419,CHEMBL2056,Dopamine D1 receptor,Ki,=,35.5,nM,CHEMBL5385551,B,Displacement of [3H]-SCH23390 from Dopamine D1 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC3
CHEMBL5426242,CHEMBL2056,Dopamine D1 receptor,Ki,=,190.55,nM,CHEMBL5385551,B,Displacement of [3H]-SCH23390 from Dopamine D1 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2ccc(=O)[nH]c2c1)CC3
CHEMBL5409419,CHEMBL2056,Dopamine D1 receptor,Ki,=,36.31,nM,CHEMBL5385551,B,Displacement of [3H]-SCH23390 from Dopamine D1 receptor (unknown origin) expressed in HEK293T cell membrane incubated for 2 hrs by radioligand competitive binding based MicroBeta TriLux reader method,CHEMBL5380874,KI,COc1cccc2c3c(oc12)CN(CCCCOc1ccc2c(c1)NC(=O)CC2)CC3
CHEMBL1256876,CHEMBL2056,Dopamine D1 receptor,Ki,=,9.257,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cl.NC[C@@H]1O[C@H](C23CC4CC(CC(C4)C2)C3)Cc2c1ccc(O)c2O
CHEMBL1489369,CHEMBL2056,Dopamine D1 receptor,Ki,=,2.92,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Br.CN1CCc2cc(Br)c(O)cc2C(c2ccccc2)C1
CHEMBL43383,CHEMBL2056,Dopamine D1 receptor,Ki,=,740.29,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CCN(CC)CCCCC1CCN(CC(=O)N2c3ccccc3C(=O)Nc3cccnc32)CC1
CHEMBL405355,CHEMBL2056,Dopamine D1 receptor,Ki,=,370.43,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,COC(=O)C1=C(C)NC(C)=C(C(=O)OCCCN2CCC(c3ccccc3)(c3ccccc3)CC2)[C@H]1c1cccc([N+](=O)[O-])c1
CHEMBL9387,CHEMBL2056,Dopamine D1 receptor,Ki,=,3019.95,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1cccc(NC(=O)N[C@@H]2N=C(c3ccccc3)c3ccccc3N(C)C2=O)c1
CHEMBL445102,CHEMBL2056,Dopamine D1 receptor,Ki,=,1077.96,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,OC1(c2ccc(Cl)cc2)CCN(Cc2c[nH]c3ccccc23)CC1
CHEMBL281350,CHEMBL2056,Dopamine D1 receptor,Ki,=,369.36,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1nc(-c2ccc(-c3ccc(C(=O)N4CCc5cc6c(cc54)C4(CCN(C)CC4)CO6)cc3)c(C)c2)no1
CHEMBL103769,CHEMBL2056,Dopamine D1 receptor,Ki,=,1717.71,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,S=C(NCCCc1c[nH]cn1)NCCCN(Cc1ccc(Cl)c(Cl)c1)c1ccc(Br)cn1
CHEMBL74355,CHEMBL2056,Dopamine D1 receptor,Ki,=,859.31,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,COc1cccc([C@H](O)C2CCN(CCc3ccc(F)cc3)CC2)c1OC
CHEMBL267777,CHEMBL2056,Dopamine D1 receptor,Ki,=,330.14,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1
CHEMBL499,CHEMBL2056,Dopamine D1 receptor,Ki,=,5280.8,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1
CHEMBL1200809,CHEMBL2056,Dopamine D1 receptor,Ki,=,577.17,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1CCCC(n2nc(Cc3ccc(Cl)cc3)c3ccccc3c2=O)CC1.Cl
CHEMBL1633,CHEMBL2056,Dopamine D1 receptor,Ki,=,299.47,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1.O=C(O)/C=C/C(=O)O
CHEMBL1200492,CHEMBL2056,Dopamine D1 receptor,Ki,=,711.62,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CCc1nn(CCCN2CCN(c3cccc(Cl)c3)CC2)c(=O)n1CCOc1ccccc1.Cl
CHEMBL2105760,CHEMBL2056,Dopamine D1 receptor,Ki,=,37.46,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,O=c1ccc2ccc(OCCCCN3CCN(c4cccc5sccc45)CC3)cc2[nH]1
CHEMBL5076314,CHEMBL2056,Dopamine D1 receptor,Ki,=,4543.6,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,CN1CCN(c2ccc(Nc3c4ccccc4nc4ccccc34)cc2)CC1.Cl.Cl.O
CHEMBL540612,CHEMBL2056,Dopamine D1 receptor,Ki,=,412.0,nM,CHEMBL5442197,B,"PDSP Secondary Binding target: DRD1 - Compounds are tested at 10 uM concentration, plate are incubated at room temperature in the dark for 90 minutes. Reaction are stopped by vacuum filtration onto 0.3% polyethyleneimine soaked filter mats using Filtermate harvester. Scintillation cocktail is then melted onto microwave-dried filters on a hot plate and the radio activity is counted in Microbia counter. Compounds showing a minimum of 50% inhibition at 10 uM concentration are carried forward in this secondary binding assay to determine equilibrium binding affinity.",CHEMBL5442175,KI,COc1ccccc1N1CCN(CCCCNC(=O)c2ccc3ccccc3c2)CC1.Cl
CHEMBL4580220,CHEMBL2056,Dopamine D1 receptor,Ki,=,634.31,nM,CHEMBL5476306,B,Selectivity interaction (GPCR panel (PDSP screen)) EUB0000311b DRD1,CHEMBL5465560,KI,CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12
CHEMBL25856,CHEMBL2056,Dopamine D1 receptor,EC50,=,14.0,nM,CHEMBL672093,B,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D1,CHEMBL1128531,EC50,Oc1cc2c(cc1O)[C@H]1c3ccccc3CN[C@@H]1CC2
CHEMBL291143,CHEMBL2056,Dopamine D1 receptor,EC50,=,3.0,nM,CHEMBL672093,B,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D1,CHEMBL1128531,EC50,NC[C@@H]1O[C@H](C23CC4CC(CC(C4)C2)C3)Cc2c1ccc(O)c2O
CHEMBL24077,CHEMBL2056,Dopamine D1 receptor,EC50,=,59.0,nM,CHEMBL672093,B,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D1,CHEMBL1128531,EC50,Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2
CHEMBL28338,CHEMBL2056,Dopamine D1 receptor,EC50,=,9.0,nM,CHEMBL672093,B,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D1,CHEMBL1128531,EC50,CCCc1cc2c(s1)CN[C@@H]1CCc3cc(O)c(O)cc3[C@@H]21
CHEMBL544814,CHEMBL2056,Dopamine D1 receptor,EC50,=,1700.0,nM,CHEMBL672093,B,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D1,CHEMBL1128531,EC50,CCCc1cc2c(s1)CN[C@H]1CCc3cc(O)c(O)cc3[C@H]21.Cl
CHEMBL59,CHEMBL2056,Dopamine D1 receptor,EC50,=,100.0,nM,CHEMBL672093,B,Adenylate cyclase assay carried out in LTK cells transfected with human Dopamine receptor D1,CHEMBL1128531,EC50,NCCc1ccc(O)c(O)c1
CHEMBL286080,CHEMBL2056,Dopamine D1 receptor,EC50,=,247.5,nM,CHEMBL3888604,B,"[35S]GTPγS Binding Assay: For detecting the agonism action of the compounds, the [35S]GTPγS binding assay was performed at 30° C. for 40 mins in reaction buffer containing 50 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EDTA, 100 mM NaCl and 1 mM (DL)-dithiothreitol (DTT). The assay mixture (200 μL) contained 30 μg of membraneprotein, 0.1 nM [35S]GTPγS, and 40 μM guanosine triphosphate (GDP) with various concentration of the compound. The D1 receptor agonist SKF38393 and sntagonist SCH23390 were used for reference. Non specific binding was measured in the presence of 100 μM 50-guanylimidodiphosphate (Gpp(NH)p). The reaction was terminated by adding 3 mL of ice-cold washing buffer (50 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EDTA, and 100 mM NaCl) and was rapidly filtered with GF/C glass fiber filters (Whatman) and rinsed for three times.",CHEMBL3886775,EC50,Oc1cc2c(cc1O)C(c1ccccc1)CNCC2
CHEMBL4435882,CHEMBL2056,Dopamine D1 receptor,EC50,=,41.69,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,COc1cccc(-c2cc3c(c(OC(C)=O)c2OC(C)=O)-c2cccc4c2[C@@H](C3)N(C)CC4)c1
CHEMBL4437552,CHEMBL2056,Dopamine D1 receptor,EC50,=,0.3802,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCc1cc2c(c(OC(C)=O)c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL4523054,CHEMBL2056,Dopamine D1 receptor,EC50,=,14.45,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CC(=O)Oc1c(C)cc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL4589737,CHEMBL2056,Dopamine D1 receptor,EC50,=,0.7943,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,COc1ccc2c(c1OC)-c1ccc(C)c3c1[C@@H](C2)N(C)CC3
CHEMBL4442011,CHEMBL2056,Dopamine D1 receptor,EC50,=,251.19,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCc1ccc2c3c1CCN(C)[C@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL4439029,CHEMBL2056,Dopamine D1 receptor,EC50,=,37.15,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCc1ccc2c3c1CCN(C)[C@@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL53,CHEMBL2056,Dopamine D1 receptor,EC50,=,501.19,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL4591021,CHEMBL2056,Dopamine D1 receptor,EC50,=,7.943,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,COCOc1ccc2c(c1OCOC)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL225230,CHEMBL2056,Dopamine D1 receptor,EC50,=,1862.09,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL4555547,CHEMBL2056,Dopamine D1 receptor,EC50,=,5011.87,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(OC(C)=O)c(OC(C)=O)c1-3
CHEMBL4470553,CHEMBL2056,Dopamine D1 receptor,EC50,=,1949.84,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCCN1CCc2cccc3c2[C@H]1Cc1ccc2c(c1-3)OCO2
CHEMBL53,CHEMBL2056,Dopamine D1 receptor,EC50,=,520.8,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL4439029,CHEMBL2056,Dopamine D1 receptor,EC50,=,36.86,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCc1ccc2c3c1CCN(C)[C@@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL4442011,CHEMBL2056,Dopamine D1 receptor,EC50,=,246.8,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCc1ccc2c3c1CCN(C)[C@H]3Cc1ccc(OC)c(OC)c1-2
CHEMBL4589737,CHEMBL2056,Dopamine D1 receptor,EC50,=,0.8,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,COc1ccc2c(c1OC)-c1ccc(C)c3c1[C@@H](C2)N(C)CC3
CHEMBL4523054,CHEMBL2056,Dopamine D1 receptor,EC50,=,14.45,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CC(=O)Oc1c(C)cc2c(c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL4437552,CHEMBL2056,Dopamine D1 receptor,EC50,=,0.38,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCc1cc2c(c(OC(C)=O)c1OC(C)=O)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL4435882,CHEMBL2056,Dopamine D1 receptor,EC50,=,41.36,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,COc1cccc(-c2cc3c(c(OC(C)=O)c2OC(C)=O)-c2cccc4c2[C@@H](C3)N(C)CC4)c1
CHEMBL4591021,CHEMBL2056,Dopamine D1 receptor,EC50,=,8.45,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,COCOc1ccc2c(c1OCOC)-c1cccc3c1[C@@H](C2)N(C)CC3
CHEMBL225230,CHEMBL2056,Dopamine D1 receptor,EC50,=,1884.0,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL4555547,CHEMBL2056,Dopamine D1 receptor,EC50,=,5496.0,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(OC(C)=O)c(OC(C)=O)c1-3
CHEMBL4470553,CHEMBL2056,Dopamine D1 receptor,EC50,=,1949.0,nM,CHEMBL4345326,B,Agonist activity at C-terminal RLuc8-fused D1R (unknown origin) transfected in human HEK293T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 5 mins in presence of coelenterazine H by BRET assay,CHEMBL4342494,EC50,CCCN1CCc2cccc3c2[C@H]1Cc1ccc2c(c1-3)OCO2
CHEMBL1196161,CHEMBL2056,Dopamine D1 receptor,EC50,=,2.3,nM,CHEMBL4371579,B,Agonist activity at human dopamine D1 receptor expressed in CHOK1 cells assessed as assessed as increase in beta-arrestin-2 recruitment after 60 mins by luminescence assay,CHEMBL4371007,EC50,C=CCN1CCc2c(cc(O)c(O)c2Cl)C(c2cccc(C)c2)C1
CHEMBL1160787,CHEMBL2056,Dopamine D1 receptor,EC50,=,13.2,nM,CHEMBL4371579,B,Agonist activity at human dopamine D1 receptor expressed in CHOK1 cells assessed as assessed as increase in beta-arrestin-2 recruitment after 60 mins by luminescence assay,CHEMBL4371007,EC50,Oc1cc2c(c(Cl)c1O)CCNC[C@@H]2c1ccccc1
CHEMBL35354,CHEMBL2056,Dopamine D1 receptor,EC50,=,2.0,nM,CHEMBL4371579,B,Agonist activity at human dopamine D1 receptor expressed in CHOK1 cells assessed as assessed as increase in beta-arrestin-2 recruitment after 60 mins by luminescence assay,CHEMBL4371007,EC50,C=CCN1CCc2c(cc(O)c(O)c2Cl)C(c2ccccc2)C1
CHEMBL588,CHEMBL2056,Dopamine D1 receptor,EC50,=,31.7,nM,CHEMBL4371579,B,Agonist activity at human dopamine D1 receptor expressed in CHOK1 cells assessed as assessed as increase in beta-arrestin-2 recruitment after 60 mins by luminescence assay,CHEMBL4371007,EC50,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1
CHEMBL4519818,CHEMBL2056,Dopamine D1 receptor,EC50,=,165.0,nM,CHEMBL4372478,B,Positive allosteric modulation of D1R (unknown origin) by HTS assay,CHEMBL4371045,EC50,C[C@H]1c2ccccc2CCN1C(=O)Cc1c(Cl)cccc1Cl
CHEMBL4465320,CHEMBL2056,Dopamine D1 receptor,EC50,=,1870.0,nM,CHEMBL4372478,B,Positive allosteric modulation of D1R (unknown origin) by HTS assay,CHEMBL4371045,EC50,CC1c2ccsc2CCN1C(=O)Nc1c(Cl)cccc1Cl
CHEMBL4277264,CHEMBL2056,Dopamine D1 receptor,EC50,=,110.0,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12
CHEMBL4277264,CHEMBL2056,Dopamine D1 receptor,EC50,=,114.82,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12
CHEMBL4439333,CHEMBL2056,Dopamine D1 receptor,EC50,=,2600.0,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)nc2cnccn12
CHEMBL4439333,CHEMBL2056,Dopamine D1 receptor,EC50,=,2570.4,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)nc2cnccn12
CHEMBL4294397,CHEMBL2056,Dopamine D1 receptor,EC50,=,180.0,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12
CHEMBL4294397,CHEMBL2056,Dopamine D1 receptor,EC50,=,177.83,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12
CHEMBL4591207,CHEMBL2056,Dopamine D1 receptor,EC50,=,1100.0,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1cc(Oc2nccc3occc23)ccc1-c1cc(N)cnc1C
CHEMBL4591207,CHEMBL2056,Dopamine D1 receptor,EC50,=,1122.02,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1cc(Oc2nccc3occc23)ccc1-c1cc(N)cnc1C
CHEMBL4450338,CHEMBL2056,Dopamine D1 receptor,EC50,=,210.0,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1N
CHEMBL4450338,CHEMBL2056,Dopamine D1 receptor,EC50,=,208.93,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1N
CHEMBL4572614,CHEMBL2056,Dopamine D1 receptor,EC50,=,230.0,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F
CHEMBL4572614,CHEMBL2056,Dopamine D1 receptor,EC50,=,229.09,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1ncc2nccn2c1-c1ccc(Oc2nccc3occc23)cc1C(F)(F)F
CHEMBL4465393,CHEMBL2056,Dopamine D1 receptor,EC50,=,22.0,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1cc(Oc2nccc3ccsc23)ccc1-c1c(C)ncc2nccn12
CHEMBL4465393,CHEMBL2056,Dopamine D1 receptor,EC50,=,21.38,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1cc(Oc2nccc3ccsc23)ccc1-c1c(C)ncc2nccn12
CHEMBL4467080,CHEMBL2056,Dopamine D1 receptor,EC50,=,690.0,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1cc(Oc2nccn3cccc23)ccc1-c1c(C)ncc2nccn12
CHEMBL4467080,CHEMBL2056,Dopamine D1 receptor,EC50,=,691.83,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Cc1cc(Oc2nccn3cccc23)ccc1-c1c(C)ncc2nccn12
CHEMBL4548284,CHEMBL2056,Dopamine D1 receptor,EC50,=,790.0,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Nc1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12
CHEMBL4548284,CHEMBL2056,Dopamine D1 receptor,EC50,=,794.33,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,Nc1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12
CHEMBL4469848,CHEMBL2056,Dopamine D1 receptor,EC50,=,270.0,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12
CHEMBL4469848,CHEMBL2056,Dopamine D1 receptor,EC50,=,269.15,nM,CHEMBL4392122,B,Agonist activity at recombinant C-terminal RLuc8-fused human D1 receptor expressed in HEK29T cells co-expressing N-terminal Venus-tagged beta-arrestin2 assessed as increase in beta-arrestin2 recruitment measured after 15 mins in presence of coelenterazine H by BRET assay,CHEMBL4390674,EC50,FC(F)(F)c1cc(Oc2nccc3occc23)ccc1-c1cccc2nccn12
CHEMBL353335,CHEMBL2056,Dopamine D1 receptor,EC50,=,9500.0,nM,CHEMBL4397363,B,Agonist activity at recombinant human D1 receptor expressed in CHOK1 cells assessed as induction of beta arrestin2 recruitment measured after 30 mins by coelenterazine-based beta-galactosidase reporter gene assay,CHEMBL4396871,EC50,Oc1cc2c(c(Cl)c1O)CCNCC2c1ccccc1
CHEMBL292418,CHEMBL2056,Dopamine D1 receptor,EC50,=,40.4,nM,CHEMBL4397364,B,Antagonist activity at recombinant human D1 receptor expressed in CHOK1 cells assessed as inhibition of SKF81297-induced beta arrestin2 recruitment preincubated for 30 mins followed by SKF81297 addition and measured after 90 mins by coelenterazine-based beta-galactosidase reporter gene assay,CHEMBL4396871,EC50,Oc1cc2c(cc1Cl)CCNCC2c1ccccc1
CHEMBL59,CHEMBL2056,Dopamine D1 receptor,EC50,=,1400.0,nM,CHEMBL4433965,B,Agonist activity at wild type human D1R expressed in HEK293 cells assessed as effect on beta-arrestin2 recruitment by PRESTO-Tango beta-arrestin2 recruitment assay,CHEMBL4433225,EC50,NCCc1ccc(O)c(O)c1
CHEMBL353335,CHEMBL2056,Dopamine D1 receptor,EC50,=,360.0,nM,CHEMBL4433965,B,Agonist activity at wild type human D1R expressed in HEK293 cells assessed as effect on beta-arrestin2 recruitment by PRESTO-Tango beta-arrestin2 recruitment assay,CHEMBL4433225,EC50,Oc1cc2c(c(Cl)c1O)CCNCC2c1ccccc1
CHEMBL4469983,CHEMBL2056,Dopamine D1 receptor,EC50,=,490.0,nM,CHEMBL4433965,B,Agonist activity at wild type human D1R expressed in HEK293 cells assessed as effect on beta-arrestin2 recruitment by PRESTO-Tango beta-arrestin2 recruitment assay,CHEMBL4433225,EC50,Cc1n[nH]c(=O)c(C)c1-c1ccc(Oc2nccc3occc23)cc1F
CHEMBL4277264,CHEMBL2056,Dopamine D1 receptor,EC50,=,320.0,nM,CHEMBL4433965,B,Agonist activity at wild type human D1R expressed in HEK293 cells assessed as effect on beta-arrestin2 recruitment by PRESTO-Tango beta-arrestin2 recruitment assay,CHEMBL4433225,EC50,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)ncc2nccn12
CHEMBL4437012,CHEMBL2056,Dopamine D1 receptor,EC50,=,1100.0,nM,CHEMBL4433965,B,Agonist activity at wild type human D1R expressed in HEK293 cells assessed as effect on beta-arrestin2 recruitment by PRESTO-Tango beta-arrestin2 recruitment assay,CHEMBL4433225,EC50,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)cnnc1C
CHEMBL4453318,CHEMBL2056,Dopamine D1 receptor,EC50,=,35.0,nM,CHEMBL4433965,B,Agonist activity at wild type human D1R expressed in HEK293 cells assessed as effect on beta-arrestin2 recruitment by PRESTO-Tango beta-arrestin2 recruitment assay,CHEMBL4433225,EC50,Cc1cc(Oc2nccc3occc23)ccc1-c1c(C)c(=O)[nH]c(=O)n1C
CHEMBL4796389,CHEMBL2056,Dopamine D1 receptor,EC50,=,840.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cn1c2ccccc2c(=O)c2c(=O)n(-c3ccccc3)c(C3CC3)nc21
CHEMBL4740312,CHEMBL2056,Dopamine D1 receptor,EC50,=,650.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cn1c2ccccc2c(=O)c2c(=O)[nH]c(C3CCCC3)nc21
CHEMBL4759814,CHEMBL2056,Dopamine D1 receptor,EC50,=,1800.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,COc1ccc(-n2c(CC3CCCCC3)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1Cl
CHEMBL4796761,CHEMBL2056,Dopamine D1 receptor,EC50,=,1500.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cn1c2ccccc2c(=O)c2c(=O)n(-c3cccc(Cl)c3)c(CC3CCCCC3)nc21
CHEMBL4787728,CHEMBL2056,Dopamine D1 receptor,EC50,=,1500.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cn1c2ccccc2c(=O)c2c(=O)n(-c3ccc(Cl)cc3)c(CC3CCCCC3)nc21
CHEMBL4740497,CHEMBL2056,Dopamine D1 receptor,EC50,=,1400.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cc1ccc(-n2c(CC3CCCCC3)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1
CHEMBL4754761,CHEMBL2056,Dopamine D1 receptor,EC50,=,1600.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cn1c2ccccc2c(=O)c2c(=O)n(-c3ccccc3)c(CC3CCCCC3)nc21
CHEMBL4755709,CHEMBL2056,Dopamine D1 receptor,EC50,=,580.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,COc1ccc(-n2c(C3CCCC3)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1Cl
CHEMBL4754602,CHEMBL2056,Dopamine D1 receptor,EC50,=,150.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,COc1ccc(-n2c(C3CCCC3)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1
CHEMBL4744261,CHEMBL2056,Dopamine D1 receptor,EC50,=,160.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cn1c2ccccc2c(=O)c2c(=O)n(-c3cccc(Cl)c3)c(C3CCCC3)nc21
CHEMBL4755481,CHEMBL2056,Dopamine D1 receptor,EC50,=,320.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cn1c2ccccc2c(=O)c2c(=O)n(-c3ccc(Cl)cc3)c(C3CCCC3)nc21
CHEMBL4759339,CHEMBL2056,Dopamine D1 receptor,EC50,=,200.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cc1ccc(-n2c(C3CCCC3)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1
CHEMBL4784295,CHEMBL2056,Dopamine D1 receptor,EC50,=,320.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cn1c2ccccc2c(=O)c2c(=O)n(-c3ccccc3)c(C3CCCC3)nc21
CHEMBL4790277,CHEMBL2056,Dopamine D1 receptor,EC50,=,510.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,COc1ccc(-n2c(CC(C)C)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1Cl
CHEMBL4756163,CHEMBL2056,Dopamine D1 receptor,EC50,=,150.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,COc1ccc(-n2c(CC(C)C)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1
CHEMBL4784143,CHEMBL2056,Dopamine D1 receptor,EC50,=,630.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,CC(C)Cc1nc2c(c(=O)c3ccccc3n2C)c(=O)n1-c1cccc(Cl)c1
CHEMBL4779641,CHEMBL2056,Dopamine D1 receptor,EC50,=,380.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,CC(C)Cc1nc2c(c(=O)c3ccccc3n2C)c(=O)n1-c1ccc(Cl)cc1
CHEMBL4790909,CHEMBL2056,Dopamine D1 receptor,EC50,=,370.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cc1ccc(-n2c(CC(C)C)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1
CHEMBL4760355,CHEMBL2056,Dopamine D1 receptor,EC50,=,180.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,CC(C)Cc1nc2c(c(=O)c3ccccc3n2C)c(=O)n1-c1ccccc1
CHEMBL4764398,CHEMBL2056,Dopamine D1 receptor,EC50,=,830.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,COc1ccc(-n2c(C3CCCCC3)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1Cl
CHEMBL4740678,CHEMBL2056,Dopamine D1 receptor,EC50,=,410.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,COc1ccc(-n2c(C3CCCCC3)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1
CHEMBL4756486,CHEMBL2056,Dopamine D1 receptor,EC50,=,1190.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cn1c2ccccc2c(=O)c2c(=O)n(-c3cccc(Cl)c3)c(C3CCCCC3)nc21
CHEMBL4789255,CHEMBL2056,Dopamine D1 receptor,EC50,=,800.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cn1c2ccccc2c(=O)c2c(=O)n(-c3ccc(Cl)cc3)c(C3CCCCC3)nc21
CHEMBL4762375,CHEMBL2056,Dopamine D1 receptor,EC50,=,510.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cc1ccc(-n2c(C3CCCCC3)nc3c(c(=O)c4ccccc4n3C)c2=O)cc1
CHEMBL1311333,CHEMBL2056,Dopamine D1 receptor,EC50,=,320.0,nM,CHEMBL4677859,B,Positive allosteric modulator activity at human dopamine D1 receptor expressed in CHO-K1 cells assessed as potentiation of dopamine-induced beta-arrestin2 recruitment by measuring dopamine EC50 at 50 uM incubated for 90 mins by PathHunter assay (Rvb = 1.4 uM),CHEMBL4673311,EC50,Cn1c2ccccc2c(=O)c2c(=O)n(-c3ccccc3)c(C3CCCCC3)nc21
CHEMBL4468760,CHEMBL2056,Dopamine D1 receptor,EC50,=,11.7,nM,CHEMBL5104730,B,Positive allosteric modulation of human D1 receptor in HEK293 cells assessed as increase in cyclic AMP production measured after 60 mins in presence of dopamine by HTRF assay,CHEMBL5104100,EC50,C[C@H]1c2cccc(-c3cnn(C)c3)c2C[C@H](CO)N1C(=O)Cc1c(Cl)cccc1Cl
CHEMBL4464150,CHEMBL2056,Dopamine D1 receptor,EC50,=,6.41,nM,CHEMBL5104730,B,Positive allosteric modulation of human D1 receptor in HEK293 cells assessed as increase in cyclic AMP production measured after 60 mins in presence of dopamine by HTRF assay,CHEMBL5104100,EC50,C[C@H]1c2cccc(-c3cn[nH]c3)c2C[C@H](CO)N1C(=O)Cc1c(Cl)cccc1Cl
CHEMBL4573538,CHEMBL2056,Dopamine D1 receptor,EC50,=,15.9,nM,CHEMBL5104730,B,Positive allosteric modulation of human D1 receptor in HEK293 cells assessed as increase in cyclic AMP production measured after 60 mins in presence of dopamine by HTRF assay,CHEMBL5104100,EC50,CCn1cc(-c2cccc3c2C[C@H](CO)N(C(=O)Cc2c(Cl)cccc2Cl)[C@H]3C)cn1
CHEMBL4559891,CHEMBL2056,Dopamine D1 receptor,EC50,=,10.3,nM,CHEMBL5104730,B,Positive allosteric modulation of human D1 receptor in HEK293 cells assessed as increase in cyclic AMP production measured after 60 mins in presence of dopamine by HTRF assay,CHEMBL5104100,EC50,C[C@H]1c2cccc(-c3cnn(C4CC4)c3)c2C[C@H](CO)N1C(=O)Cc1c(Cl)cccc1Cl
CHEMBL5187909,CHEMBL2056,Dopamine D1 receptor,EC50,=,25.6,nM,CHEMBL5104730,B,Positive allosteric modulation of human D1 receptor in HEK293 cells assessed as increase in cyclic AMP production measured after 60 mins in presence of dopamine by HTRF assay,CHEMBL5104100,EC50,C[C@H]1c2cccc(-c3cnn(C4COC4)c3)c2C[C@H](CO)N1C(=O)Cc1c(Cl)cccc1Cl
CHEMBL150800,CHEMBL2056,Dopamine D1 receptor,Kd,=,0.28,nM,CHEMBL671941,B,Ability to inhibit [3H]-SCH- 23390 binding to Dopamine receptor D1 of canine striatal membranes,CHEMBL1125039,KD,CN1CCc2cc(I)c(O)cc2[C@H](c2ccc(N=[N+]=[N-])cc2)C1
CHEMBL62,CHEMBL2056,Dopamine D1 receptor,Kd,=,0.38,nM,CHEMBL671942,B,Ability to inhibit the binding of [3H]-SCH- 23390 to canine striatal membrane,CHEMBL1123996,KD,CN1CCc2cc(Cl)c(O)cc2[C@@H](c2ccccc2)C1
CHEMBL434215,CHEMBL2056,Dopamine D1 receptor,Kd,=,0.15,nM,CHEMBL671942,B,Ability to inhibit the binding of [3H]-SCH- 23390 to canine striatal membrane,CHEMBL1123996,KD,CN1CCc2cc(I)c(O)cc2C(c2ccc(N=[N+]=[N-])cc2)C1
CHEMBL39,CHEMBL2056,Dopamine D1 receptor,Kd,=,9690.0,nM,CHEMBL669035,B,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,CHEMBL1129489,KD,NCCc1c[nH]c2ccc(O)cc12
CHEMBL24077,CHEMBL2056,Dopamine D1 receptor,Kd,=,150.0,nM,CHEMBL669035,B,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,CHEMBL1129489,KD,Oc1cc2c(cc1O)[C@@H](c1ccccc1)CNCC2
CHEMBL53,CHEMBL2056,Dopamine D1 receptor,Kd,=,680.0,nM,CHEMBL669035,B,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,CHEMBL1129489,KD,CN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL679,CHEMBL2056,Dopamine D1 receptor,Kd,=,55000.0,nM,CHEMBL669035,B,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,CHEMBL1129489,KD,CNC[C@H](O)c1ccc(O)c(O)c1
CHEMBL1161520,CHEMBL2056,Dopamine D1 receptor,Kd,=,1818.0,nM,CHEMBL669035,B,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,CHEMBL1129489,KD,Oc1ccc([C@@H]2CNCCc3c2cc(O)c(O)c3Cl)cc1
CHEMBL225230,CHEMBL2056,Dopamine D1 receptor,Kd,=,1816.0,nM,CHEMBL669035,B,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,CHEMBL1129489,KD,CCCN1CCc2cccc3c2[C@H]1Cc1ccc(O)c(O)c1-3
CHEMBL1437,CHEMBL2056,Dopamine D1 receptor,Kd,=,50000.0,nM,CHEMBL669035,B,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,CHEMBL1129489,KD,NC[C@H](O)c1ccc(O)c(O)c1
CHEMBL588,CHEMBL2056,Dopamine D1 receptor,Kd,=,28.0,nM,CHEMBL669035,B,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,CHEMBL1129489,KD,Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1
CHEMBL611801,CHEMBL2056,Dopamine D1 receptor,Kd,=,4600.0,nM,CHEMBL669035,B,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,CHEMBL1129489,KD,CN(C)C1CCc2cc(O)c(O)cc2C1
CHEMBL34095,CHEMBL2056,Dopamine D1 receptor,Kd,=,384.0,nM,CHEMBL671028,B,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,CHEMBL1129489,KD,C=CCN1CCc2c(cc(O)c(O)c2Br)[C@@H](c2ccccc2)C1
CHEMBL59,CHEMBL2056,Dopamine D1 receptor,Kd,=,2500.0,nM,CHEMBL669035,B,Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells,CHEMBL1129489,KD,NCCc1ccc(O)c(O)c1
CHEMBL388509,CHEMBL2056,Dopamine D1 receptor,Kd,=,600.0,nM,CHEMBL889373,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor in lamb striatum membrane after 1 hr,CHEMBL1145382,KD,CC(C)[C@H](NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N1CCC[C@H]1C(N)=O
CHEMBL436797,CHEMBL2056,Dopamine D1 receptor,Kd,=,700.0,nM,CHEMBL889373,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor in lamb striatum membrane after 1 hr,CHEMBL1145382,KD,CC(C)[C@H](NC(=O)[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N1CCC[C@H]1C(N)=O
CHEMBL388732,CHEMBL2056,Dopamine D1 receptor,Kd,=,7800.0,nM,CHEMBL889373,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor in lamb striatum membrane after 1 hr,CHEMBL1145382,KD,CC(C)[C@H](NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1)C(=O)N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N1CCC[C@H]1C(N)=O
CHEMBL226639,CHEMBL2056,Dopamine D1 receptor,Kd,=,1200.0,nM,CHEMBL889373,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor in lamb striatum membrane after 1 hr,CHEMBL1145382,KD,CC(C)[C@H](NC(=O)[C@H](CCC1CCCCC1)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1)C(=O)N1CCC[C@H]1C(N)=O
CHEMBL390299,CHEMBL2056,Dopamine D1 receptor,Kd,=,700.0,nM,CHEMBL889373,B,Displacement of [3H]SCH 23390 from dopamine D1 receptor in lamb striatum membrane after 1 hr,CHEMBL1145382,KD,CN1C[C@H](C(=O)N[C@@H](Cc2ccc([N+](=O)[O-])cc2)C(=O)N[C@@H](Cc2ccc(F)cc2)C(=O)N2CCCC(C(N)=O)C2)C=C2c3cccc4[nH]cc(c34)C[C@H]21
CHEMBL3423409,CHEMBL2056,Dopamine D1 receptor,Kd,=,3300.0,nM,CHEMBL3423745,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N[C@@H](CCCCN)C(N)=O
CHEMBL3423408,CHEMBL2056,Dopamine D1 receptor,Kd,=,4000.0,nM,CHEMBL3423745,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N1C[C@@H](N)C[C@H]1C(N)=O
CHEMBL3423407,CHEMBL2056,Dopamine D1 receptor,Kd,=,1300.0,nM,CHEMBL3423745,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)c(F)c1)C(=O)N[C@@H](CCCCN)C(N)=O
CHEMBL3423406,CHEMBL2056,Dopamine D1 receptor,Kd,=,1900.0,nM,CHEMBL3423745,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O
CHEMBL3423405,CHEMBL2056,Dopamine D1 receptor,Kd,=,3400.0,nM,CHEMBL3423745,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1C[C@@H](N)C[C@H]1C(N)=O
CHEMBL3423404,CHEMBL2056,Dopamine D1 receptor,Kd,=,1200.0,nM,CHEMBL3423745,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O
CHEMBL3423403,CHEMBL2056,Dopamine D1 receptor,Kd,=,15000.0,nM,CHEMBL3423745,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@@H]1CCCN1C(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL3423402,CHEMBL2056,Dopamine D1 receptor,Kd,=,2900.0,nM,CHEMBL3423745,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H]1CCCN1C(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL3423401,CHEMBL2056,Dopamine D1 receptor,Kd,=,38000.0,nM,CHEMBL3423745,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)CCCCCNC(=O)[C@H]1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCCCN)C(N)=O
CHEMBL3423400,CHEMBL2056,Dopamine D1 receptor,Kd,=,27000.0,nM,CHEMBL3423745,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,CCCC[C@H](NC(=O)[C@H]1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1)C(=O)N[C@@H](Cc1ccc(F)cc1)C(=O)N1C[C@@H](N)C[C@H]1C(N)=O
CHEMBL3423410,CHEMBL2056,Dopamine D1 receptor,Kd,=,1500.0,nM,CHEMBL3423748,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@H]1CCCN1C(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL3423411,CHEMBL2056,Dopamine D1 receptor,Kd,=,1600.0,nM,CHEMBL3423748,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes assessed as high affinity constant after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@H]1CCCN1C(=O)CCCCCNC(=O)[C@@H]1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL3423410,CHEMBL2056,Dopamine D1 receptor,Kd,=,24000.0,nM,CHEMBL3423753,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@H]1CCCN1C(=O)CCCCCNC(=O)[C@H]1CC[C@@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL3423411,CHEMBL2056,Dopamine D1 receptor,Kd,=,30000.0,nM,CHEMBL3423753,B,Displacement of [3H]-SCH23390 from dopamine D1 receptor (unknown origin) expressed in sheep striatum membranes assessed as low affinity constant after 1.5 hrs by scintillation counting analysis,CHEMBL3421581,KD,NCCCC[C@H](NC(=O)[C@H](Cc1ccc(F)c(F)c1)NC(=O)[C@H]1CCCN1C(=O)CCCCCNC(=O)[C@@H]1CC[C@H]2c3[nH]c4ccccc4c3CCN2C1)C(N)=O
CHEMBL5207281,CHEMBL2056,Dopamine D1 receptor,Kd,=,0.23,nM,CHEMBL5151485,B,Displacement of [3H]SCH23390 from human D1 receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 60 mins by scintillation counting analysis,CHEMBL5149991,KD,CCCCCNC(=O)/N=C(\N)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5206565,CHEMBL2056,Dopamine D1 receptor,Kd,=,0.23,nM,CHEMBL5151485,B,Displacement of [3H]SCH23390 from human D1 receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 60 mins by scintillation counting analysis,CHEMBL5149991,KD,N/C(=N\C(=O)NCc1ccccc1)NCCCc1nnc(N)s1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F
CHEMBL5201074,CHEMBL2056,Dopamine D1 receptor,Kd,=,0.23,nM,CHEMBL5151485,B,Displacement of [3H]SCH23390 from human D1 receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 60 mins by scintillation counting analysis,CHEMBL5149991,KD,C[C@@H](NC(=O)/N=C(\N)NCCCc1ncn[nH]1)c1ccccc1.Cl.Cl
CHEMBL4860528,CHEMBL2056,Dopamine D1 receptor,Kd,=,0.23,nM,CHEMBL5151485,B,Displacement of [3H]SCH23390 from human D1 receptor stably expressed in HEK293T cells co-expressing luciferase and CEK incubated for 60 mins by scintillation counting analysis,CHEMBL5149991,KD,CCCCCNC(=O)/N=C(\N)NCCCc1sc(N)nc1C
